+ All Categories
Home > Documents > ACTION: Final ENACTED DATE: 08/19/2011 4:16 PM Appendix ......Representative brand name (If one is...

ACTION: Final ENACTED DATE: 08/19/2011 4:16 PM Appendix ......Representative brand name (If one is...

Date post: 18-May-2020
Category:
Upload: others
View: 0 times
Download: 0 times
Share this document with a friend
42
APPENDIX A BWC OUTPATIENT MEDICATION FORMULARY Page 1 of 42 Therapeutic Class Code Therapeutic Class Code Description 2 Generic Name Representative brand name (If one is in use), NOTE: Brand name products are eligible for reimbursement in accordance with OAC 4123-6-21 Dosage Form Requires Prior Authorization or Related Condition Approved in Claim Coverage restrictions or limitations for specific drugs or dosage forms are listed with the respective drugs below. Unless otherwise restricted, all dosage forms and strengths of a listed drug are eligible for reimbursement in accordance with OAC 4123-6-21. Z2N 1ST GEN ANTIHIST/DECNGEST COMB BROMPHENIRAMINE & PHENYLEPHRINE RESPAHIST-II ORAL NO BROMPHENIRAMINE & PSEUDOEPHEDRINE BROVEX SR ORAL NO CHLORPHENIRAMINE & PSEUDOEPHEDRINE WAL-FINATE-D ORAL NO CHLORPHENIRAMINE TAN-PHENYLEPHRINE TAN DALLERGY-JR ORAL NO DIPHENHYDRAMINE TAN-PHENYLEPHRINE TAN DIPHENMAX D ORAL NO PROMETHAZINE & PHENYLEPHRINE PROMETHAZINE VC ORAL NO PYRILAMINE-PHENYLEPHRINE POLY HIST FORTE ORAL NO Z2O 2ND GEN ANTIHIST-DECONG CMB ACRIVASTINE & PSEUDOEPHEDRINE SEMPREX-D ORAL YES CETIRIZINE-PSEUDOEPHEDRINE CETIRIZINE-PSEUDOEPHEDRINE ORAL YES CETIRIZINE-PSEUDOEPHEDRINE ZYRTEC-D ORAL YES DESLORATADINE & PSEUDOEPHEDRINE CLARINEX-D 12 HOUR ORAL YES FEXOFENADINE-PSE ER FEXOFENADINE-PSE ER ORAL YES FEXOFENADINE-PSEUDOEPHEDRINE ALLEGRA-D 12 HOUR ORAL YES LORATADINE ALAVERT ORAL YES LORATADINE & PSEUDOEPHEDRINE LORATA-D ORAL YES W4G 2ND GEN ANTIPROTOZOAL-ANTIBACT TINIDAZOLE TINDAMAX ORAL NO Z4E 5-LIPOXYGENASE INHIBITORS ZILEUTON ZYFLO ORAL YES W2A ABSORBABLE SULFONAMIDES SULFADIAZINE SULFADIAZINE ORAL NO SULFAMETHOXAZOLE-TRIMETHOPRIM BACTRIM DS ORAL NO SULFASALAZINE SULFASALAZINE ORAL NO A4J ACE INHIB/THIAZIDE COMBO BENAZEPRIL- HCTZ BENAZEPRIL HCL-HCTZ ORAL YES CAPTOPRIL - HCTZ CAPTOPRIL-HCTZ ORAL YES ENALAPRIL MALEATE - HCTZ ENALAPRIL MALEATE-HCTZ ORAL YES FOSINOPRIL SODIUM - HCTZ FOSINOPRIL- HCTZ ORAL YES LISINOPRIL - HCTZ ZESTORETIC ORAL YES MOEXIPRIL-HCTZ UNIRETIC ORAL YES QUINAPRIL-HCTZ QUINARETIC ORAL YES A4K ACEIN/CAL CHNL BLOCK COMBO AMLODIPINE BESYLATE-BENAZEPRIL LOTREL ORAL YES TRANDOLAPRIL-VERAPAMIL HCL TARKA ORAL YES ACTION: Final DATE: 08/19/2011 4:16 PM ENACTED Appendix 4123-6-21.3 APPENDIX p(83037) pa(144381) d(341189) ra(284272) print date: 08/19/2011 9:33 PM
Transcript
Page 1: ACTION: Final ENACTED DATE: 08/19/2011 4:16 PM Appendix ......Representative brand name (If one is in use), NOTE: Brand name products are eligible for reimbursement in accordance with

AP

PE

ND

IX A

BW

C O

UT

PA

TIE

NT

M

ED

ICA

TIO

N F

OR

MU

LAR

Y

Pa

ge

1 o

f 4

2

Th

era

pe

uti

c C

lass

Co

de

Th

era

pe

uti

c C

lass

Co

de

De

scri

pti

on

2G

en

eri

c N

am

e

Re

pre

sen

tati

ve

bra

nd

na

me

(If

on

e i

s in

use

), N

OT

E:

Bra

nd

na

me

pro

du

cts

are

eli

gib

le f

or

reim

bu

rse

me

nt

in a

cco

rda

nce

wit

h O

AC

41

23

-6-2

1D

osa

ge

Fo

rm

Re

qu

ire

s P

rio

r

Au

tho

riza

tio

n o

r

Re

late

d C

on

dit

ion

Ap

pro

ve

d i

n C

laim

Co

ve

rag

e r

est

rict

ion

s o

r li

mit

ati

on

s fo

r sp

eci

fic

dru

gs

or

do

sag

e f

orm

s a

re l

iste

d

wit

h t

he

re

spe

ctiv

e d

rug

s b

elo

w.

Un

less

oth

erw

ise

re

stri

cte

d,

all

do

sag

e f

orm

s

an

d s

tre

ng

ths

of

a l

iste

d d

rug

are

eli

gib

le f

or

reim

bu

rse

me

nt

in a

cco

rda

nce

wit

h

OA

C 4

12

3-6

-21

.

Z2

N1

ST

GE

N A

NT

IHIS

T/D

EC

NG

ES

T C

OM

B

BR

OM

PH

EN

IRA

MIN

E &

PH

EN

YLE

PH

RIN

E

RE

SP

AH

IST

-II

OR

AL

NO

BR

OM

PH

EN

IRA

MIN

E &

PS

EU

DO

EP

HE

DR

INE

BR

OV

EX

SR

OR

AL

NO

CH

LOR

PH

EN

IRA

MIN

E &

PS

EU

DO

EP

HE

DR

INE

WA

L-F

INA

TE

-DO

RA

LN

OC

HLO

RP

HE

NIR

AM

INE

TA

N-P

HE

NY

LEP

HR

INE

TA

ND

ALL

ER

GY

-JR

OR

AL

NO

DIP

HE

NH

YD

RA

MIN

E T

AN

-PH

EN

YLE

PH

RIN

E

TA

N

DIP

HE

NM

AX

DO

RA

LN

O

PR

OM

ET

HA

ZIN

E &

PH

EN

YLE

PH

RIN

E

PR

OM

ET

HA

ZIN

E V

CO

RA

LN

O

PY

RIL

AM

INE

-PH

EN

YLE

PH

RIN

EP

OLY

HIS

T F

OR

TE

OR

AL

NO

Z2

O2

ND

GE

N A

NT

IHIS

T-D

EC

ON

G C

MB

AC

RIV

AS

TIN

E &

PS

EU

DO

EP

HE

DR

INE

SE

MP

RE

X-D

OR

AL

YE

S

CE

TIR

IZIN

E-P

SE

UD

OE

PH

ED

RIN

EC

ET

IRIZ

INE

-PS

EU

DO

EP

HE

DR

INE

OR

AL

YE

S

CE

TIR

IZIN

E-P

SE

UD

OE

PH

ED

RIN

E

ZY

RT

EC

-DO

RA

LY

ES

DE

SLO

RA

TA

DIN

E &

PS

EU

DO

EP

HE

DR

INE

CLA

RIN

EX

-D 1

2 H

OU

RO

RA

LY

ES

FE

XO

FE

NA

DIN

E-P

SE

ER

FE

XO

FE

NA

DIN

E-P

SE

ER

OR

AL

YE

S

FE

XO

FE

NA

DIN

E-P

SE

UD

OE

PH

ED

RIN

EA

LLE

GR

A-D

12

HO

UR

OR

AL

YE

S

LOR

AT

AD

INE

A

LAV

ER

TO

RA

LY

ES

LOR

AT

AD

INE

& P

SE

UD

OE

PH

ED

RIN

E

LOR

AT

A-D

OR

AL

YE

S

W4

G2

ND

GE

N A

NT

IPR

OT

OZ

OA

L-A

NT

IBA

CT

TIN

IDA

ZO

LE

TIN

DA

MA

XO

RA

LN

O

Z4

E5

-LIP

OX

YG

EN

AS

E I

NH

IBIT

OR

S

ZIL

EU

TO

NZ

YF

LOO

RA

LY

ES

W2

AA

BS

OR

BA

BLE

SU

LFO

NA

MID

ES

SU

LFA

DIA

ZIN

ES

ULF

AD

IAZ

INE

OR

AL

NO

SU

LFA

ME

TH

OX

AZ

OLE

-TR

IME

TH

OP

RIM

BA

CT

RIM

DS

OR

AL

NO

SU

LFA

SA

LAZ

INE

SU

LFA

SA

LAZ

INE

OR

AL

NO

A4

JA

CE

IN

HIB

/TH

IAZ

IDE

CO

MB

O

BE

NA

ZE

PR

IL-

HC

TZ

BE

NA

ZE

PR

IL H

CL-

HC

TZ

OR

AL

YE

S

CA

PT

OP

RIL

- H

CT

ZC

AP

TO

PR

IL-H

CT

ZO

RA

LY

ES

EN

ALA

PR

IL M

ALE

AT

E -

HC

TZ

EN

ALA

PR

IL M

ALE

AT

E-H

CT

ZO

RA

LY

ES

FO

SIN

OP

RIL

SO

DIU

M -

HC

TZ

FO

SIN

OP

RIL

- H

CT

ZO

RA

LY

ES

LIS

INO

PR

IL -

HC

TZ

ZE

ST

OR

ET

ICO

RA

LY

ES

MO

EX

IPR

IL-H

CT

ZU

NIR

ET

ICO

RA

LY

ES

QU

INA

PR

IL-H

CT

ZQ

UIN

AR

ET

ICO

RA

LY

ES

A4

KA

CE

IN/C

AL

CH

NL

BLO

CK

CO

MB

O

AM

LOD

IPIN

E B

ES

YLA

TE

-BE

NA

ZE

PR

ILLO

TR

EL

OR

AL

YE

S

TR

AN

DO

LAP

RIL

-VE

RA

PA

MIL

HC

L T

AR

KA

OR

AL

YE

S

ACTION: Final DATE: 08/19/2011 4:16 PMENACTEDAppendix

4123-6-21.3

APPENDIX p(83037) pa(144381) d(341189) ra(284272) print date: 08/19/2011 9:33 PM

Page 2: ACTION: Final ENACTED DATE: 08/19/2011 4:16 PM Appendix ......Representative brand name (If one is in use), NOTE: Brand name products are eligible for reimbursement in accordance with

AP

PE

ND

IX A

BW

C O

UT

PA

TIE

NT

M

ED

ICA

TIO

N F

OR

MU

LAR

Y

Pa

ge

2 o

f 4

2

Th

era

pe

uti

c C

lass

Co

de

Th

era

pe

uti

c C

lass

Co

de

De

scri

pti

on

2G

en

eri

c N

am

e

Re

pre

sen

tati

ve

bra

nd

na

me

(If

on

e i

s in

use

), N

OT

E:

Bra

nd

na

me

pro

du

cts

are

eli

gib

le f

or

reim

bu

rse

me

nt

in a

cco

rda

nce

wit

h O

AC

41

23

-6-2

1D

osa

ge

Fo

rm

Re

qu

ire

s P

rio

r

Au

tho

riza

tio

n o

r

Re

late

d C

on

dit

ion

Ap

pro

ve

d i

n C

laim

Co

ve

rag

e r

est

rict

ion

s o

r li

mit

ati

on

s fo

r sp

eci

fic

dru

gs

or

do

sag

e f

orm

s a

re l

iste

d

wit

h t

he

re

spe

ctiv

e d

rug

s b

elo

w.

Un

less

oth

erw

ise

re

stri

cte

d,

all

do

sag

e f

orm

s

an

d s

tre

ng

ths

of

a l

iste

d d

rug

are

eli

gib

le f

or

reim

bu

rse

me

nt

in a

cco

rda

nce

wit

h

OA

C 4

12

3-6

-21

.

L1B

AC

NE

AG

EN

TS

SY

ST

EM

IC

ISO

TR

ET

INO

IN

CLA

RA

VIS

OR

AL

NO

L5H

AC

NE

AG

EN

TS

TO

PIC

AL

SU

LFA

CE

TA

MID

E S

OD

IUM

KLA

RO

NT

OP

ICA

LN

O

H8

MA

DH

D-T

X-A

LPH

A-2

A-R

EC

EP

-AG

ON

IST

GU

AN

FA

CIN

E H

CL

INT

UN

IVO

RA

LN

O

J5B

AD

RE

NE

RG

IC A

GE

NT

S,

AR

OM

AT

IC,

AM

PH

ET

AM

INE

-DE

XT

RO

AM

PH

ET

AM

INE

A

DD

ER

ALL

OR

AL

YE

S

DE

XT

RO

AM

PH

ET

AM

INE

SU

LFA

TE

D

EX

ED

RIN

EO

RA

LY

ES

LIS

DE

XA

MF

ET

AM

INE

DIM

ES

YLA

TE

VY

VA

NS

EO

RA

LY

ES

J7A

AD

RE

NE

RG

IC I

NH

IBIT

OR

S

CA

RV

ED

ILO

LC

OR

EG

OR

AL

YE

S

LAB

ET

ALO

L H

CL

NO

RM

OD

YN

EO

RA

LY

ES

J5H

AD

RE

NE

RG

IC V

AS

OP

RE

SS

OR

AG

TS

MID

OD

RIN

E H

CL

PR

OA

MA

TIN

EO

RA

LY

ES

P1

EA

DR

EN

OC

OR

TIC

OT

RO

PH

IC H

OR

MO

NE

CO

RT

ICO

TR

OP

INA

CT

HA

R H

.P.

INJE

CT

ION

YE

S

H0

EA

GE

NT

S T

O T

RE

AT

MS

GLA

TIR

AM

ER

AC

ET

AT

EC

OP

AX

ON

ES

UB

-QY

ES

INT

ER

FE

RO

N B

ET

A-1

A

AV

ON

EX

INT

RA

MU

SC

YE

S

INT

ER

FE

RO

N B

ET

A-1

A

RE

BIF

SU

B-Q

YE

S

V1

AA

LKY

LAT

ING

AG

EN

TS

CY

CLO

PH

OS

PH

AM

IDE

CY

CLO

PH

OS

PH

AM

IDE

OR

AL

YE

S

J7B

ALP

HA

AD

RE

NE

RG

IC B

LOC

KIN

G A

G

DIB

EN

ZY

LIN

ED

IBE

NZ

YLI

NE

OR

AL

YE

S

DO

XA

ZO

SIN

ME

SY

LAT

EC

AR

DU

RA

OR

AL

YE

S

PR

AZ

OS

IN H

CL

MIN

IPR

ES

SO

RA

LY

ES

TE

RA

ZO

SIN

HC

LT

ER

AZ

OS

IN H

CL

OR

AL

YE

S

H7

BA

LPH

A-2

AN

TA

GO

NIS

T A

NT

IDE

PR

ES

S

MIR

TA

ZA

PIN

ER

EM

ER

ON

OR

AL

NO

H1

AA

LZH

EIM

ER

S T

X-N

MD

A R

EC

EP

AN

TA

G

ME

MA

NT

INE

HC

L N

AM

EN

DA

OR

AL

YE

S

W1

FA

MIN

OG

LYC

OS

IDE

S

AM

IKA

CIN

SU

LFA

TE

A

MIK

AC

IN S

ULF

AT

E I

NJ

25

0 M

G/M

L

INJ

NO

GE

NT

AM

ICIN

SU

LFA

TE

GE

NT

AM

ICIN

SU

LFA

TE

IN

J 4

0 M

G/M

L

IN

JN

O

NE

OM

YC

IN S

ULF

AT

EN

EO

MY

CIN

SU

LFA

TE

OR

AL

NO

TO

BR

AM

YC

IN S

ULF

AT

ET

OB

RA

MY

CIN

NE

BU

SO

LNN

O

D9

AA

MM

ON

IA I

NH

IBIT

OR

S

AC

ET

OH

YD

RO

XA

MIC

AC

IDLI

TH

OS

TA

TO

RA

LN

O

LAC

TU

LOS

E (

EN

CE

PH

ALO

PA

TH

Y)

EN

ULO

SE

OR

AL

NO

Page 3: ACTION: Final ENACTED DATE: 08/19/2011 4:16 PM Appendix ......Representative brand name (If one is in use), NOTE: Brand name products are eligible for reimbursement in accordance with

AP

PE

ND

IX A

BW

C O

UT

PA

TIE

NT

M

ED

ICA

TIO

N F

OR

MU

LAR

Y

Pa

ge

3 o

f 4

2

Th

era

pe

uti

c C

lass

Co

de

Th

era

pe

uti

c C

lass

Co

de

De

scri

pti

on

2G

en

eri

c N

am

e

Re

pre

sen

tati

ve

bra

nd

na

me

(If

on

e i

s in

use

), N

OT

E:

Bra

nd

na

me

pro

du

cts

are

eli

gib

le f

or

reim

bu

rse

me

nt

in a

cco

rda

nce

wit

h O

AC

41

23

-6-2

1D

osa

ge

Fo

rm

Re

qu

ire

s P

rio

r

Au

tho

riza

tio

n o

r

Re

late

d C

on

dit

ion

Ap

pro

ve

d i

n C

laim

Co

ve

rag

e r

est

rict

ion

s o

r li

mit

ati

on

s fo

r sp

eci

fic

dru

gs

or

do

sag

e f

orm

s a

re l

iste

d

wit

h t

he

re

spe

ctiv

e d

rug

s b

elo

w.

Un

less

oth

erw

ise

re

stri

cte

d,

all

do

sag

e f

orm

s

an

d s

tre

ng

ths

of

a l

iste

d d

rug

are

eli

gib

le f

or

reim

bu

rse

me

nt

in a

cco

rda

nce

wit

h

OA

C 4

12

3-6

-21

.

H6

IA

MY

OT

RO

PH

IC L

AT

ER

AL

SC

LER

OS

RIL

UZ

OLE

R

ILU

TE

KO

RA

LN

O

H3

EA

NA

LGE

SIC

/AN

TIP

YR

ET

ICS

, N

ON

AC

ET

AM

INO

PH

EN

TY

LEN

OL

OR

AL

NO

AC

ET

AM

INO

PH

EN

-CA

FF

EIN

E

EX

CE

DR

IN T

EN

SIO

N H

EA

DA

CH

EO

RA

LN

O

F1

AA

ND

RO

GE

NIC

AG

EN

TS

ME

TH

YLT

ES

TO

ST

ER

ON

EA

ND

RO

IDO

RA

LY

ES

OX

AN

DR

OLO

NE

O

XA

ND

RO

LON

EO

RA

LY

ES

TE

ST

OS

TE

RO

NE

BU

CC

AL

ST

RIA

NT

BU

CC

AL

YE

S

TE

ST

OS

TE

RO

NE

TD

A

ND

RO

DE

RM

TR

AN

SD

ER

MY

ES

A4

IA

NG

RE

C A

NT

G I

I T

HIA

Z C

OM

BO

CA

ND

ES

AR

TA

N C

ILE

XE

TIL

-HC

TZ

A

TA

CA

ND

HC

TO

RA

LY

ES

EP

RO

SA

RT

AN

ME

SY

LAT

E-H

CT

ZT

EV

ET

EN

HC

TO

RA

LY

ES

IRB

ES

AR

TA

N-

HC

TZ

AV

ALI

DE

OR

AL

YE

S

LOS

AR

TA

N P

OT

AS

SIU

M -

HC

TZ

HY

ZA

AR

OR

AL

YE

S

OLM

ES

AR

TA

N M

ED

OX

OM

IL-H

CT

ZB

EN

ICA

R H

CT

OR

AL

YE

S

TE

LMIS

AR

TA

N-H

CT

ZM

ICA

RD

IS H

CT

OR

AL

YE

S

VA

LSA

RT

AN

-HC

TZ

DIO

VA

N H

CT

OR

AL

YE

S

A4

VA

NG

IOT

EN

-RE

C A

NT

/CA

-CH

BLK

R/T

HZ

AM

LOD

IPIN

E-V

ALS

AR

TA

N-H

CT

ZE

XF

OR

GE

HC

TO

RA

LN

O

A4

HA

NG

-RE

C A

NT

G C

A C

HA

N B

LCK

RA

MLO

DIP

INE

BE

SY

LAT

E-O

LME

SA

RT

AN

ME

DO

XO

MIL

AZ

OR

OR

AL

YE

S

AM

LOD

IPIN

E B

ES

YLA

TE

-VA

LSA

RT

AN

E

XF

OR

GE

OR

AL

YE

S

J8A

AN

OR

EX

IC A

GE

NT

S

BE

NZ

PH

ET

AM

INE

HC

LB

EN

ZP

HE

TA

MIN

E H

CL

OR

AL

NO

D4

BA

NT

AC

IDS

All

co

mb

ina

tio

ns

an

d o

ral

do

sag

e f

orm

s a

re c

ov

ere

d

ALU

M &

MA

G H

YD

RO

XID

E-S

IME

TH

ICO

NE

R

ULO

XO

RA

LN

O

ALU

MIN

UM

& M

AG

NE

SIU

M H

YD

RO

XID

ES

A

LAM

AG

OR

AL

NO

ALU

MIN

UM

HY

DR

OX

IDE

A

LTE

RN

AG

EL

OR

AL

NO

ALU

MIN

UM

HY

DR

OX

IDE

-MA

GN

ES

IUM

TR

ISIL

ICA

TE

G

AV

ISC

ON

OR

AL

NO

CA

LCIU

M C

AR

BO

NA

TE

T

UM

SO

RA

LN

O

CA

LCIU

M C

AR

BO

NA

TE

-MA

G H

YD

RO

XID

EM

YLA

NT

A U

LTR

AO

RA

LN

O

CA

LCIU

M C

AR

BO

NA

TE

-MA

G H

YD

RO

XID

E

RO

LAID

SO

RA

LN

O

Ina

ctiv

eP

HIL

LIP

S'

MIL

K O

F M

AG

NE

SIA

OR

AL

NO

SO

DIU

M B

ICA

RB

ON

AT

ES

OD

IUM

BIC

AR

BO

NA

TE

OR

AL

NO

Page 4: ACTION: Final ENACTED DATE: 08/19/2011 4:16 PM Appendix ......Representative brand name (If one is in use), NOTE: Brand name products are eligible for reimbursement in accordance with

AP

PE

ND

IX A

BW

C O

UT

PA

TIE

NT

M

ED

ICA

TIO

N F

OR

MU

LAR

Y

Pa

ge

4 o

f 4

2

Th

era

pe

uti

c C

lass

Co

de

Th

era

pe

uti

c C

lass

Co

de

De

scri

pti

on

2G

en

eri

c N

am

e

Re

pre

sen

tati

ve

bra

nd

na

me

(If

on

e i

s in

use

), N

OT

E:

Bra

nd

na

me

pro

du

cts

are

eli

gib

le f

or

reim

bu

rse

me

nt

in a

cco

rda

nce

wit

h O

AC

41

23

-6-2

1D

osa

ge

Fo

rm

Re

qu

ire

s P

rio

r

Au

tho

riza

tio

n o

r

Re

late

d C

on

dit

ion

Ap

pro

ve

d i

n C

laim

Co

ve

rag

e r

est

rict

ion

s o

r li

mit

ati

on

s fo

r sp

eci

fic

dru

gs

or

do

sag

e f

orm

s a

re l

iste

d

wit

h t

he

re

spe

ctiv

e d

rug

s b

elo

w.

Un

less

oth

erw

ise

re

stri

cte

d,

all

do

sag

e f

orm

s

an

d s

tre

ng

ths

of

a l

iste

d d

rug

are

eli

gib

le f

or

reim

bu

rse

me

nt

in a

cco

rda

nce

wit

h

OA

C 4

12

3-6

-21

.

C0

DA

NT

IALC

OH

OLI

C P

RE

PA

RA

TIO

NS

AC

AM

PR

OS

AT

E C

ALC

IUM

CA

MP

RA

LO

RA

LY

ES

DIS

ULF

IRA

M

AN

TA

BU

SE

OR

AL

YE

S

A2

CA

NT

IAN

GIN

AL

AN

TI

ISC

HE

MIC

DR

UG

RA

NO

LAZ

INE

RA

NE

XA

OR

AL

YE

S

H2

FA

NT

I-A

NX

IET

Y D

RU

GS

ALP

RA

ZO

LAM

X

AN

AX

OR

AL

NO

BU

SP

IRO

NE

HC

LB

US

PA

RO

RA

LN

O

CH

LOR

DIA

ZE

PO

XID

E H

CL

LIB

RIU

MO

RA

LN

O

CLO

RA

ZE

PA

TE

DIP

OT

AS

SIU

MT

RA

NX

EN

EO

RA

LN

O

CLO

RA

ZE

PA

TE

DIP

OT

AS

SIU

M

TR

AN

XE

NE

T-T

AB

OR

AL

NO

DIA

ZE

PA

MV

ALI

UM

OR

AL

NO

LOR

AZ

EP

AM

A

TIV

AN

OR

AL

NO

ME

PR

OB

AM

AT

EM

ILT

OW

NO

RA

LN

O

OX

AZ

EP

AM

SE

RA

XO

RA

LN

O

A2

AA

NT

IAR

RH

YT

HM

ICS

A2

DA

NT

IAR

RH

YT

HM

ICS

AM

IOD

AR

ON

E H

CL

PA

CE

RO

NE

OR

AL

YE

S

DO

FE

TIL

IDE

TIK

OS

YN

OR

AL

YE

S

DR

ON

ED

AR

ON

EM

ULT

AQ

OR

AL

YE

S

FLE

CA

INID

E A

CE

TA

TE

TA

MB

OC

OR

OR

AL

YE

S

ME

XIL

ET

INE

HC

LM

EX

ILE

TIN

E H

CL

OR

AL

YE

S

PR

OP

AF

EN

ON

E H

CL

RY

TH

MO

L

OR

AL

YE

S

PR

OP

AF

EN

ON

E H

CL

RY

TH

MO

L S

RO

RA

LY

ES

QU

INID

INE

GLU

CO

NA

TE

QU

INID

INE

GLU

CO

NA

TE

OR

AL

YE

S

S2

NA

NT

IAR

TH

RIC

S F

OLA

TE

AN

TA

G A

GT

ME

TH

OT

RE

XA

TE

SO

DIU

MR

HE

UM

AT

RE

XO

RA

LY

ES

S2

KA

NT

IAR

TH

RIT

IC/C

HE

LAT

ING

AG

EN

TS

PE

NIC

ILLA

MIN

EC

UP

RIM

INE

OR

AL

YE

S

S2

HA

NT

IAR

TH

RIT

ICS

AG

EN

TS

MIS

C.

GLU

CO

SA

MIN

E S

ULF

AT

EG

LUC

OS

AM

INE

SU

LFA

TE

OR

AL

YE

S

GLU

CO

SA

MIN

E-C

HO

ND

RO

ITIN

AR

TH

X D

SO

RA

LY

ES

J2D

AN

TIC

HO

LIN

ER

GIC

S,

AN

TIS

PA

SM

O

DIC

YC

LOM

INE

HC

LB

EN

TY

LO

RA

LN

O

J2B

AN

TIC

HO

LIN

ER

GIC

S,

QU

AN

TE

RN

AR

CH

LOR

DIA

ZE

PO

XID

E-C

LID

INIU

MLI

BR

AX

OR

AL

NO

GLY

CO

PY

RR

OLA

TE

RO

BIN

UL

OR

AL

NO

PR

OP

AN

TH

ELI

NE

BR

OM

IDE

PR

O-B

AN

TH

INE

OR

AL

NO

H4

BA

NT

ICO

NV

ULS

AN

TS

CA

RB

AM

AZ

EP

INE

TE

GR

ET

OL

OR

AL

NO

CLO

NA

ZE

PA

MK

LON

OP

INO

RA

LN

O

DIA

ZE

PA

M

DIA

ST

AT

AC

UD

IAL

RE

CT

AL

NO

Page 5: ACTION: Final ENACTED DATE: 08/19/2011 4:16 PM Appendix ......Representative brand name (If one is in use), NOTE: Brand name products are eligible for reimbursement in accordance with

AP

PE

ND

IX A

BW

C O

UT

PA

TIE

NT

M

ED

ICA

TIO

N F

OR

MU

LAR

Y

Pa

ge

5 o

f 4

2

Th

era

pe

uti

c C

lass

Co

de

Th

era

pe

uti

c C

lass

Co

de

De

scri

pti

on

2G

en

eri

c N

am

e

Re

pre

sen

tati

ve

bra

nd

na

me

(If

on

e i

s in

use

), N

OT

E:

Bra

nd

na

me

pro

du

cts

are

eli

gib

le f

or

reim

bu

rse

me

nt

in a

cco

rda

nce

wit

h O

AC

41

23

-6-2

1D

osa

ge

Fo

rm

Re

qu

ire

s P

rio

r

Au

tho

riza

tio

n o

r

Re

late

d C

on

dit

ion

Ap

pro

ve

d i

n C

laim

Co

ve

rag

e r

est

rict

ion

s o

r li

mit

ati

on

s fo

r sp

eci

fic

dru

gs

or

do

sag

e f

orm

s a

re l

iste

d

wit

h t

he

re

spe

ctiv

e d

rug

s b

elo

w.

Un

less

oth

erw

ise

re

stri

cte

d,

all

do

sag

e f

orm

s

an

d s

tre

ng

ths

of

a l

iste

d d

rug

are

eli

gib

le f

or

reim

bu

rse

me

nt

in a

cco

rda

nce

wit

h

OA

C 4

12

3-6

-21

.

AN

TIC

ON

VU

LSA

NT

S (

CO

NT

)D

IVA

LPR

OE

X S

OD

IUM

DE

PA

KO

TE

OR

AL

NO

ET

HO

SU

XIM

IDE

ZA

RO

NT

INO

RA

LN

O

FE

LBA

MA

TE

FE

LBA

TO

LO

RA

LN

O

GA

BA

PE

NT

IN

NE

UR

ON

TIN

OR

AL

NO

LAM

OT

RIG

INE

LAM

ICT

AL

OR

AL

NO

ME

PH

OB

AR

BIT

AL

ME

BA

RA

LO

RA

LN

O

OX

CA

RB

AZ

EP

INE

TR

ILE

PT

AL

OR

AL

NO

PH

EN

YT

OIN

SO

DIU

M

DIL

AN

TIN

OR

AL

NO

PR

IMID

ON

EM

YS

OLI

NE

OR

AL

NO

TO

PIR

AM

AT

E

TO

PA

MA

XO

RA

LN

O

VA

LPR

OIC

AC

IDS

TA

VZ

OR

OR

AL

NO

H4

CA

NT

ICO

NV

ULS

AN

TS

(C

ON

T)

LAC

OS

AM

IDE

VIM

PA

TO

RA

LN

O

LEV

ET

IRA

CE

TA

MK

EP

PR

AO

RA

LN

O

PR

EG

AB

ALI

N

LYR

ICA

OR

AL

NO

TIA

GA

BIN

E H

CL

GA

BIT

RIL

OR

AL

NO

ZO

NIS

AM

IDE

ZO

NE

GR

AN

OR

AL

NO

D4

DA

NT

IDIA

RR

HE

AL

MIC

RO

AG

EN

TS

LAC

TO

BA

CIL

LUS

BA

CID

OR

AL

NO

LAC

TO

BA

CIL

LUS

LA

CT

INE

XO

RA

LN

O

LAC

TO

BA

CIL

LUS

RH

AM

NO

SU

S (

GG

)C

ULT

UR

ELL

EO

RA

LN

O

PR

OB

IOT

IC P

RO

DU

CT

ALI

GN

OR

AL

NO

PR

OB

IOT

IC P

RO

DU

CT

RIS

AQ

UA

DO

RA

LN

O

SA

CC

HA

RO

MY

CE

S B

OU

LAR

DII

F

LOR

AS

TO

RO

RA

LN

O

D6

DA

NT

IDIA

RR

HE

ALS

BIS

MU

TH

SU

BS

ALI

CY

LAT

E

PE

PT

O-B

ISM

OL

OR

AL

NO

DIF

EN

OX

IN W

/ A

TR

OP

INE

M

OT

OF

EN

OR

AL

NO

DIP

HE

NO

XY

LAT

E W

/ A

TR

OP

INE

LOM

OT

ILO

RA

LN

O

LOP

ER

AM

IDE

IMO

DIU

M A

-DO

RA

LN

O

PA

RE

GO

RIC

P

AR

EG

OR

ICO

RA

LN

O

P2

BA

NT

IDIU

RE

TIC

AN

D V

AS

OP

RE

SS

OR

DE

SM

OP

RE

SS

IN A

CE

TA

TE

D

DA

VP

INJE

CT

ION

YE

S

H6

JA

NT

I-E

ME

TIC

S

AP

RE

PIT

AN

TE

ME

ND

OR

AL

YE

S

DIM

EN

HY

DR

INA

TE

D

RA

MA

MIN

EO

RA

LY

ES

DO

LAS

ET

RO

N M

ES

YLA

TE

AN

ZE

ME

TO

RA

LY

ES

DR

ON

AB

INO

L M

AR

INO

LO

RA

LY

ES

GR

AN

ISE

TR

ON

HC

LK

YT

RIL

OR

AL

YE

S

ME

CLI

ZIN

E H

CL

AN

TIV

ER

TO

RA

LY

ES

ON

DA

NS

ET

RO

N H

CL

ZO

FR

AN

OR

AL

YE

S

PR

OC

HLO

RP

ER

AZ

INE

MA

LEA

TE

CO

MP

AZ

INE

OR

AL

YE

S

PR

OC

HLO

RP

ER

AZ

INE

MA

LEA

TE

CO

MP

AZ

INE

RE

CT

AL

YE

S

Page 6: ACTION: Final ENACTED DATE: 08/19/2011 4:16 PM Appendix ......Representative brand name (If one is in use), NOTE: Brand name products are eligible for reimbursement in accordance with

AP

PE

ND

IX A

BW

C O

UT

PA

TIE

NT

M

ED

ICA

TIO

N F

OR

MU

LAR

Y

Pa

ge

6 o

f 4

2

Th

era

pe

uti

c C

lass

Co

de

Th

era

pe

uti

c C

lass

Co

de

De

scri

pti

on

2G

en

eri

c N

am

e

Re

pre

sen

tati

ve

bra

nd

na

me

(If

on

e i

s in

use

), N

OT

E:

Bra

nd

na

me

pro

du

cts

are

eli

gib

le f

or

reim

bu

rse

me

nt

in a

cco

rda

nce

wit

h O

AC

41

23

-6-2

1D

osa

ge

Fo

rm

Re

qu

ire

s P

rio

r

Au

tho

riza

tio

n o

r

Re

late

d C

on

dit

ion

Ap

pro

ve

d i

n C

laim

Co

ve

rag

e r

est

rict

ion

s o

r li

mit

ati

on

s fo

r sp

eci

fic

dru

gs

or

do

sag

e f

orm

s a

re l

iste

d

wit

h t

he

re

spe

ctiv

e d

rug

s b

elo

w.

Un

less

oth

erw

ise

re

stri

cte

d,

all

do

sag

e f

orm

s

an

d s

tre

ng

ths

of

a l

iste

d d

rug

are

eli

gib

le f

or

reim

bu

rse

me

nt

in a

cco

rda

nce

wit

h

OA

C 4

12

3-6

-21

.

AN

TI-

EM

ET

ICS

(C

ON

T)

PR

OM

ET

HA

ZIN

E H

CL

PH

EN

ER

GA

NO

RA

LY

ES

PR

OM

ET

HA

ZIN

E H

CL

PH

EN

ER

GA

NR

EC

TA

LY

ES

SC

OP

OLA

MIN

E H

YD

RO

BR

OM

IDE

SC

OP

AC

EO

RA

LY

ES

SC

OP

OLA

MIN

E T

D

TR

AN

SD

ER

M-S

CO

PT

RA

NS

DE

RM

YE

S

TR

IME

TH

OB

EN

ZA

MID

E H

CL

TIG

AN

OR

AL

YE

S

M9

DA

NT

IFIB

RIN

OLY

TIC

AG

EN

TS

AM

INO

CA

PR

OIC

AC

IDA

MIN

OC

AP

RO

IC A

CID

OR

AL

NO

D4

NA

NT

IFLA

TU

LEN

TS

SIM

ET

HIC

ON

E

SIM

ET

HIC

ON

EO

RA

LN

O

W3

BA

NT

IFU

NG

AL

AG

EN

TS

W3

BA

NT

IFU

NG

AL

AG

EN

TS

W3

CA

NT

IFU

NG

AL

AG

EN

TS

CLO

TR

IMA

ZO

LEC

LOT

RIM

AZ

OLE

MU

CO

US

ME

MN

O

CLO

TR

IMA

ZO

LEM

YC

ELE

XM

UC

OU

S M

EM

NO

FLU

CO

NA

ZO

LEF

LUC

ON

AZ

OLE

OR

AL

NO

ITR

AC

ON

AZ

OLE

SP

OR

AN

OX

OR

AL

NO

KE

TO

CO

NA

ZO

LEK

ET

OC

ON

AZ

OLE

OR

AL

NO

TE

RB

INA

FIN

E H

CL

LAM

ISIL

OR

AL

NO

W3

DA

NT

IFU

NG

AL

AG

EN

TS

(C

ON

T 2

)

PO

SA

CO

NA

ZO

LEN

OX

AF

ILO

RA

LN

O

VO

RIC

ON

AZ

OLE

VF

EN

DO

RA

LN

O

W3

AA

NT

IFU

NG

AL

AN

TIB

IOT

ICS

GR

ISE

OF

ULV

IN

GR

IFU

LVIN

VO

RA

LN

O

ME

FLO

QU

INE

HC

L M

EF

LOQ

UIN

E H

CL

OR

AL

NO

NY

ST

AT

INN

YS

TA

TIN

OR

AL

NO

Z2

PA

NT

IHIS

TA

MIN

ES

- 1

ST

GE

NE

RA

TIO

BR

OM

PH

EN

IRA

MIN

E &

PS

EU

DO

EP

HE

DR

INE

LO

DR

AN

EO

RA

LN

O

BR

OM

PH

EN

IRA

MIN

E M

ALE

AT

ELO

HIS

T 1

2H

RO

RA

LN

O

CA

RB

INO

XA

MIN

E M

ALE

AT

EC

AR

BIN

OX

AM

INE

MA

LEA

TE

OR

AL

NO

CA

RB

INO

XA

MIN

E M

ALE

AT

EP

ALG

ICO

RA

LN

O

CLE

MA

ST

INE

FU

MA

RA

TE

CLE

MA

ST

INE

FU

MA

RA

TE

OR

AL

NO

CY

PR

OH

EP

TA

DIN

E H

CL

CY

PR

OH

EP

TA

DIN

E H

CL

OR

AL

NO

DIP

HE

NH

YD

RA

MIN

E H

CL

BE

NA

DR

YL

OR

AL

NO

DIP

HE

NH

YD

RA

MIN

E H

CL

DIP

HE

NH

YD

RA

MIN

E H

CL

INJE

CT

ION

NO

DIP

HE

NH

YD

RA

MIN

E T

AN

NA

TE

DIP

HE

NM

AX

OR

AL

NO

HY

DR

OX

YZ

INE

HC

LH

YD

RO

XY

ZIN

E H

CL

OR

AL

NO

PR

OM

ET

HA

ZIN

E H

CL

PH

EN

ER

GA

NO

RA

LN

O

Z2

QA

NT

IHIS

TA

MIN

ES

- 2

ND

GE

NE

RA

TIO

CE

TIR

IZIN

E H

CL

ZY

RT

EC

OR

AL

YE

S

DE

SLO

RA

TA

DIN

E

CLA

RIN

EX

OR

AL

YE

S

DIP

HE

NH

YD

RA

MIN

E H

CL

ALL

ER

GY

RE

LIE

FO

RA

LY

ES

Page 7: ACTION: Final ENACTED DATE: 08/19/2011 4:16 PM Appendix ......Representative brand name (If one is in use), NOTE: Brand name products are eligible for reimbursement in accordance with

AP

PE

ND

IX A

BW

C O

UT

PA

TIE

NT

M

ED

ICA

TIO

N F

OR

MU

LAR

Y

Pa

ge

7 o

f 4

2

Th

era

pe

uti

c C

lass

Co

de

Th

era

pe

uti

c C

lass

Co

de

De

scri

pti

on

2G

en

eri

c N

am

e

Re

pre

sen

tati

ve

bra

nd

na

me

(If

on

e i

s in

use

), N

OT

E:

Bra

nd

na

me

pro

du

cts

are

eli

gib

le f

or

reim

bu

rse

me

nt

in a

cco

rda

nce

wit

h O

AC

41

23

-6-2

1D

osa

ge

Fo

rm

Re

qu

ire

s P

rio

r

Au

tho

riza

tio

n o

r

Re

late

d C

on

dit

ion

Ap

pro

ve

d i

n C

laim

Co

ve

rag

e r

est

rict

ion

s o

r li

mit

ati

on

s fo

r sp

eci

fic

dru

gs

or

do

sag

e f

orm

s a

re l

iste

d

wit

h t

he

re

spe

ctiv

e d

rug

s b

elo

w.

Un

less

oth

erw

ise

re

stri

cte

d,

all

do

sag

e f

orm

s

an

d s

tre

ng

ths

of

a l

iste

d d

rug

are

eli

gib

le f

or

reim

bu

rse

me

nt

in a

cco

rda

nce

wit

h

OA

C 4

12

3-6

-21

.

AN

TIH

IST

AM

INE

S -

2N

D G

EN

ER

AT

IO (

CO

NT

)F

EX

OF

EN

AD

INE

HC

L A

LLE

GR

AO

RA

LY

ES

Ina

ctiv

eN

ON

-DR

OW

SY

ALL

ER

GY

OR

AL

YE

S

LEV

OC

ET

IRIZ

INE

DIH

YD

RO

CH

LOR

IDE

XY

ZA

LO

RA

LY

ES

LOR

AT

AD

INE

C

LEA

R-A

TA

DIN

EO

RA

LY

ES

B5

SA

NT

IHIS

T-A

NA

LGE

SIC

,NO

N,S

AL

DIP

HE

NH

YD

RA

MIN

E W

/ A

PA

P T

AB

EX

CE

DR

IN P

.M.

OR

AL

NO

PH

EN

YLT

OLO

XA

MIN

E W

/ A

PA

P

FLE

XT

RA

-65

0O

RA

LN

O

B3

XA

NT

IHIS

T-D

EC

ON

G-A

NT

ICH

OLI

N-C

MB

CH

LOR

PH

EN

-PS

E-A

TR

OP

INE

-HY

OS

-SC

OP

OL

TA

B S

RR

U-T

US

SO

RA

LN

O

PE

-ME

TH

SC

OP

TA

BA

LLE

RX

PE

OR

AL

NO

C4

FA

NT

IHY

PE

RG

LY,D

PP

4 I

NH

IB+

BIG

UA

N

SIT

AG

LIP

TIN

-ME

TF

OR

MIN

JA

NU

ME

TO

RA

LY

ES

C4

JA

NT

IHY

PE

RG

LYC

EM

IC D

PP

-4 I

NH

IB

SIT

AG

LIP

TIN

PH

OS

PH

AT

E

JAN

UV

IAO

RA

LY

ES

C4

IA

NT

I-H

YP

ER

GLY

CIC

,IN

CR

ET

IN-M

IMT

EX

EN

AT

IDE

B

YE

TT

AS

UB

-QY

ES

LIR

AG

LUT

IDE

LIR

AG

LUT

IDE

IN

J S

UB

-QY

ES

C4

HA

NT

I-H

YP

ER

GLY

CIC

-AM

YLI

N-A

NA

LOG

PR

AM

LIN

TID

E A

CE

TA

TE

SY

MLI

NS

UB

-QY

ES

W4

AA

NT

IMA

LAR

IAL

DR

UG

S

CH

LOR

OQ

UIN

E P

HO

SP

HA

TE

CH

LOR

OQ

UIN

E P

HO

SP

HA

TE

OR

AL

NO

HY

DR

OX

YC

HLO

RO

QU

INE

SU

LFA

TE

HY

DR

OX

YC

HLO

RO

QU

INE

SU

LFA

TE

OR

AL

NO

QU

ININ

E S

ULF

AT

E

QU

ALA

QU

INO

RA

LN

O

H2

MA

NT

I-M

AN

IA D

RU

GS

CA

RB

AM

AZ

EP

INE

T

EG

RE

TO

LO

RA

LN

O

LIT

HIU

M C

AR

BO

NA

TE

ES

KA

LIT

HO

RA

LN

O

LIT

HIU

M C

ITR

AT

EC

IBA

LIT

H-S

OR

AL

NO

V1

BA

NT

IME

TA

BO

LIT

ES

CA

PE

CIT

AB

INE

XE

LOD

AO

RA

LY

ES

ME

TH

OT

RE

XA

TE

ME

TH

OT

RE

XA

TE

OR

AL

YE

S

H3

FA

NT

IMIG

RA

INE

PR

EP

AR

AT

ION

S

ALM

OT

RIP

TA

N M

ALA

TE

AX

ER

TO

RA

LY

ES

12

un

its

pe

r 3

0 d

ay

s

AP

AP

-IS

OM

ET

HE

PT

EN

E-D

ICH

LOR

AL

EP

IDR

INO

RA

LY

ES

DIH

YD

RO

ER

GO

TA

MIN

E M

ES

YLA

TE

MIG

RA

NA

LN

AS

AL

YE

S

ELE

TR

IPT

AN

HY

DR

OB

RO

MID

ER

ELP

AX

OR

AL

YE

S6

un

its

pe

r 3

0 d

ay

s

ER

GO

TA

MIN

E T

AR

TR

AT

EE

RG

OM

AR

SU

BLI

NG

UA

LY

ES

ER

GO

TA

MIN

E-C

AF

FE

INE

ER

GO

TA

MIN

E-C

AF

FE

INE

OR

AL

YE

S

FR

OV

AT

RIP

TA

N S

UC

CIN

AT

EF

RO

VA

OR

AL

YE

S9

un

its

pe

r 3

0 d

ay

s

ISO

ME

TH

-D-C

HLO

RA

LPH

EN

AZ

-AP

AP

MID

RIN

OR

AL

YE

S

NA

RA

TR

IPT

AN

HC

L A

ME

RG

EO

RA

LY

ES

9 u

nit

s p

er

30

da

ys

Page 8: ACTION: Final ENACTED DATE: 08/19/2011 4:16 PM Appendix ......Representative brand name (If one is in use), NOTE: Brand name products are eligible for reimbursement in accordance with

AP

PE

ND

IX A

BW

C O

UT

PA

TIE

NT

M

ED

ICA

TIO

N F

OR

MU

LAR

Y

Pa

ge

8 o

f 4

2

Th

era

pe

uti

c C

lass

Co

de

Th

era

pe

uti

c C

lass

Co

de

De

scri

pti

on

2G

en

eri

c N

am

e

Re

pre

sen

tati

ve

bra

nd

na

me

(If

on

e i

s in

use

), N

OT

E:

Bra

nd

na

me

pro

du

cts

are

eli

gib

le f

or

reim

bu

rse

me

nt

in a

cco

rda

nce

wit

h O

AC

41

23

-6-2

1D

osa

ge

Fo

rm

Re

qu

ire

s P

rio

r

Au

tho

riza

tio

n o

r

Re

late

d C

on

dit

ion

Ap

pro

ve

d i

n C

laim

Co

ve

rag

e r

est

rict

ion

s o

r li

mit

ati

on

s fo

r sp

eci

fic

dru

gs

or

do

sag

e f

orm

s a

re l

iste

d

wit

h t

he

re

spe

ctiv

e d

rug

s b

elo

w.

Un

less

oth

erw

ise

re

stri

cte

d,

all

do

sag

e f

orm

s

an

d s

tre

ng

ths

of

a l

iste

d d

rug

are

eli

gib

le f

or

reim

bu

rse

me

nt

in a

cco

rda

nce

wit

h

OA

C 4

12

3-6

-21

.

AN

TIM

IGR

AIN

E P

RE

PA

RA

TIO

NS

(C

ON

T)

RIZ

AT

RIP

TA

N B

EN

ZO

AT

EM

AX

ALT

OR

AL

YE

S1

2 u

nit

s p

er

30

da

ys

RIZ

AT

RIP

TA

N B

EN

ZO

AT

EM

AX

ALT

MLT

OR

AL

YE

S1

2 u

nit

s p

er

30

da

ys

SU

MA

TR

IPT

AN

IM

ITR

EX

OR

AL

YE

S9

un

its

pe

r 3

0 d

ay

s

SU

MA

TR

IPT

AN

IM

ITR

EX

NA

SA

LY

ES

9 u

nit

s p

er

30

da

ys

SU

MA

TR

IPT

AN

IM

ITR

EX

SU

B-Q

YE

S9

un

its

pe

r 3

0 d

ay

s

SU

MA

TR

IPT

AN

-NA

PR

OX

EN

TR

EX

IME

TO

RA

LY

ES

9 u

nit

s p

er

30

da

ys

ZO

LMIT

RIP

TA

NZ

OM

IG 2

.5 M

GO

RA

LY

ES

12

un

its

pe

r 3

0 d

ay

s

ZO

LMIT

RIP

TA

NZ

OM

IG 5

.0 M

GO

RA

LY

ES

6 u

nit

s p

er

30

da

ys

ZO

LMIT

RIP

TA

NZ

OM

IGN

AS

AL

YE

S1

2 u

nit

s p

er

30

da

ys

ZO

LMIT

RIP

TA

NZ

OM

IG Z

MT

2.5

MG

OR

AL

YE

S1

2 u

nit

s p

er

30

da

ys

ZO

LMIT

RIP

TA

NZ

OM

IG Z

MT

5 M

GO

RA

LY

ES

6 u

nit

s p

er

30

da

ys

H7

WA

NT

I-N

AR

CO

LEP

SY

/AN

TI-

CA

TA

PLE

XY

SO

DIU

M O

XY

BA

TE

X

YR

EM

OR

AL

NO

H2

VA

NT

I-N

AR

CO

LEP

SY

/AN

TI-

HY

PE

RA

ll o

ral

form

ula

tio

ns

an

d s

tre

ng

ths

are

co

ve

red

fo

r a

llo

we

d c

on

dit

ion

s.

AR

MO

DA

FIN

ILN

UV

IGIL

OR

AL

YE

S

DE

XM

ET

HY

LPH

EN

IDA

TE

HC

LF

OC

ALI

NO

RA

LY

ES

ME

TH

YLP

HE

NID

AT

E H

CL

RIT

ALI

NO

RA

LY

ES

ME

TH

YLP

HE

NID

AT

E H

CL

CO

NC

ER

TA

OR

AL

YE

S

MO

DA

FIN

ILP

RO

VIG

ILO

RA

LY

ES

V1

MA

NT

INE

OP

L IM

MU

NO

DU

LAT

OR

AG

T

LEN

ALI

DO

MID

E

RE

VLI

MID

OR

AL

NO

V3

FA

NT

INE

OP

LAS

TIC

-AR

OM

AT

AS

E I

NH

IB

AN

AS

TR

OZ

OLE

AR

IMID

EX

OR

AL

NO

EX

EM

ES

TA

NE

A

RO

MA

SIN

OR

AL

NO

LET

RO

ZO

LEF

EM

AR

AO

RA

LN

O

Z1

EA

NT

IOX

IDA

NT

AG

EN

TS

LUT

EIN

-ZE

AX

AN

TH

IN

LUT

EIN

OR

AL

NO

H6

BA

NT

IPA

RK

INS

ON

ISM

DR

UG

S,

AN

TI

BE

NZ

TR

OP

INE

ME

SY

LAT

EC

OG

EN

TIN

OR

AL

YE

S

TR

IHE

XY

PH

EN

IDY

L H

CL

AR

TA

NE

OR

AL

YE

S

H6

AA

NT

IPA

RK

INS

ON

ISM

DR

UG

S,

OT

HE

AM

AN

TA

DIN

E H

CL

SY

MM

ET

RE

LO

RA

LY

ES

BR

OM

OC

RIP

TIN

E M

ES

YLA

TE

PA

RLO

DE

LO

RA

LY

ES

CA

RB

IDO

PA

-LE

VO

DO

PA

SIN

EM

ET

OR

AL

YE

S

CA

RB

IDO

PA

-LE

VO

DO

PA

-EN

TA

CA

PO

NE

S

TA

LEV

O 1

50

OR

AL

YE

S

EN

TA

CA

PO

NE

CO

MT

AN

OR

AL

YE

S

PE

RG

OLI

DE

ME

SY

LAT

EP

ER

MA

XO

RA

LY

ES

PR

AM

IPE

XO

LE D

IHY

DR

OC

HLO

RID

EM

IRA

PE

XO

RA

LY

ES

RA

SA

GIL

INE

ME

SY

LAT

EA

ZIL

EC

TO

RA

LY

ES

RO

PIN

IRO

LE H

CL

RO

PIN

IRO

LE H

CL

OR

AL

YE

S

RO

PIN

IRO

LE H

YD

RO

CH

LOR

IDE

RE

QU

IPO

RA

LY

ES

Page 9: ACTION: Final ENACTED DATE: 08/19/2011 4:16 PM Appendix ......Representative brand name (If one is in use), NOTE: Brand name products are eligible for reimbursement in accordance with

AP

PE

ND

IX A

BW

C O

UT

PA

TIE

NT

M

ED

ICA

TIO

N F

OR

MU

LAR

Y

Pa

ge

9 o

f 4

2

Th

era

pe

uti

c C

lass

Co

de

Th

era

pe

uti

c C

lass

Co

de

De

scri

pti

on

2G

en

eri

c N

am

e

Re

pre

sen

tati

ve

bra

nd

na

me

(If

on

e i

s in

use

), N

OT

E:

Bra

nd

na

me

pro

du

cts

are

eli

gib

le f

or

reim

bu

rse

me

nt

in a

cco

rda

nce

wit

h O

AC

41

23

-6-2

1D

osa

ge

Fo

rm

Re

qu

ire

s P

rio

r

Au

tho

riza

tio

n o

r

Re

late

d C

on

dit

ion

Ap

pro

ve

d i

n C

laim

Co

ve

rag

e r

est

rict

ion

s o

r li

mit

ati

on

s fo

r sp

eci

fic

dru

gs

or

do

sag

e f

orm

s a

re l

iste

d

wit

h t

he

re

spe

ctiv

e d

rug

s b

elo

w.

Un

less

oth

erw

ise

re

stri

cte

d,

all

do

sag

e f

orm

s

an

d s

tre

ng

ths

of

a l

iste

d d

rug

are

eli

gib

le f

or

reim

bu

rse

me

nt

in a

cco

rda

nce

wit

h

OA

C 4

12

3-6

-21

.

L8B

AN

TIP

ER

SP

IRA

NT

S

ALU

MIN

UM

CH

LOR

IDE

D

RY

SO

LT

OP

ICA

LN

O

L3P

AN

TIP

RU

RIT

ICS

, T

OP

ICA

L

DIP

HE

NH

YD

RA

MIN

E H

CL

BE

NA

DR

YL

ITC

H S

TO

PP

ING

TO

PIC

AL

NO

DO

XE

PIN

HC

LP

RU

DO

XIN

TO

PIC

AL

NO

PR

AM

OX

INE

-BE

NZ

YL

ALC

OH

OL

ITC

H-X

TO

PIC

AL

NO

PR

AM

OX

INE

-ZIN

C A

CE

TA

TE

C

ALA

DR

YL

CLE

AR

TO

PIC

AL

NO

L1A

AN

TIP

SO

RIA

TIC

AG

EN

T S

YS

TE

MIC

AC

ITR

ET

INS

OR

IAT

AN

EO

RA

LY

ES

L5F

AN

TIP

SO

RIA

TIC

S A

GE

NT

S

CA

LCIP

OT

RIE

NE

DO

VO

NE

XT

OP

ICA

LY

ES

TA

ZA

RO

TE

NE

TA

ZO

RA

CT

OP

ICA

LY

ES

H7

TA

NT

IPS

YC

HO

TIC

-AT

YP

ICA

L A

NT

AG

ON

AS

EN

AP

INE

MA

LEA

TE

SA

PH

RIS

SU

BLI

NG

UA

LN

O

CLO

ZA

PIN

EC

LOZ

AR

ILO

RA

LN

O

OLA

NZ

AP

INE

ZY

PR

EX

AO

RA

LN

O

PA

LIP

ER

IDO

NE

IN

VE

GA

OR

AL

NO

QU

ET

IAP

INE

FU

MA

RA

TE

S

ER

OQ

UE

LO

RA

LN

O

RIS

PE

RID

ON

ER

ISP

ER

DA

LO

RA

LN

O

ZIP

RA

SID

ON

E H

CL

GE

OD

ON

OR

AL

NO

H7

OA

NT

IPS

YC

HO

TIC

-BU

TY

RO

NP

HE

NO

NE

S

HA

LOP

ER

IDO

L H

ALD

OL

OR

AL

NO

H7

SA

NT

IPS

YC

HO

TIC

-DIH

YD

RO

IND

OLO

NE

S

MO

LIN

DO

NE

HC

L M

OB

AN

OR

AL

NO

H7

RA

NT

IPS

YC

HO

TIC

-DIP

HE

NY

LBU

TY

LPIP

PIM

OZ

IDE

O

RA

PO

RA

LN

O

H7

UA

NT

IPS

YC

HO

TIC

-DO

PA

/SE

RO

AN

TG

LOX

AP

INE

SU

CC

INA

TE

LO

XIT

AN

EO

RA

LN

O

H2

GA

NT

I-P

SY

CH

OT

ICS

,PH

EN

OT

HIA

ZIN

CH

LOR

PR

OM

AZ

INE

HC

LT

HO

RA

ZIN

EO

RA

LN

O

FLU

PH

EN

AZ

INE

HC

LP

RO

LIX

INO

RA

LN

O

PE

RP

HE

NA

ZIN

ET

RIL

AF

ON

OR

AL

NO

TH

IOR

IDA

ZIN

E H

CL

ME

LLA

RIL

OR

AL

NO

TR

IFLU

OP

ER

AZ

INE

HC

LS

TE

LAZ

INE

OR

AL

NO

H7

XA

NT

IPS

YC

HO

TIC

S-A

TY

PIC

AL,

D2

/5H

T

AR

IPIP

RA

ZO

LE

AB

ILIF

YO

RA

LN

O

H7

PA

NT

IPS

YC

HO

TIC

-TH

IOX

AN

TH

EN

ES

TH

IOT

HIX

EN

E

NA

VA

NE

OR

AL

NO

W2

EA

NT

ITU

BE

RC

ULA

R A

GE

NT

S

ET

HA

MB

UT

OL

HC

LE

TH

AM

BU

TO

L H

CL

OR

AL

NO

ISO

NIA

ZID

IS

ON

IAZ

IDO

RA

LN

O

PY

RA

ZIN

AM

IDE

P

YR

AZ

INA

MID

EO

RA

LN

O

RIF

AB

UT

INM

YC

OB

UT

INO

RA

LN

O

Page 10: ACTION: Final ENACTED DATE: 08/19/2011 4:16 PM Appendix ......Representative brand name (If one is in use), NOTE: Brand name products are eligible for reimbursement in accordance with

AP

PE

ND

IX A

BW

C O

UT

PA

TIE

NT

M

ED

ICA

TIO

N F

OR

MU

LAR

Y

Pa

ge

10

of

42

Th

era

pe

uti

c C

lass

Co

de

Th

era

pe

uti

c C

lass

Co

de

De

scri

pti

on

2G

en

eri

c N

am

e

Re

pre

sen

tati

ve

bra

nd

na

me

(If

on

e i

s in

use

), N

OT

E:

Bra

nd

na

me

pro

du

cts

are

eli

gib

le f

or

reim

bu

rse

me

nt

in a

cco

rda

nce

wit

h O

AC

41

23

-6-2

1D

osa

ge

Fo

rm

Re

qu

ire

s P

rio

r

Au

tho

riza

tio

n o

r

Re

late

d C

on

dit

ion

Ap

pro

ve

d i

n C

laim

Co

ve

rag

e r

est

rict

ion

s o

r li

mit

ati

on

s fo

r sp

eci

fic

dru

gs

or

do

sag

e f

orm

s a

re l

iste

d

wit

h t

he

re

spe

ctiv

e d

rug

s b

elo

w.

Un

less

oth

erw

ise

re

stri

cte

d,

all

do

sag

e f

orm

s

an

d s

tre

ng

ths

of

a l

iste

d d

rug

are

eli

gib

le f

or

reim

bu

rse

me

nt

in a

cco

rda

nce

wit

h

OA

C 4

12

3-6

-21

.

W1

GA

NT

ITU

BE

RC

ULA

R A

NT

IBIO

TIC

S

RIF

AM

PIN

RIF

AD

INO

RA

LN

O

B3

SA

NT

ITU

SS

-AN

TIH

IST

-DE

CO

NG

-EX

PE

C

PH

EN

YLE

PH

-CH

LOR

PH

EN

W/

DM

-GG

Q

UA

L-T

US

SIN

OR

AL

NO

B3

TA

NT

ITU

SS

-EX

PE

CT

OR

AN

T-C

OM

BIN

AT

I

DE

XT

RO

ME

TH

OR

PH

AN

-GU

AIF

EN

ES

IN S

YR

UP

RO

BIT

US

SIN

-DM

CO

UG

HO

RA

LN

O

H6

CA

NT

ITU

SS

IVE

, N

ON

-NA

RC

OT

IC

BE

NZ

ON

AT

AT

ET

ES

SA

LON

OR

AL

NO

DE

XT

RO

ME

TH

OR

PH

AN

PO

LIS

TIR

EX

D

ELS

YM

OR

AL

NO

B3

RA

NT

ITU

SS

IVE

-AN

TIH

IST

-DE

CO

NG

ES

TB

RO

MP

HE

NIR

AM

INE

&

DE

XT

RO

ME

TH

OR

PH

AN

BR

OM

FE

D-D

MO

RA

LN

OP

HE

NY

LEP

H T

AN

-PY

RIL

AM

INE

TA

N-C

AR

BE

TA

TA

N T

AB

TU

SS

I-1

2D

OR

AL

NO

PH

EN

YLE

PH

-EP

HE

D-C

PM

W/

CA

RB

ET

AP

EN

TA

NE

R

YN

AT

US

SO

RA

LN

O

PH

EN

YLE

PH

RIN

E-C

HLO

RP

HE

N-D

M

C-P

HE

N D

MO

RA

LN

O

PH

EN

YLE

PH

RIN

E-P

YR

ILA

MIN

E-D

MC

OD

AL-

DM

OR

AL

NO

PS

EU

DO

EP

H-B

RO

MP

HE

N W

/

HY

DR

OC

OD

ON

E S

OLN

B

RO

MP

LEX

DM

OR

AL

NO

PS

EU

DO

EP

HE

D T

AN

-BR

OM

PH

EN

TA

N-D

M

TA

N S

US

PA

NA

PLE

X D

MX

OR

AL

NO

PS

EU

DO

EP

HE

D-B

RO

MP

HE

N-D

M S

YR

UP

BR

OM

ET

AN

E D

XO

RA

LN

O

PS

EU

DO

EP

HE

D-B

RO

MP

HE

NP

HE

NIR

AM

INE

PS

E B

RO

MO

RA

LN

O

D4

FA

NT

IULC

ER

H P

YLO

RI

AG

EN

TS

AM

OX

ICIL

LIN

CA

P-C

LAR

ITH

RO

TA

B-

LAN

SO

PR

AZ

P

RE

VP

AC

OR

AL

YE

SM

ET

RO

NID

AZ

TA

B-T

ET

RA

CY

C C

AP

-BIS

SU

BS

AL

HE

LID

AC

OR

AL

YE

S

D4

EA

NT

IULC

ER

PR

EP

AR

AT

ION

S

MIS

OP

RO

ST

OL

CY

TO

TE

CO

RA

LN

O

SU

CR

ALF

AT

E

CA

RA

FA

TE

OR

AL

NO

W5

HA

NT

IVIR

AL

GE

NE

RA

L C

ON

T.

1

VA

LGA

NC

ICLO

VIR

HC

LV

ALC

YT

EO

RA

LY

ES

W5

AA

NT

IVIR

ALS

AC

YC

LOV

IRA

CY

CLO

VIR

OR

AL

YE

S

FA

MC

ICLO

VIR

FA

MV

IRO

RA

LY

ES

OS

ELT

AM

IVIR

PH

OS

PH

AT

E

TA

MIF

LUO

RA

LY

ES

VA

LAC

YC

LOV

IR H

CL

VA

LTR

EX

OR

AL

YE

S

C7

FA

PP

ET

ITE

ST

IMU

LAN

TS

AN

OR

EX

IA

ME

GE

ST

RO

L A

CE

TA

TE

M

EG

AC

EO

RA

LY

ES

Page 11: ACTION: Final ENACTED DATE: 08/19/2011 4:16 PM Appendix ......Representative brand name (If one is in use), NOTE: Brand name products are eligible for reimbursement in accordance with

AP

PE

ND

IX A

BW

C O

UT

PA

TIE

NT

M

ED

ICA

TIO

N F

OR

MU

LAR

Y

Pa

ge

11

of

42

Th

era

pe

uti

c C

lass

Co

de

Th

era

pe

uti

c C

lass

Co

de

De

scri

pti

on

2G

en

eri

c N

am

e

Re

pre

sen

tati

ve

bra

nd

na

me

(If

on

e i

s in

use

), N

OT

E:

Bra

nd

na

me

pro

du

cts

are

eli

gib

le f

or

reim

bu

rse

me

nt

in a

cco

rda

nce

wit

h O

AC

41

23

-6-2

1D

osa

ge

Fo

rm

Re

qu

ire

s P

rio

r

Au

tho

riza

tio

n o

r

Re

late

d C

on

dit

ion

Ap

pro

ve

d i

n C

laim

Co

ve

rag

e r

est

rict

ion

s o

r li

mit

ati

on

s fo

r sp

eci

fic

dru

gs

or

do

sag

e f

orm

s a

re l

iste

d

wit

h t

he

re

spe

ctiv

e d

rug

s b

elo

w.

Un

less

oth

erw

ise

re

stri

cte

d,

all

do

sag

e f

orm

s

an

d s

tre

ng

ths

of

a l

iste

d d

rug

are

eli

gib

le f

or

reim

bu

rse

me

nt

in a

cco

rda

nce

wit

h

OA

C 4

12

3-6

-21

.

Q6

TA

RT

IFIC

IAL

TE

AR

S

AR

TIF

ICIA

L T

EA

RS

AK

WA

TE

AR

SO

PH

TH

ALM

ICN

O

AR

TIF

ICIA

L T

EA

RS

LAC

RIS

ER

TO

PH

TH

ALM

ICN

O

AR

TIF

ICIA

L T

EA

RS

N

AT

UR

E'S

TE

AR

SO

PH

TH

ALM

ICN

O

CA

RB

OX

YM

ET

HY

LCE

LLU

LOS

E S

OD

IUM

RE

FR

ES

H P

LUS

OP

HT

HA

LMIC

NO

CA

RB

OX

YM

ET

HY

LCE

LLU

LOS

E-G

LYC

ER

INO

PT

IVE

OP

HT

HA

LMIC

NO

GLY

CE

RIN

-PO

LYS

OR

BA

TE

80

RE

FR

ES

H D

RY

EY

E T

HE

RA

PY

OP

HT

HA

LMIC

NO

HY

PR

OM

ELL

OS

EG

EN

TE

AL

OP

HT

HA

LMIC

NO

HY

PR

OM

ELL

OS

EIS

OP

TO

TE

AR

SO

PH

TH

ALM

ICN

O

Ina

ctiv

eR

EF

RE

SH

LIQ

UIG

EL

OP

HT

HA

LMIC

NO

PO

LYE

TH

YLE

NE

GLY

CO

L-P

OLY

VIN

YL

ALC

OH

OL

HY

PO

TE

AR

SO

PH

TH

ALM

ICN

O

PO

LYE

TH

YLE

NE

GLY

CO

L-P

RO

PY

LEN

E G

LYC

OL

SY

ST

AN

EO

PH

TH

ALM

ICN

O

PO

LYV

INY

L A

LCO

HO

L T

EA

RG

EN

OP

HT

HA

LMIC

NO

PO

LYV

INY

L A

LCO

HO

L-P

OV

IDO

NE

R

EF

RE

SH

OP

HT

HA

LMIC

NO

PO

LYV

INY

L A

LC-P

OV

IDO

NE

-2,4

-D

DIM

ET

HY

LAM

INE

FR

ES

HK

OT

EO

PH

TH

ALM

ICN

O

L4A

AS

TR

ING

EN

TS

ALU

MIN

UM

AC

ET

AT

EA

-MA

NT

LET

OP

ICA

LN

O

ALU

MIN

UM

AC

ET

AT

E S

OLN

ALU

MIN

UM

AC

ET

AT

E S

OLN

TO

PIC

AL

NO

WIT

CH

HA

ZE

L (H

AM

AM

ELI

S V

IRG

INIA

NA

)T

UC

KS

TO

PIC

AL

NO

WIT

CH

HA

ZE

L-G

LYC

ER

IN

ME

DI

PA

DS

TO

PIC

AL

NO

H2

DB

AR

BIT

UR

AT

ES

BU

TIS

OL

SO

DIU

MB

UT

ISO

L S

OD

IUM

OR

AL

YE

S

PH

EN

OB

AR

BIT

AL

PH

EN

OB

AR

BIT

AL

OR

AL

YE

S

SE

CO

BA

RB

ITA

L S

OD

IUM

S

EC

ON

AL

SO

DIU

MO

RA

LY

ES

J2A

BE

LLA

DO

NN

A A

LKA

LOID

S

AT

RO

PIN

E S

ULF

AT

E

SA

L-T

RO

PIN

EO

RA

LN

O

BE

LLA

DO

NN

A A

LKA

LOID

S-P

HE

NO

BA

RB

ITA

L D

ON

NA

TA

LO

RA

LN

O

HY

OS

CY

AM

INE

SU

LFA

TE

LE

VS

INO

RA

LN

O

ME

TH

SC

OP

OLA

MIN

E B

RO

MID

E

PA

MIN

EO

RA

LN

O

Q9

BB

EN

IGN

PR

OS

TA

TIC

HY

PE

RT

RO

PH

Y

ALF

UZ

OS

IN H

CL

UR

OX

AT

RA

LO

RA

LY

ES

DU

TA

ST

ER

IDE

AV

OD

AR

TO

RA

LY

ES

FIN

AS

TE

RID

EF

INA

ST

ER

IDE

OR

AL

YE

S

SIL

OD

OS

IN

RA

PA

FLO

OR

AL

YE

S

TA

MS

ULO

SIN

HC

LF

LOM

AX

OR

AL

YE

S

J7C

BE

TA

AD

RE

NE

RG

IC B

LOC

KIN

G A

GE

S

AC

EB

UT

OLO

L H

CL

AC

EB

UT

OLO

L H

CL

OR

AL

YE

S

AT

EN

OLO

LT

EN

OR

MIN

OR

AL

YE

S

BIS

OP

RO

LOL

FU

MA

RA

TE

BIS

OP

RO

LOL

FU

MA

RA

TE

OR

AL

YE

S

Page 12: ACTION: Final ENACTED DATE: 08/19/2011 4:16 PM Appendix ......Representative brand name (If one is in use), NOTE: Brand name products are eligible for reimbursement in accordance with

AP

PE

ND

IX A

BW

C O

UT

PA

TIE

NT

M

ED

ICA

TIO

N F

OR

MU

LAR

Y

Pa

ge

12

of

42

Th

era

pe

uti

c C

lass

Co

de

Th

era

pe

uti

c C

lass

Co

de

De

scri

pti

on

2G

en

eri

c N

am

e

Re

pre

sen

tati

ve

bra

nd

na

me

(If

on

e i

s in

use

), N

OT

E:

Bra

nd

na

me

pro

du

cts

are

eli

gib

le f

or

reim

bu

rse

me

nt

in a

cco

rda

nce

wit

h O

AC

41

23

-6-2

1D

osa

ge

Fo

rm

Re

qu

ire

s P

rio

r

Au

tho

riza

tio

n o

r

Re

late

d C

on

dit

ion

Ap

pro

ve

d i

n C

laim

Co

ve

rag

e r

est

rict

ion

s o

r li

mit

ati

on

s fo

r sp

eci

fic

dru

gs

or

do

sag

e f

orm

s a

re l

iste

d

wit

h t

he

re

spe

ctiv

e d

rug

s b

elo

w.

Un

less

oth

erw

ise

re

stri

cte

d,

all

do

sag

e f

orm

s

an

d s

tre

ng

ths

of

a l

iste

d d

rug

are

eli

gib

le f

or

reim

bu

rse

me

nt

in a

cco

rda

nce

wit

h

OA

C 4

12

3-6

-21

.

BE

TA

AD

RE

NE

RG

IC B

LOC

KIN

G A

GE

S (

CO

NT

)M

ET

OP

RO

LOL

SU

CC

INA

TE

TO

PR

OL

XL

OR

AL

YE

S

ME

TO

PR

OLO

L T

AR

TR

AT

ELO

PR

ES

SO

RO

RA

LY

ES

NA

DO

LOL

CO

RG

AR

DO

RA

LY

ES

PIN

DO

LOL

PIN

DO

LOL

OR

AL

YE

S

PR

OP

RA

NO

LOL

HC

L IN

DE

RA

LO

RA

LY

ES

SO

TA

LOL

SO

TA

LOL

OR

AL

YE

S

TIM

OLO

L M

ALE

AT

ET

IMO

LOL

MA

LEA

TE

OR

AL

YE

S

J7D

BE

TA

AD

RE

NE

RG

IC B

LOC

KIN

G C

ON

NE

BIV

OLO

L H

CL

BY

ST

OLI

CO

RA

LN

O

J5D

BE

TA

-AD

RE

NE

RG

IC A

GE

NT

S

ALB

UT

ER

OL

SU

LFA

TE

ALB

UT

ER

OL

INH

ALA

TIO

NN

O

ALB

UT

ER

OL

SU

LFA

TE

PR

OV

EN

TIL

OR

AL

NO

AR

FO

RM

OT

ER

OL

TA

RT

RA

TE

B

RO

VA

NA

INH

ALA

TIO

NN

O

FO

RM

OT

ER

OL

FU

MA

RA

TE

F

OR

AD

ILIN

HA

LAT

ION

NO

LEV

ALB

UT

ER

OL

HC

LX

OP

EN

EX

INH

ALA

TIO

NN

O

ME

TA

PR

OT

ER

EN

OL

SU

LFA

TE

ME

TA

PR

EL

OR

AL

NO

ME

TA

PR

OT

ER

EN

OL

SU

LFA

TE

ME

TA

PR

EL

INH

ALA

TIO

NN

O

PIR

BU

TE

RO

L A

CE

TA

TE

MA

XA

IR A

UT

OH

ALE

RIN

HA

LAT

ION

NO

SA

LME

TE

RO

L X

INA

FO

AT

ES

ER

EV

EN

T D

ISK

US

INH

ALA

TIO

NN

O

TE

RB

UT

ALI

NE

SU

LFA

TE

BR

ET

HIN

EO

RA

LN

O

J5J

BE

TA

-AD

RE

NE

RG

IC/A

NT

ICH

OLI

N C

MB

IPR

AT

RO

PIU

M-A

LBU

TE

RO

L C

OM

BIV

EN

TIN

HA

LAT

ION

NO

J5G

BE

TA

-AD

RE

NE

RG

ICS

GLU

CO

CO

RT

ICB

UD

ES

ON

IDE

-FO

RM

OT

ER

OL

FU

MA

RA

TE

DIH

YD

SY

MB

ICO

RT

INH

ALA

TIO

NN

O

FLU

TIC

AS

ON

E-S

ALM

ET

ER

OL

AD

VA

IR

INH

ALA

TIO

NN

OM

OM

ET

AS

ON

E F

UR

OA

TE

-FO

RM

OT

ER

OL

FU

MA

RA

TE

DU

LER

AIN

HA

LAT

ION

NO

J7H

BE

TA

-BLO

CK

ER

/TH

IAZ

IDE

CO

MB

O

AT

EN

OLO

L-C

HLO

RT

HA

LID

ON

EA

TE

NO

LOL-

CH

LOR

TH

ALI

DO

NE

OR

AL

NO

BIS

OP

RO

LOL

& H

YD

RO

CH

LOR

OT

HIA

ZID

EZ

IAC

OR

AL

NO

BIS

OP

RO

LOL

FU

MA

RA

TE

-HC

TZ

BIS

OP

RO

LOL

FU

MA

RA

TE

-HC

TZ

OR

AL

NO

ME

TO

PR

OLO

L-H

YD

RO

CH

LOR

OT

HIA

ZID

EM

ET

OP

RO

LOL-

HY

DR

OC

HLO

RO

TH

IAZ

IDE

OR

AL

NO

D7

LB

ILE

SA

LT I

NH

IBIT

OR

S

CH

OLE

ST

YR

AM

INE

PR

EV

ALI

TE

OR

AL

YE

S

CO

LES

EV

ELA

M H

CL

WE

LCH

OL

OR

AL

YE

S

CO

LES

TIP

OL

HC

L C

OLE

ST

IDO

RA

LY

ES

D7

AB

ILE

SA

LTS

UR

SO

DIO

L U

RS

O F

OR

TE

OR

AL

YE

S

P4

BB

ON

E F

OR

M S

TIM

AG

TS

-PT

HO

RM

O

TE

RIP

AR

AT

IDE

(R

EC

OM

BIN

AN

T)

FO

RT

EO

SU

B-Q

YE

S

Page 13: ACTION: Final ENACTED DATE: 08/19/2011 4:16 PM Appendix ......Representative brand name (If one is in use), NOTE: Brand name products are eligible for reimbursement in accordance with

AP

PE

ND

IX A

BW

C O

UT

PA

TIE

NT

M

ED

ICA

TIO

N F

OR

MU

LAR

Y

Pa

ge

13

of

42

Th

era

pe

uti

c C

lass

Co

de

Th

era

pe

uti

c C

lass

Co

de

De

scri

pti

on

2G

en

eri

c N

am

e

Re

pre

sen

tati

ve

bra

nd

na

me

(If

on

e i

s in

use

), N

OT

E:

Bra

nd

na

me

pro

du

cts

are

eli

gib

le f

or

reim

bu

rse

me

nt

in a

cco

rda

nce

wit

h O

AC

41

23

-6-2

1D

osa

ge

Fo

rm

Re

qu

ire

s P

rio

r

Au

tho

riza

tio

n o

r

Re

late

d C

on

dit

ion

Ap

pro

ve

d i

n C

laim

Co

ve

rag

e r

est

rict

ion

s o

r li

mit

ati

on

s fo

r sp

eci

fic

dru

gs

or

do

sag

e f

orm

s a

re l

iste

d

wit

h t

he

re

spe

ctiv

e d

rug

s b

elo

w.

Un

less

oth

erw

ise

re

stri

cte

d,

all

do

sag

e f

orm

s

an

d s

tre

ng

ths

of

a l

iste

d d

rug

are

eli

gib

le f

or

reim

bu

rse

me

nt

in a

cco

rda

nce

wit

h

OA

C 4

12

3-6

-21

.

P4

LB

ON

E O

SS

IFIC

AT

ION

SU

PP

RE

SS

IO

ALE

ND

RO

NA

TE

SO

DIU

MF

OS

AM

AX

OR

AL

YE

S

CA

LCIT

ON

IN (

SA

LMO

N)

MIA

CA

LCIN

NA

SA

LY

ES

ET

IDR

ON

AT

E D

ISO

DIU

ME

TID

RO

NA

TE

DIS

OD

IUM

OR

AL

YE

S

IBA

ND

RO

NA

TE

SO

DIU

M

BO

NIV

AO

RA

LY

ES

RA

LOX

IFE

NE

HC

L E

VIS

TA

OR

AL

YE

S

RIS

ED

RO

NA

TE

SO

DIU

MA

CT

ON

EL

OR

AL

YE

S

P4

OB

ON

E R

ES

OR

P I

NH

IB-C

ALC

IUM

CO

MR

ISE

DR

ON

AT

E S

OD

WIT

H C

ALC

IUM

CA

RB

ON

AT

EA

CT

ON

EL

WIT

H C

ALC

IUM

OR

AL

YE

S

P4

NB

ON

E R

ES

OR

PT

ION

IN

HIB

& V

IT D

ALE

ND

RO

NA

TE

SO

DIU

M-C

HO

LEC

ALC

IFE

RO

L F

OS

AM

AX

PLU

S D

OR

AL

YE

S

P4

MB

ON

E R

I, S

EN

SIT

IVIT

Y E

NH

AN

CE

R

CIN

AC

ALC

ET

HC

L S

EN

SIP

AR

OR

AL

YE

S

C6

SC

6S

VIT

AM

IN B

& C

CO

MB

INA

TIO

N

All

co

mb

ina

tio

ns

an

d s

tre

ng

ths

of

ora

l d

osa

ge

fo

rms

are

co

ve

red

fo

r a

llo

we

d

con

dit

ion

s

MU

LTIP

LE V

ITA

MIN

S W

/ M

INE

RA

LST

HE

RA

PE

UT

IC-M

OR

AL

NO

C6

VC

6V

PR

NT

L V

ITA

MIN

PR

EP

S(C

ON

T1

)

All

co

mb

ina

tio

ns

an

d s

tre

ng

ths

of

ora

l d

osa

ge

fo

rms

are

co

ve

red

fo

r a

llo

we

d

con

dit

ion

s

PR

EN

AT

AL

VIT

W/

DS

S-I

RO

N C

AR

BO

NY

L-F

A

ULT

RA

NA

TA

LCA

RE

OR

AL

YE

S

A9

AC

ALC

IUM

CH

AN

NE

L B

LOC

KIN

G A

GT

AM

LOD

IPIN

E B

ES

YLA

TE

NO

RV

AS

CO

RA

LY

ES

DIL

TIA

ZE

M H

CL

CA

RD

IZE

M

OR

AL

YE

S

FE

LOD

IPIN

EF

ELO

DIP

INE

ER

OR

AL

YE

S

ISR

AD

IPIN

ED

YN

AC

IRC

CR

OR

AL

YE

S

NIC

AR

DIP

INE

HC

LC

AR

DE

NE

O

RA

LY

ES

NIF

ED

IPIN

EP

RO

CA

RD

IAO

RA

LY

ES

NIS

OLD

IPIN

ES

ULA

RO

RA

LY

ES

VE

RA

PA

MIL

HC

L V

ER

ELA

NO

RA

LY

ES

C1

FC

ALC

IUM

RE

PLA

CE

ME

NT

All

ca

lciu

m s

alt

s a

nd

ora

l d

osa

ge

fo

rms

are

co

ve

red

fo

r a

llo

we

d c

on

dit

ion

s

CA

LCIU

M C

AR

BO

NA

TE

-VIT

AM

IN D

CA

LCIU

M 5

00

+ V

IT D

OR

AL

YE

S

CA

LCIU

M C

ITR

AT

E-V

ITA

MIN

DC

ALC

ITR

AT

EO

RA

LY

ES

CA

LCIU

M G

LUC

ON

AT

E

CA

LCIU

M G

LUC

ON

AT

EO

RA

LY

ES

CA

LCIU

M W

/ M

AG

NE

SIU

MC

ALC

IUM

-MA

GN

ES

IUM

OR

AL

YE

S

R1

EC

AR

BO

NIC

AN

HY

DR

AS

E I

NH

IBIT

OR

AC

ET

AZ

OLA

MID

EA

CE

TA

ZO

LAM

IDE

OR

AL

YE

S

ME

TH

AZ

OLA

MID

EM

ET

HA

ZO

LAM

IDE

OR

AL

YE

S

W1

WC

EP

HA

LOS

PR

OR

IN,

1S

T G

EN

ER

AT

CE

FA

DR

OX

ILC

EF

AD

RO

XIL

OR

AL

NO

CE

PH

ALE

XIN

KE

FLE

XO

RA

LN

O

Page 14: ACTION: Final ENACTED DATE: 08/19/2011 4:16 PM Appendix ......Representative brand name (If one is in use), NOTE: Brand name products are eligible for reimbursement in accordance with

AP

PE

ND

IX A

BW

C O

UT

PA

TIE

NT

M

ED

ICA

TIO

N F

OR

MU

LAR

Y

Pa

ge

14

of

42

Th

era

pe

uti

c C

lass

Co

de

Th

era

pe

uti

c C

lass

Co

de

De

scri

pti

on

2G

en

eri

c N

am

e

Re

pre

sen

tati

ve

bra

nd

na

me

(If

on

e i

s in

use

), N

OT

E:

Bra

nd

na

me

pro

du

cts

are

eli

gib

le f

or

reim

bu

rse

me

nt

in a

cco

rda

nce

wit

h O

AC

41

23

-6-2

1D

osa

ge

Fo

rm

Re

qu

ire

s P

rio

r

Au

tho

riza

tio

n o

r

Re

late

d C

on

dit

ion

Ap

pro

ve

d i

n C

laim

Co

ve

rag

e r

est

rict

ion

s o

r li

mit

ati

on

s fo

r sp

eci

fic

dru

gs

or

do

sag

e f

orm

s a

re l

iste

d

wit

h t

he

re

spe

ctiv

e d

rug

s b

elo

w.

Un

less

oth

erw

ise

re

stri

cte

d,

all

do

sag

e f

orm

s

an

d s

tre

ng

ths

of

a l

iste

d d

rug

are

eli

gib

le f

or

reim

bu

rse

me

nt

in a

cco

rda

nce

wit

h

OA

C 4

12

3-6

-21

.

W1

XC

EP

HA

LOS

PR

OR

IN,

2N

D G

EN

ER

AT

CE

FA

CLO

R

CE

FA

CLO

RO

RA

LN

O

CE

FP

RO

ZIL

CE

FP

RO

ZIL

OR

AL

NO

CE

FU

RO

XIM

E A

XE

TIL

CE

FT

INO

RA

LN

O

W1

YC

EP

HA

LOS

PR

OR

IN,

3R

D G

EN

ER

AT

CE

FD

INIR

O

MN

ICE

FO

RA

LN

O

CE

FD

ITO

RE

N P

IVO

XIL

S

PE

CT

RA

CE

FO

RA

LN

O

CE

FIX

IME

SU

PR

AX

OR

AL

NO

CE

FT

AZ

IDIM

EC

EF

TA

ZID

IME

INJE

CT

ION

NO

CE

FT

IBU

TE

N

CE

DA

XO

RA

LN

O

CE

FT

RIA

XO

NE

CE

FT

RIA

XO

NE

INJE

CT

ION

NO

W1

ZC

EP

HA

LOS

PR

OR

IN,

4T

H G

EN

ER

AT

CE

FE

PIM

E H

CL

CE

FE

PIM

EIN

TR

AV

EN

NO

CE

FE

PIM

E H

CL

CE

FE

PIM

E H

CL

INJE

CT

ION

NO

J1B

CH

OLI

NE

ST

ER

AS

E I

NH

IBIT

OR

S

DO

NE

PE

ZIL

HY

DR

OC

HLO

RID

EA

RIC

EP

TO

RA

LY

ES

GA

LAN

TA

MIN

E H

YD

RO

BR

OM

IDE

RA

ZA

DY

NE

OR

AL

YE

S

PY

RID

OS

TIG

MIN

E B

RO

MID

EM

ES

TIN

ON

OR

AL

YE

S

RIV

AS

TIG

MIN

E T

AR

TR

AT

E

EX

ELO

NO

RA

LY

ES

Z2

FC

HR

OM

OLY

N A

ND

DE

RIV

AT

IVE

S

CR

OM

OLY

N S

OD

IUM

CR

OM

OLY

N S

OD

IUM

INH

ALA

TIO

NN

O

D6

FC

HR

ON

IC C

OLO

N I

NF

LAM

DR

UG

TX

BA

LSA

LAZ

IDE

DIS

OD

IUM

BA

LSA

LAZ

IDE

DIS

OD

IUM

O

RA

LY

ES

ME

SA

LAM

INE

A

SA

CO

LO

RA

LY

ES

OLS

ALA

ZIN

E S

OD

IUM

D

IPE

NT

UM

OR

AL

YE

S

S2

AC

OLC

HIC

INE

CO

LCH

ICIN

EC

OLC

HIC

INE

OR

AL

YE

S

Q3

EC

OLO

N I

NF

LAM

DR

UG

, R

EC

TA

L

ME

SA

LAM

INE

C

AN

AS

AR

EC

TA

LY

ES

A7

BC

OR

ON

AR

Y V

AS

OD

ILA

TO

RS

ISO

SO

RB

IDE

DIN

ITR

AT

EIS

OS

OR

BID

E D

INIT

RA

TE

OR

AL

YE

S

ISO

SO

RB

IDE

MO

NO

NIT

RA

TE

ISM

OO

RA

LY

ES

NIT

RO

GLY

CE

RIN

NIT

RO

GLY

CE

RIN

OR

AL

YE

S

NIT

RO

GLY

CE

RIN

OIN

T 2

%

NIT

RO

-BID

OIN

TT

RA

NS

DE

RM

YE

S

NIT

RO

GLY

CE

RIN

PA

TC

HN

ITR

OG

LYC

ER

IN P

AT

CH

TR

AN

SD

ER

MY

ES

NIT

RO

GLY

CE

RIN

SL

NIT

RO

ST

AT

SU

BLI

NG

UA

LY

ES

NIT

RO

GLY

CE

RIN

TL

SO

LNN

ITR

OLI

NG

UA

LT

RA

NS

LIN

GY

ES

B4

TD

EC

ON

GE

ST

-AN

ALG

ES

IC,N

ON

-SA

LIC

YLA

TE

CO

MB

.

PH

EN

YLE

PH

RIN

E W

/ A

CE

TA

MIN

OP

HE

NP

HE

NY

LEP

HR

INE

W/

AC

ET

AM

INO

PH

EN

OR

AL

NO

Page 15: ACTION: Final ENACTED DATE: 08/19/2011 4:16 PM Appendix ......Representative brand name (If one is in use), NOTE: Brand name products are eligible for reimbursement in accordance with

AP

PE

ND

IX A

BW

C O

UT

PA

TIE

NT

M

ED

ICA

TIO

N F

OR

MU

LAR

Y

Pa

ge

15

of

42

Th

era

pe

uti

c C

lass

Co

de

Th

era

pe

uti

c C

lass

Co

de

De

scri

pti

on

2G

en

eri

c N

am

e

Re

pre

sen

tati

ve

bra

nd

na

me

(If

on

e i

s in

use

), N

OT

E:

Bra

nd

na

me

pro

du

cts

are

eli

gib

le f

or

reim

bu

rse

me

nt

in a

cco

rda

nce

wit

h O

AC

41

23

-6-2

1D

osa

ge

Fo

rm

Re

qu

ire

s P

rio

r

Au

tho

riza

tio

n o

r

Re

late

d C

on

dit

ion

Ap

pro

ve

d i

n C

laim

Co

ve

rag

e r

est

rict

ion

s o

r li

mit

ati

on

s fo

r sp

eci

fic

dru

gs

or

do

sag

e f

orm

s a

re l

iste

d

wit

h t

he

re

spe

ctiv

e d

rug

s b

elo

w.

Un

less

oth

erw

ise

re

stri

cte

d,

all

do

sag

e f

orm

s

an

d s

tre

ng

ths

of

a l

iste

d d

rug

are

eli

gib

le f

or

reim

bu

rse

me

nt

in a

cco

rda

nce

wit

h

OA

C 4

12

3-6

-21

.

B4

WD

EC

ON

GE

ST

AN

T-E

XP

EC

TO

RA

NT

CO

MB

PH

EN

YLE

PH

RIN

E-G

UA

IFE

NE

SIN

CA

P S

R

GE

NE

XA

LA

OR

AL

NO

PS

EU

DO

EP

HE

DR

INE

-GU

AIF

EN

ES

IN T

AB

SR

M

UC

INE

X D

OR

AL

NO

B4

UD

EC

ON

GE

ST

-AN

TIC

HO

LIN

ER

GIC

CM

BP

SE

UD

OE

PH

ED

RIN

E-M

ET

HS

CO

PO

LAM

INE

TA

B

PS

EU

DO

EP

HE

DR

INE

-ME

TH

SC

OP

OLA

MIN

E

TA

BO

RA

LN

O

D1

DD

EN

TA

L A

IDS

AN

D P

RE

PA

RA

TIO

NS

CH

LOR

HE

XID

INE

GLU

CO

NA

TE

P

ER

IOG

AR

DM

UC

OU

S M

EM

YE

S

TR

IAM

CIN

OLO

NE

AC

ET

ON

IDE

T

RIA

MC

INO

LON

E A

CE

TO

NID

ED

EN

TA

LY

ES

L8A

DE

OD

OR

AN

TS

OS

TO

MY

SU

PP

LIE

SM

9M

ISC

ELL

NO

L0C

DIA

BE

TIC

ULS

ER

PR

EP

TO

PIC

AL

BE

CA

PLE

RM

IN

RE

GR

AN

EX

TO

PIC

AL

YE

S

A1

AD

IGIT

ALI

S G

LYC

OS

IDE

S

DIG

OX

INLA

NO

XIN

Ora

lY

ES

F2

AD

RU

GS

TO

TR

EA

T I

MP

OT

EN

CY

ALP

RO

ST

AD

IL

CA

VE

RJE

CT

INT

RA

CA

VE

RY

ES

6 U

NIT

S P

ER

30

DA

YS

ALP

RO

ST

AD

IL

ED

EX

INT

RA

CA

VE

RY

ES

6 U

NIT

S P

ER

30

DA

YS

ALP

RO

ST

AD

IL U

RE

TH

RA

L P

ELL

ET

MU

SE

UR

ET

HR

AL

YE

S6

UN

ITS

PE

R 3

0 D

AY

S

SIL

DE

NA

FIL

CIT

RA

TE

VIA

GR

AO

RA

LY

ES

6 U

NIT

S P

ER

30

DA

YS

TA

DA

LAF

ILC

IALI

SO

RA

LY

ES

10

mg

or

20

mg

= 6

Un

its

pe

r 3

0 d

ay

s,

2.5

mg

or

5m

g =

30

un

its

pe

r 3

0 d

ay

s

VA

RD

EN

AF

IL H

CL

LEV

ITR

AO

RA

LY

ES

6 U

NIT

S P

ER

30

DA

YS

YO

HIM

BIN

E H

CL

YO

HIM

BIN

E H

CL

OR

AL

YE

SP

A r

eq

uir

ed

bu

t n

o m

on

thly

qu

an

tity

re

stri

ctio

ns

Q8

WE

AR

PR

EP

S A

NT

IBIO

TIC

S

Ina

ctiv

eA

NT

IBIO

TIC

EA

R S

US

PE

NS

ION

OT

ICN

O

Ina

ctiv

eF

LOX

INO

TIC

NO

NE

OM

YC

IN-C

OLI

ST

IN-H

C-T

HO

NZ

ON

IUM

C

OR

TIS

PO

RIN

-TC

OT

ICN

O

NE

OM

YC

IN-P

OLY

MY

XIN

-HC

CO

RT

OM

YC

INO

TIC

NO

OF

LOX

AC

IN

OF

LOX

AC

INO

TIC

NO

Q8

PE

AR

PR

EP

S A

NT

IIN

FLA

MM

AT

OR

Y

FLU

OC

INO

LON

E A

CE

TO

NID

ED

ER

MO

TIC

OT

ICN

O

Q8

HE

AR

PR

EP

S L

OC

AL

AN

ES

TH

ET

IC

AC

ET

IC A

CID

-AN

TIP

YR

INE

-

BE

NZ

OC

AIN

E-P

OLY

CO

SA

NO

LA

CE

TIC

AC

ID-A

NT

IPY

RIN

E-B

EN

ZO

CA

IO

TIC

NO

AN

TIP

YR

INE

-BE

NZ

OC

AIN

E-P

OLY

CO

SA

NO

LA

UR

ALG

AN

OT

ICN

O

BE

NZ

OC

AIN

E-A

NT

IPY

RIN

E

AU

RO

DE

X E

AR

DR

OP

SO

TIC

NO

Q8

BE

AR

PR

EP

S M

ISC

AN

TII

NF

EC

TIV

E

AC

ET

IC A

CID

AC

ET

IC A

CID

OT

ICN

O

AC

ET

IC A

CID

-ALU

MIN

UM

AC

ET

IC A

CID

-ALU

MIN

UM

OT

ICN

O

AC

ET

IC A

CID

-HY

DR

OC

OR

TIS

ON

EA

CE

TIC

AC

ID-H

YD

RO

CO

RT

ISO

NE

OT

ICN

O

CR

ES

YL

AC

ET

AT

EC

RE

SY

LAT

EO

TIC

NO

Page 16: ACTION: Final ENACTED DATE: 08/19/2011 4:16 PM Appendix ......Representative brand name (If one is in use), NOTE: Brand name products are eligible for reimbursement in accordance with

AP

PE

ND

IX A

BW

C O

UT

PA

TIE

NT

M

ED

ICA

TIO

N F

OR

MU

LAR

Y

Pa

ge

16

of

42

Th

era

pe

uti

c C

lass

Co

de

Th

era

pe

uti

c C

lass

Co

de

De

scri

pti

on

2G

en

eri

c N

am

e

Re

pre

sen

tati

ve

bra

nd

na

me

(If

on

e i

s in

use

), N

OT

E:

Bra

nd

na

me

pro

du

cts

are

eli

gib

le f

or

reim

bu

rse

me

nt

in a

cco

rda

nce

wit

h O

AC

41

23

-6-2

1D

osa

ge

Fo

rm

Re

qu

ire

s P

rio

r

Au

tho

riza

tio

n o

r

Re

late

d C

on

dit

ion

Ap

pro

ve

d i

n C

laim

Co

ve

rag

e r

est

rict

ion

s o

r li

mit

ati

on

s fo

r sp

eci

fic

dru

gs

or

do

sag

e f

orm

s a

re l

iste

d

wit

h t

he

re

spe

ctiv

e d

rug

s b

elo

w.

Un

less

oth

erw

ise

re

stri

cte

d,

all

do

sag

e f

orm

s

an

d s

tre

ng

ths

of

a l

iste

d d

rug

are

eli

gib

le f

or

reim

bu

rse

me

nt

in a

cco

rda

nce

wit

h

OA

C 4

12

3-6

-21

.

EA

R P

RE

PS

MIS

C A

NT

IIN

FE

CT

IVE

CO

NT

HY

DR

OC

OR

TIS

ON

E W

/ A

CE

TIC

AC

ID

AC

ET

AS

OL

HC

OT

ICN

O

PR

AM

OX

INE

-HC

-CH

LOR

OX

YLE

NO

L

P

RA

MO

XIN

E-H

C-C

HLO

RO

XY

LEN

OL

OT

IC S

OLN

O

TIC

NO

Q8

YE

AR

PR

EP

S M

ISC

OT

C O

NLY

Ina

ctiv

eS

TA

R-O

TIC

OT

ICN

O

C1

AE

LEC

TR

OLY

TE

DE

PLE

TE

RS

CA

LCIU

M A

CE

TA

TE

(P

HO

SP

HA

TE

BIN

DE

R)

PH

OS

LOO

RA

LY

ES

LAN

TH

AN

UM

CA

RB

ON

AT

EF

OS

RE

NO

LO

RA

LY

ES

SE

VE

LAM

ER

CA

RB

ON

AT

ER

EN

VE

LAO

RA

LY

ES

SE

VE

LAM

ER

HC

L R

EN

AG

EL

OR

AL

YE

S

SO

DIU

M P

OLY

ST

YR

EN

E S

ULF

ON

AT

EK

AY

EX

ALA

TE

OR

AL

YE

S

C1

ZE

LEC

TR

OLY

TE

RE

PLA

CE

ME

NT

SA

LIV

A S

UB

ST

ITU

TE

SA

LIV

A S

UB

ST

ITU

TE

MU

CO

US

ME

MN

O

L2A

EM

OLL

IEN

TS

ALO

E V

ER

AA

LOE

VE

RA

TO

PIC

AL

NO

AM

MO

NIU

M L

AC

TA

TE

AM

MO

NIU

M L

AC

TA

TE

TO

PIC

AL

NO

BA

BY

OIL

BA

BY

OIL

TO

PIC

AL

NO

DE

RM

AT

OLO

GIC

AL

PR

OD

UC

TS

MIS

CX

CLA

IRT

OP

ICA

LN

O

EM

OLL

IEN

TN

IVE

AT

OP

ICA

LN

O

EM

OLL

IEN

TS

HE

PA

RD

'S S

KIN

CR

EA

MT

OP

ICA

LN

O

LAC

TIC

AC

ID (

AM

MO

NIU

M L

AC

TA

TE

)LA

C-H

YD

RIN

TO

PIC

AL

NO

LAN

OLI

NLA

NO

LIN

TO

PIC

AL

NO

NE

OM

YC

IN-P

OLY

MY

XIN

B-G

RA

MIC

IDIN

N

EO

SP

OR

INT

OP

ICA

LN

O

SA

LIN

E N

AS

AL

AY

R S

ALI

NE

TO

PIC

AL

NO

SC

AR

TR

EA

TM

EN

T P

RO

DU

CT

SM

ED

ER

MA

TO

PIC

AL

NO

SK

IN P

RO

TE

CT

AN

TS

MIS

CE

UC

ER

INT

OP

ICA

LN

O

TR

OLA

MIN

E S

ALI

CY

LAT

E

AS

PE

RC

RE

ME

TO

PIC

AL

NO

VIT

AM

INS

A &

DV

ITA

MIN

A &

DT

OP

ICA

LN

O

L2B

EM

OLL

IEN

TS

(C

ON

T 1

)

EM

OLL

IEN

TE

LET

ON

ET

OP

ICA

LN

O

WO

UN

D D

RE

SS

ING

SB

IAF

INE

TO

PIC

AL

NO

L2C

EM

OLL

IEN

TS

(C

ON

TIN

UE

D 2

)

DE

RM

AT

OLO

GIC

AL

PR

OD

UC

TS

MIS

CE

PIC

ER

AM

TO

PIC

AL

NO

EM

OLL

IEN

TM

IMY

XT

OP

ICA

LN

O

SK

IN P

RO

TE

CT

AN

TS

MIS

C

EU

CE

RIN

TO

PIC

AL

NO

G1

AE

ST

RO

GE

NIC

AG

EN

TS

ES

TR

AD

IOL

ES

TR

AD

IOL

OR

AL

YE

S

W7

BE

XA

NT

HE

MA

TO

US

AN

D T

UM

OR

CA

U

ZO

ST

ER

VA

CC

INE

LIV

E

ZO

ST

AV

AX

SU

B-Q

NO

Page 17: ACTION: Final ENACTED DATE: 08/19/2011 4:16 PM Appendix ......Representative brand name (If one is in use), NOTE: Brand name products are eligible for reimbursement in accordance with

AP

PE

ND

IX A

BW

C O

UT

PA

TIE

NT

M

ED

ICA

TIO

N F

OR

MU

LAR

Y

Pa

ge

17

of

42

Th

era

pe

uti

c C

lass

Co

de

Th

era

pe

uti

c C

lass

Co

de

De

scri

pti

on

2G

en

eri

c N

am

e

Re

pre

sen

tati

ve

bra

nd

na

me

(If

on

e i

s in

use

), N

OT

E:

Bra

nd

na

me

pro

du

cts

are

eli

gib

le f

or

reim

bu

rse

me

nt

in a

cco

rda

nce

wit

h O

AC

41

23

-6-2

1D

osa

ge

Fo

rm

Re

qu

ire

s P

rio

r

Au

tho

riza

tio

n o

r

Re

late

d C

on

dit

ion

Ap

pro

ve

d i

n C

laim

Co

ve

rag

e r

est

rict

ion

s o

r li

mit

ati

on

s fo

r sp

eci

fic

dru

gs

or

do

sag

e f

orm

s a

re l

iste

d

wit

h t

he

re

spe

ctiv

e d

rug

s b

elo

w.

Un

less

oth

erw

ise

re

stri

cte

d,

all

do

sag

e f

orm

s

an

d s

tre

ng

ths

of

a l

iste

d d

rug

are

eli

gib

le f

or

reim

bu

rse

me

nt

in a

cco

rda

nce

wit

h

OA

C 4

12

3-6

-21

.

B3

JE

XP

EC

TO

RA

NT

S

GU

AIF

EN

ES

INR

OB

ITU

SS

IN

OR

AL

NO

Q6

IE

YE

AN

TIB

IOT

IC-C

OR

TIC

OID

GE

NT

AM

ICIN

-PR

ED

NIS

OLO

NE

PR

ED

-GO

PH

TH

ALM

ICN

O

LOT

EP

RE

DN

OL

ET

AB

ON

AT

E-T

OB

RA

MY

CIN

Z

YLE

TO

PH

TH

ALM

ICN

O

NE

OM

YC

IN-B

AC

ITR

AC

IN-P

OLY

-HC

NE

OM

YC

IN

OP

HT

HA

LMIC

NO

NE

OM

YC

IN-P

OLY

MY

XIN

-DE

XA

ME

TH

NE

O-D

EC

AD

RO

NO

PH

TH

ALM

ICN

O

NE

OM

YC

IN-P

OLY

MY

XIN

-HC

PO

LYM

YC

INO

PH

TH

ALM

ICN

O

TO

BR

AM

YC

IN-D

EX

AM

ET

HA

SO

NE

T

OB

RA

DE

XO

PH

TH

ALM

ICN

O

Q6

WE

YE

AN

TIB

IOT

ICS

AZ

ITH

RO

MY

CIN

AZ

AS

ITE

OP

HT

HA

LMIC

NO

BA

CIT

RA

CIN

BA

CIT

RA

CIN

OP

HT

HA

LMIC

NO

BA

CIT

RA

CIN

-PO

LYM

YX

INB

AC

ITR

AC

IN-P

OLY

MY

XIN

OP

HT

HA

LMIC

NO

BA

CIT

RA

CIN

-PO

LYM

YX

IN B

AK

-PO

LY-B

AC

OP

HT

HA

LMIC

NO

BE

SIF

LOX

AC

IN H

CL

BE

SIV

AN

CE

OP

HT

HA

LMIC

NO

CIP

RO

FLO

XA

CIN

HC

LC

ILO

XA

NO

PH

TH

ALM

ICN

O

ER

YT

HR

OM

YC

INE

RY

TH

RO

MY

CIN

OP

HT

HA

LMIC

NO

GA

TIF

LOX

AC

IN

ZY

MA

RO

PH

TH

ALM

ICN

O

GE

NT

AM

ICIN

SU

LFA

TE

GE

NT

AK

OP

HT

HA

LMIC

NO

LEV

OF

LOX

AC

INIQ

UIX

OP

HT

HA

LMIC

NO

MO

XIF

LOX

AC

IN H

CL

VIG

AM

OX

OP

HT

HA

LMIC

NO

NA

TA

MY

CIN

NA

TA

MY

CIN

OP

HT

H S

US

PO

PH

TH

ALM

ICN

O

NE

OM

YC

IN-B

AC

ITR

AC

IN-P

OLY

MY

XIN

NE

OM

YC

IN-B

AC

ITR

AC

IN-P

OLY

MY

XIN

OP

HT

HA

LMIC

NO

NE

OM

YC

IN-P

OLY

MY

XIN

-GR

AM

ICID

INN

EO

MY

CIN

-PO

LYM

YX

IN-G

RA

MIC

IDIN

OP

HT

HA

LMIC

NO

OF

LOX

AC

INO

CU

FLO

XO

PH

TH

ALM

ICN

O

PO

LYM

YX

IN B

SU

L-T

RIM

ET

HO

PR

IMP

OLY

MY

XIN

B S

UL-

TR

IME

TH

OP

RIM

OP

HT

HA

LMIC

NO

TO

BR

AM

YC

IN S

ULF

AT

ET

OB

RE

XO

PH

TH

ALM

ICN

O

Q6

RE

YE

AN

TIH

IST

AM

INE

S

AZ

ELA

ST

INE

HC

LA

ZE

LAS

TIN

E H

CL

OP

HT

HA

LMIC

NO

AZ

ELA

ST

INE

HC

L O

PT

IVA

RO

PH

TH

ALM

ICN

O

EP

INA

ST

INE

HC

LE

LES

TA

TO

PH

TH

ALM

ICN

O

KE

TO

TIF

EN

FU

MA

RA

TE

ALA

WA

YO

PH

TH

ALM

ICN

O

KE

TO

TIF

EN

FU

MA

RA

TE

EY

E I

TC

H R

ELI

EF

OP

HT

HA

LMIC

NO

KE

TO

TIF

EN

FU

MA

RA

TE

ZA

DIT

OR

OP

HT

HA

LMIC

NO

OLO

PA

TA

DIN

E H

CL

PA

TA

NO

LO

PH

TH

ALM

ICN

O

Q6

PE

YE

AN

TII

NF

LAM

MA

TO

RY

AG

EN

TS

BR

OM

FE

NA

C S

OD

IUM

X

IBR

OM

OP

HT

HA

LMIC

NO

DE

XA

ME

TH

AS

ON

E

MA

XID

EX

OP

HT

HA

LMIC

NO

DE

XA

ME

TH

AS

ON

E S

OD

IUM

PH

OS

PH

AT

ED

EX

AM

ET

HA

SO

NE

SO

DIU

M P

HO

SP

HA

TE

OP

HT

HA

LMIC

NO

DIC

LOF

EN

AC

SO

DIU

MV

OLT

AR

EN

OP

HT

HA

LMIC

NO

Page 18: ACTION: Final ENACTED DATE: 08/19/2011 4:16 PM Appendix ......Representative brand name (If one is in use), NOTE: Brand name products are eligible for reimbursement in accordance with

AP

PE

ND

IX A

BW

C O

UT

PA

TIE

NT

M

ED

ICA

TIO

N F

OR

MU

LAR

Y

Pa

ge

18

of

42

Th

era

pe

uti

c C

lass

Co

de

Th

era

pe

uti

c C

lass

Co

de

De

scri

pti

on

2G

en

eri

c N

am

e

Re

pre

sen

tati

ve

bra

nd

na

me

(If

on

e i

s in

use

), N

OT

E:

Bra

nd

na

me

pro

du

cts

are

eli

gib

le f

or

reim

bu

rse

me

nt

in a

cco

rda

nce

wit

h O

AC

41

23

-6-2

1D

osa

ge

Fo

rm

Re

qu

ire

s P

rio

r

Au

tho

riza

tio

n o

r

Re

late

d C

on

dit

ion

Ap

pro

ve

d i

n C

laim

Co

ve

rag

e r

est

rict

ion

s o

r li

mit

ati

on

s fo

r sp

eci

fic

dru

gs

or

do

sag

e f

orm

s a

re l

iste

d

wit

h t

he

re

spe

ctiv

e d

rug

s b

elo

w.

Un

less

oth

erw

ise

re

stri

cte

d,

all

do

sag

e f

orm

s

an

d s

tre

ng

ths

of

a l

iste

d d

rug

are

eli

gib

le f

or

reim

bu

rse

me

nt

in a

cco

rda

nce

wit

h

OA

C 4

12

3-6

-21

.

EY

E A

NT

IIN

FLA

MM

AT

OR

Y A

GE

NT

S (

CO

NT

)D

IFLU

PR

ED

NA

TE

DU

RE

ZO

LO

PH

TH

ALM

ICN

O

FLU

OR

OM

ET

HO

LON

EF

LUO

RO

ME

TH

OLO

NE

OP

HT

HA

LMIC

NO

FLU

OR

OM

ET

HO

LON

E

FM

L F

OR

TE

OP

HT

HA

LMIC

NO

FLU

OR

OM

ET

HO

LON

E A

CE

TA

TE

FLA

RE

XO

PH

TH

ALM

ICN

O

FLU

RB

IPR

OF

EN

SO

DIU

MF

LUR

BIP

RO

FE

N S

OD

IUM

OP

HT

HA

LMIC

NO

KE

TO

RO

LAC

TR

OM

ET

HA

MIN

EK

ET

OR

OLA

C T

RO

ME

TH

AM

INE

OP

HT

HA

LMIC

NO

KE

TO

RO

LAC

TR

OM

ET

HA

MIN

E

AC

ULA

RO

PH

TH

ALM

ICN

O

LOT

EP

RE

DN

OL

ET

AB

ON

AT

ELO

TE

MA

XO

PH

TH

ALM

ICN

O

LOT

EP

RE

DN

OL

ET

AB

ON

AT

E

ALR

EX

OP

HT

HA

LMIC

NO

NE

PA

FE

NA

CN

EV

AN

AC

OP

HT

HA

LMIC

NO

PR

ED

NIS

OLO

NE

AC

ET

AT

EO

MN

IPR

ED

OP

HT

HA

LMIC

NO

PR

ED

NIS

OLO

NE

SO

DIU

M P

HO

SP

HA

TE

PR

ED

NIS

OLO

NE

SO

DIU

M P

HO

SP

HA

TE

OP

HT

HA

LMIC

NO

RIM

EX

OLO

NE

VE

XO

LO

PH

TH

ALM

ICN

O

Q6

VE

YE

AN

TIV

IRA

LS

TR

IFLU

RID

INE

VIR

OP

TIC

OP

HT

HA

LMIC

NO

Q6

EE

YE

IR

RIG

AT

ION

S

OP

HT

HA

LMIC

IR

RIG

AT

ION

SO

LUT

ION

BS

SIN

TR

AO

CU

LRN

O

Q6

YE

YE

PR

EP

AR

AT

ION

S,

MIS

C O

TC

AR

TIF

ICIA

L T

EA

RS

LAC

RI-

LUB

E S

.O.P

.O

PH

TH

ALM

ICN

O

PO

LYV

INY

L A

LCO

HO

LA

KW

A T

EA

RS

OP

HT

HA

LMIC

NO

PR

OP

YLE

NE

GLY

CO

L-G

LYC

ER

IN

SO

OT

HE

OP

HT

HA

LMIC

NO

TY

LOX

AP

OL

EN

UC

LEN

EO

PH

TH

ALM

ICN

O

WH

ITE

PE

TR

OLA

TU

M-M

INE

RA

L O

ILP

UR

ALU

BE

OP

HT

HA

LMIC

NO

Q6

AE

YE

PR

EP

S,

MIS

C (

RX

ON

LY)

SO

DIU

M C

HLO

RID

ES

OD

IUM

CH

LOR

IDE

OP

HT

HA

LMIC

NO

Q6

SE

YE

SU

LFO

NA

MID

S

SU

LFA

CE

TA

MID

E S

OD

IUM

BLE

PH

-10

OP

HT

HA

LMIC

NO

SU

LFA

CE

TA

MID

E S

OD

IUM

-PR

ED

NIS

OLO

NE

BLE

PH

AM

IDE

OP

HT

HA

LMIC

NO

SU

LFA

CE

TA

MID

E-P

RE

DN

ISO

LON

ES

ULF

AC

ET

AM

IDE

-PR

ED

NIS

OLO

NE

OP

HT

HA

LMIC

NO

Q6

CE

YE

VA

SO

CO

NS

TR

ICT

RS

(RX

ON

LY)

NA

PH

AZ

OLI

NE

HC

LA

K-C

ON

OP

HT

HA

LMIC

NO

Q6

DE

YE

VA

SO

CO

NS

TR

ITR

S (

OT

C O

NLY

NA

PH

AZ

OLI

NE

W/

PH

EN

IRA

MIN

EN

AP

HC

ON

-AO

PH

TH

ALM

ICN

O

H0

GF

IBR

OM

YA

LGIA

AG

EN

TS

, S

NR

I

MIL

NA

CIP

RA

N H

CL

SA

VE

LLA

OR

AL

NO

D2

AF

LUO

RID

E P

RE

PA

RA

TIO

NS

SO

DIU

M F

LUO

RID

E

DE

NT

A 5

00

0 P

LUS

DE

NT

AL

YE

S

C6

MF

OLI

C A

CID

PR

EP

AR

AT

ION

S

All

co

mb

ina

tio

ns

an

d s

tre

ng

ths

of

ora

l d

osa

ge

fo

rms

are

co

ve

red

fo

r a

llo

we

d

con

dit

ion

s

FO

LIC

AC

ID

FO

LIC

AC

IDO

RA

LY

ES

L-M

ET

HY

LFO

LAT

E

DE

PLI

NO

RA

LY

ES

Page 19: ACTION: Final ENACTED DATE: 08/19/2011 4:16 PM Appendix ......Representative brand name (If one is in use), NOTE: Brand name products are eligible for reimbursement in accordance with

AP

PE

ND

IX A

BW

C O

UT

PA

TIE

NT

M

ED

ICA

TIO

N F

OR

MU

LAR

Y

Pa

ge

19

of

42

Th

era

pe

uti

c C

lass

Co

de

Th

era

pe

uti

c C

lass

Co

de

De

scri

pti

on

2G

en

eri

c N

am

e

Re

pre

sen

tati

ve

bra

nd

na

me

(If

on

e i

s in

use

), N

OT

E:

Bra

nd

na

me

pro

du

cts

are

eli

gib

le f

or

reim

bu

rse

me

nt

in a

cco

rda

nce

wit

h O

AC

41

23

-6-2

1D

osa

ge

Fo

rm

Re

qu

ire

s P

rio

r

Au

tho

riza

tio

n o

r

Re

late

d C

on

dit

ion

Ap

pro

ve

d i

n C

laim

Co

ve

rag

e r

est

rict

ion

s o

r li

mit

ati

on

s fo

r sp

eci

fic

dru

gs

or

do

sag

e f

orm

s a

re l

iste

d

wit

h t

he

re

spe

ctiv

e d

rug

s b

elo

w.

Un

less

oth

erw

ise

re

stri

cte

d,

all

do

sag

e f

orm

s

an

d s

tre

ng

ths

of

a l

iste

d d

rug

are

eli

gib

le f

or

reim

bu

rse

me

nt

in a

cco

rda

nce

wit

h

OA

C 4

12

3-6

-21

.

B5

RF

ST

GE

N A

NT

IHIS

TA

MIN

E A

NA

LGE

S

AP

AP

-MG

SA

LIC

YLA

TE

-PH

EN

YLT

OLO

X-

CA

FF

EIN

E-A

PA

P-M

AG

DU

RA

BA

C F

OR

TE

OR

AL

NO

D4

GG

AS

TR

IC E

NZ

YM

ES

LAC

TA

SE

D

AIR

Y R

ELI

EF

OR

AL

NO

A1

DG

EN

ER

AL

BR

ON

CH

OD

IALA

TO

RS

IPR

AT

RO

PIU

M B

RO

MID

E H

FA

AT

RO

VE

NT

HF

AIn

ha

lati

on

NO

TIO

TR

OP

IUM

BR

OM

IDE

IN

HS

PIR

IVA

Inh

ala

tio

nN

O

B0

AG

EN

ER

AL

INH

ALA

TIO

N A

GE

NT

S

SO

DIU

M C

HLO

RID

E A

ER

O S

OLN

B

RO

NC

HO

SA

LIN

EIN

HA

LAT

ION

NO

T0

C

SIN

EC

AT

EC

HIN

SV

ER

EG

EN

TO

PIC

AL

NO

C6

GG

ER

IAT

RIC

VIT

AM

IN P

RE

PA

RE

All

co

mb

ina

tio

ns

an

d s

tre

ng

ths

of

ora

l d

osa

ge

fo

rms

are

co

ve

red

fo

r a

llo

we

d

con

dit

ion

s

MU

LTIP

LE V

ITA

MIN

S W

/ M

INE

RA

LSC

EN

TR

UM

SIL

VE

RO

RA

LY

ES

P5

AG

LUC

OR

TIC

OID

S,

SY

ST

EM

IC

P5

B

BE

CLO

ME

TH

AS

ON

E D

IPR

OP

ION

AT

EQ

VA

RIN

HA

LAT

ION

NO

BU

DE

SO

NID

EP

ULM

ICO

RT

INH

ALA

TIO

NN

O

CO

RT

ISO

NE

AC

ET

AT

E

CO

RT

ISO

NE

OR

AL

NO

DE

XA

ME

TH

AS

ON

ED

EC

AD

RO

NO

RA

LN

O

HY

DR

OC

OR

TIS

ON

E

CO

RT

EF

OR

AL

NO

ME

TH

YLP

RE

DN

ISO

LON

E

ME

DR

OL

OR

AL

NO

PR

ED

NIS

OLO

NE

M

ILLI

PR

ED

OR

AL

NO

PR

ED

NIS

OLO

NE

SO

DIU

M P

HO

SP

HA

TE

PR

ED

NIS

OLO

NE

SO

DIU

M P

HO

SP

HA

TE

OR

AL

NO

PR

ED

NIS

ON

EP

RE

DN

ISO

NE

OR

AL

NO

P5

CG

LUC

OR

TIC

OID

S,

TO

PIC

AL

FLU

NIS

OLI

DE

AE

RO

BID

INH

ALA

TIO

NN

O

FLU

TIC

AS

ON

E P

RO

PIO

NA

TE

FLO

VE

NT

DIS

KU

SIN

HA

LAT

ION

NO

MO

ME

TA

SO

NE

FU

RO

AT

EA

SM

AN

EX

INH

ALA

TIO

NN

O

TR

IAM

CIN

OLO

NE

AC

ET

ON

IDE

AZ

MA

CO

RT

INH

ALA

TIO

NN

O

S2

CG

OLD

SA

LTS

AU

RA

NO

FIN

RID

AU

RA

OR

AL

YE

S

P1

AG

RO

WT

H H

OR

MO

NE

S

SO

MA

TR

OP

INH

UM

AT

RO

PE

INJE

CT

ION

NO

N1

BH

EM

AT

INIC

S,

OT

HE

R

DA

RB

EP

OE

TIN

ALF

A-P

OLY

SO

RB

AT

E 8

0

DA

RB

EP

OE

TIN

ALF

A-P

OLY

SO

RB

AT

E 8

0

SO

LNIN

JEC

TIO

NY

ES

EP

OE

TIN

ALF

A

PR

OC

RIT

INJE

CT

ION

YE

S

M9

SH

EM

OR

RH

EO

LOG

IC A

GE

NT

PE

NT

OX

IFY

LLIN

ET

RE

NT

AL

OR

AL

YE

S

Page 20: ACTION: Final ENACTED DATE: 08/19/2011 4:16 PM Appendix ......Representative brand name (If one is in use), NOTE: Brand name products are eligible for reimbursement in accordance with

AP

PE

ND

IX A

BW

C O

UT

PA

TIE

NT

M

ED

ICA

TIO

N F

OR

MU

LAR

Y

Pa

ge

20

of

42

Th

era

pe

uti

c C

lass

Co

de

Th

era

pe

uti

c C

lass

Co

de

De

scri

pti

on

2G

en

eri

c N

am

e

Re

pre

sen

tati

ve

bra

nd

na

me

(If

on

e i

s in

use

), N

OT

E:

Bra

nd

na

me

pro

du

cts

are

eli

gib

le f

or

reim

bu

rse

me

nt

in a

cco

rda

nce

wit

h O

AC

41

23

-6-2

1D

osa

ge

Fo

rm

Re

qu

ire

s P

rio

r

Au

tho

riza

tio

n o

r

Re

late

d C

on

dit

ion

Ap

pro

ve

d i

n C

laim

Co

ve

rag

e r

est

rict

ion

s o

r li

mit

ati

on

s fo

r sp

eci

fic

dru

gs

or

do

sag

e f

orm

s a

re l

iste

d

wit

h t

he

re

spe

ctiv

e d

rug

s b

elo

w.

Un

less

oth

erw

ise

re

stri

cte

d,

all

do

sag

e f

orm

s

an

d s

tre

ng

ths

of

a l

iste

d d

rug

are

eli

gib

le f

or

reim

bu

rse

me

nt

in a

cco

rda

nce

wit

h

OA

C 4

12

3-6

-21

.

Q3

HH

EM

OR

RH

OID

AL

PR

EP

(C

ON

T)

DIB

UC

AIN

EN

UP

ER

CA

INA

LR

EC

TA

LY

ES

LID

OC

AIN

ELM

X 5

TO

PIC

AL

YE

S

Q3

DH

EM

OR

RH

OID

AL

PR

EP

AR

AT

ION

S

HY

DR

OC

OR

TIS

ON

E -

PR

AM

OX

INE

AN

ALP

RA

M H

CR

EC

TA

LY

ES

PH

EN

YLE

PH

-SH

AR

K L

IVE

R O

IL-C

OC

OA

BU

TT

ER

H

EM

OR

RH

OID

AL

SU

PP

OS

ITO

RIE

SR

EC

TA

LY

ES

PR

AM

OX

INE

HC

LP

RO

CT

OF

OA

MT

OP

ICA

LY

ES

PR

AM

OX

-PE

-GLY

CE

RIN

-PE

TR

OLA

TU

M

RE

CT

AL

PR

EP

AR

AT

ION

HR

EC

TA

LY

ES

Q3

I

LID

OC

AIN

E-H

YD

RO

CO

RT

ISO

NE

LI

DA

ZO

NE

HC

RE

CT

AL

YE

S

M9

KH

EP

AR

IN P

RE

PA

RA

TIO

NS

DA

LTE

PA

RIN

SO

DIU

MF

RA

GM

INS

UB

-QN

O

EN

OX

AP

AR

INLO

VE

NO

XS

UB

-QN

O

FO

ND

AP

AR

INU

X S

OD

IUM

AR

IXT

RA

SU

B-Q

NO

W5

FH

EP

AT

ITIS

B T

RE

AT

ME

NT

LAM

IVU

DIN

EE

PIV

IR H

BV

OR

AL

YE

S

W5

GH

EP

AT

ITIS

C T

RE

AT

ME

NT

PE

GIN

TE

RF

ER

ON

ALF

A-2

AP

EG

AS

YS

SU

B-Q

YE

S

RIB

AV

IRIN

RIB

AS

PH

ER

EO

RA

LY

ES

Z2

DH

IST

AM

INE

H2

IN

HIB

ITO

RS

CIM

ET

IDIN

EC

IME

TID

INE

OR

AL

NO

FA

MO

TID

INE

PE

PC

ID A

CO

RA

LN

O

NIZ

AT

IDIN

EA

XID

OR

AL

NO

RA

NIT

IDIN

E H

CL

ZA

NT

AC

OR

AL

NO

W5

QH

IV-A

NT

IRE

TR

OV

IAL

CO

MB

INA

TIO

N

EF

AV

IRE

NZ

-EM

TR

ICIT

AB

INE

-TE

NO

FO

VIR

A

TR

IPLA

OR

AL

NO

W5

OH

IV-S

PE

C A

V-N

UC

LEO

SID

E/T

IDE

EM

TR

ICIT

AB

INE

-TE

NO

FO

VIR

DIS

OP

RO

XIL

FU

MA

RA

TE

TR

UV

AD

AO

RA

LN

O

W5

JH

IV-S

PE

C N

EC

LEO

SID

E A

NLG

, R

TI

LAM

IVU

DIN

E

EP

IVIR

OR

AL

NO

ZID

OV

UD

INE

ZID

OV

UD

INE

OR

AL

NO

W5

KH

IV-S

PE

C N

ON

-NE

CLE

OS

IDE

, R

TI

EF

AV

IRE

NZ

SU

ST

IVA

OR

AL

NO

W5

LH

IV-S

PE

C N

UC

LEO

SID

E,

RT

I C

OM

BO

LAM

IVU

DIN

E-Z

IDO

VU

DIN

E

CO

MB

IVIR

OR

AL

NO

W5

MH

IV-S

PE

C P

RO

TE

AS

E I

NH

IB C

OM

BO

LOP

INA

VIR

-RIT

ON

AV

IR

KA

LET

RA

OR

AL

NO

M4

MH

MG

CO

A I

NH

IB C

HO

LST

AB

IN

HIB

EZ

ET

IMIB

E-S

IMV

AS

TA

TIN

V

YT

OR

INO

RA

LY

ES

Page 21: ACTION: Final ENACTED DATE: 08/19/2011 4:16 PM Appendix ......Representative brand name (If one is in use), NOTE: Brand name products are eligible for reimbursement in accordance with

AP

PE

ND

IX A

BW

C O

UT

PA

TIE

NT

M

ED

ICA

TIO

N F

OR

MU

LAR

Y

Pa

ge

21

of

42

Th

era

pe

uti

c C

lass

Co

de

Th

era

pe

uti

c C

lass

Co

de

De

scri

pti

on

2G

en

eri

c N

am

e

Re

pre

sen

tati

ve

bra

nd

na

me

(If

on

e i

s in

use

), N

OT

E:

Bra

nd

na

me

pro

du

cts

are

eli

gib

le f

or

reim

bu

rse

me

nt

in a

cco

rda

nce

wit

h O

AC

41

23

-6-2

1D

osa

ge

Fo

rm

Re

qu

ire

s P

rio

r

Au

tho

riza

tio

n o

r

Re

late

d C

on

dit

ion

Ap

pro

ve

d i

n C

laim

Co

ve

rag

e r

est

rict

ion

s o

r li

mit

ati

on

s fo

r sp

eci

fic

dru

gs

or

do

sag

e f

orm

s a

re l

iste

d

wit

h t

he

re

spe

ctiv

e d

rug

s b

elo

w.

Un

less

oth

erw

ise

re

stri

cte

d,

all

do

sag

e f

orm

s

an

d s

tre

ng

ths

of

a l

iste

d d

rug

are

eli

gib

le f

or

reim

bu

rse

me

nt

in a

cco

rda

nce

wit

h

OA

C 4

12

3-6

-21

.

M4

DH

MG

CO

A R

ED

UC

TA

SE

IN

HIB

ITO

RS

AT

OR

VA

ST

AT

IN C

ALC

IUM

LIP

ITO

RO

RA

LY

ES

FLU

VA

ST

AT

IN S

OD

IUM

LES

CO

L X

LO

RA

LY

ES

LOV

AS

TA

TIN

ALT

OP

RE

VO

RA

LY

ES

PIT

AV

AS

TA

TIN

CA

LCIU

M

LIV

ALO

OR

AL

YE

S

PR

AV

AS

TA

TIN

SO

DIU

MP

RA

VA

CH

OL

OR

AL

YE

S

RO

SU

VA

ST

AT

IN C

ALC

IUM

C

RE

ST

OR

OR

AL

YE

S

SIM

VA

ST

AT

INZ

OC

OR

OR

AL

YE

S

M4

LH

MG

CO

A R

ED

UC

TS

E I

NH

IB N

IAC

IN

NIA

CIN

-LO

VA

ST

AT

INA

DV

ICO

RO

RA

LY

ES

NIA

CIN

-SIM

VA

ST

AT

IN

SIM

CO

RO

RA

LY

ES

M4

GH

YP

ER

GLY

CE

MIC

S

GLU

CA

GO

N (

RD

NA

)G

LUC

AG

ON

EM

ER

GE

NC

Y K

ITIN

JEC

TIO

NY

ES

GLU

CO

SE

INS

TA

-GLU

CO

SE

OR

AL

YE

S

P4

DH

YP

ER

PA

RA

TH

YR

OID

TX

AG

EN

TS

DO

XE

RC

ALC

IFE

RO

LH

EC

TO

RO

LO

RA

LY

ES

PA

RIC

ALC

ITO

LZ

EM

PLA

RO

RA

LY

ES

H8

BH

YP

NO

TIC

S-M

ELA

TO

NIN

AG

ON

IST

S

RA

ME

LTE

ON

R

OZ

ER

EM

OR

AL

NO

H8

FH

YP

NO

TIC

S-M

ELA

TO

NIN

CO

MB

OS

ME

LAT

ON

INM

ELA

TO

NIN

OR

AL

NO

C4

SH

YP

OG

LY I

NS

UL

RE

L B

IGU

AN

CM

B

GLY

BU

RID

E-M

ET

FO

RM

IN

GLU

CO

VA

NC

EO

RA

LY

ES

C4

TH

YP

OG

LY I

NS

UL

RE

SP

BIG

UA

N C

MB

RO

SIG

LIT

AZ

ON

E M

ALE

AT

E-M

ET

FO

RM

IN H

CL

AV

AN

DA

ME

TO

RA

LY

ES

C4

LH

YP

OG

LYC

EM

IC N

ON

-SU

LFO

NY

LU

ME

TF

OR

MIN

HC

L M

ET

FO

RM

IN H

CL

OR

AL

YE

S

C4

KH

YP

OG

LYC

EM

IC S

ULF

ON

YLU

RE

AS

GLI

ME

PIR

IDE

AM

AR

YL

OR

AL

YE

S

GLI

PIZ

IDE

G

LIP

IZID

EO

RA

LY

ES

GLY

BU

RID

EG

LYB

UR

IDE

OR

AL

YE

S

NA

TE

GLI

NID

ES

TA

RLI

XO

RA

LY

ES

C4

MH

YP

OG

LYC

EM

ICS

ALP

HA

IN

HIB

AC

AR

BO

SE

P

RE

CO

SE

OR

AL

YE

S

C4

NH

YP

OG

LYC

EM

ICS

IN

SU

LIN

EN

H

PIO

GLI

TA

ZO

NE

HC

L A

CT

OS

OR

AL

YE

S

PIO

GLI

TA

ZO

NE

HC

L-M

ET

FO

RM

INA

CT

OP

LUS

ME

TO

RA

LY

ES

RO

SIG

LIT

AZ

ON

E M

ALE

AT

E

AV

AN

DIA

OR

AL

YE

S

A4

FH

YP

OT

EN

SIV

ES

AN

GIO

RE

CP

T A

NT

CA

ND

ES

AR

TA

N C

ILE

XE

TIL

A

TA

CA

ND

OR

AL

YE

S

EP

RO

SA

RT

AN

ME

SY

LAT

ET

EV

ET

EN

OR

AL

YE

S

IRB

ES

AR

TA

NA

VA

PR

OO

RA

LY

ES

Page 22: ACTION: Final ENACTED DATE: 08/19/2011 4:16 PM Appendix ......Representative brand name (If one is in use), NOTE: Brand name products are eligible for reimbursement in accordance with

AP

PE

ND

IX A

BW

C O

UT

PA

TIE

NT

M

ED

ICA

TIO

N F

OR

MU

LAR

Y

Pa

ge

22

of

42

Th

era

pe

uti

c C

lass

Co

de

Th

era

pe

uti

c C

lass

Co

de

De

scri

pti

on

2G

en

eri

c N

am

e

Re

pre

sen

tati

ve

bra

nd

na

me

(If

on

e i

s in

use

), N

OT

E:

Bra

nd

na

me

pro

du

cts

are

eli

gib

le f

or

reim

bu

rse

me

nt

in a

cco

rda

nce

wit

h O

AC

41

23

-6-2

1D

osa

ge

Fo

rm

Re

qu

ire

s P

rio

r

Au

tho

riza

tio

n o

r

Re

late

d C

on

dit

ion

Ap

pro

ve

d i

n C

laim

Co

ve

rag

e r

est

rict

ion

s o

r li

mit

ati

on

s fo

r sp

eci

fic

dru

gs

or

do

sag

e f

orm

s a

re l

iste

d

wit

h t

he

re

spe

ctiv

e d

rug

s b

elo

w.

Un

less

oth

erw

ise

re

stri

cte

d,

all

do

sag

e f

orm

s

an

d s

tre

ng

ths

of

a l

iste

d d

rug

are

eli

gib

le f

or

reim

bu

rse

me

nt

in a

cco

rda

nce

wit

h

OA

C 4

12

3-6

-21

.

HY

PO

TE

NS

IVE

S A

NG

IO R

EC

PT

AN

T (

CO

NT

)LO

SA

RT

AN

PO

TA

SS

IUM

C

OZ

AA

RO

RA

LY

ES

OLM

ES

AR

TA

N M

ED

OX

OM

ILB

EN

ICA

RO

RA

LY

ES

TE

LMIS

AR

TA

N

MIC

AR

DIS

OR

AL

YE

S

VA

LSA

RT

AN

D

IOV

AN

OR

AL

YE

S

A4

DH

YP

OT

EN

SIV

ES

AN

GIO

TE

NS

IN B

LK

BE

NA

ZE

PR

IL H

CL

BE

NA

ZE

PR

IL H

CL

OR

AL

YE

S

CA

PT

OP

RIL

CA

PT

OP

RIL

OR

AL

YE

S

EN

ALA

PR

IL M

ALE

AT

EE

NA

LAP

RIL

MA

LEA

TE

OR

AL

YE

S

FO

SIN

OP

RIL

SO

DIU

MF

OS

INO

PR

IL S

OD

IUM

OR

AL

YE

S

LIS

INO

PR

ILP

RIN

IVIL

OR

AL

YE

S

MO

EX

IPR

IL H

CL

UN

IVA

SC

OR

AL

YE

S

PE

RIN

DO

PR

IL E

RB

UM

INE

AC

EO

NO

RA

LY

ES

QU

INA

PR

IL H

CL

QU

INA

PR

IL H

CL

OR

AL

YE

S

RA

MIP

RIL

ALT

AC

EO

RA

LY

ES

TR

AN

DO

LAP

RIL

MA

VIK

OR

AL

YE

S

A4

BH

YP

OT

EN

SIV

ES

SY

MP

AT

HO

LYT

IC

CLO

NID

INE

HC

LC

AT

AP

RE

SO

RA

LY

ES

CLO

NID

INE

HC

L T

D P

AT

CH

CLO

NID

INE

TR

AN

SD

ER

MY

ES

GU

AN

FA

CIN

E H

CL

TE

NE

XO

RA

LY

ES

A4

AH

YP

OT

EN

SIV

ES

VA

SO

DIL

AT

OR

S

HY

DR

ALA

ZIN

E H

CL

AP

RE

SO

LIN

EO

RA

LY

ES

MIN

OX

IDIL

MIN

OX

IDIL

OR

AL

YE

S

Z2

LIM

MU

NO

GLO

BU

LIN

E(I

GE

) B

LOC

KE

RS

OM

ALI

ZU

MA

BX

OLA

IRS

UB

-QY

ES

Z2

GIM

MU

NO

MO

DU

LAT

OR

S

IMIQ

UIM

OD

A

LDA

RA

TO

PIC

AL

YE

S

INT

ER

FE

RO

N G

AM

MA

-1B

AC

TIM

MU

NE

SU

B-Q

YE

S

Z2

EIM

MU

NO

SU

PP

RE

SIV

ES

AZ

AT

HIO

PR

INE

AZ

AT

HIO

PR

INE

OR

AL

YE

S

CY

CLO

SP

OR

INE

G

EN

GR

AF

OR

AL

YE

S

MY

CO

PH

EN

OLA

TE

MO

FE

TIL

CE

LLC

EP

TO

RA

LY

ES

MY

CO

PH

EN

OLA

TE

SO

DIU

MM

YF

OR

TIC

OR

AL

YE

S

SIR

OLI

MU

S

RA

PA

MU

NE

OR

AL

YE

S

TA

CR

OLI

MU

SP

RO

GR

AF

OR

AL

YE

S

TA

CR

OLI

MU

ST

AC

RO

LIM

US

AN

HY

DR

OU

SO

RA

LY

ES

W5

CIN

HIB

ITO

RS

HIV

PR

OT

EA

SE

AT

AZ

AN

AV

IR S

ULF

AT

ER

EY

AT

AZ

OR

AL

NO

IND

INA

VIR

SU

LFA

TE

CR

IXIV

AN

OR

AL

NO

NE

LFIN

AV

IR M

ES

YLA

TE

VIR

AC

EP

TO

RA

LN

O

RIT

ON

AV

IRN

OR

VIR

OR

AL

NO

Page 23: ACTION: Final ENACTED DATE: 08/19/2011 4:16 PM Appendix ......Representative brand name (If one is in use), NOTE: Brand name products are eligible for reimbursement in accordance with

AP

PE

ND

IX A

BW

C O

UT

PA

TIE

NT

M

ED

ICA

TIO

N F

OR

MU

LAR

Y

Pa

ge

23

of

42

Th

era

pe

uti

c C

lass

Co

de

Th

era

pe

uti

c C

lass

Co

de

De

scri

pti

on

2G

en

eri

c N

am

e

Re

pre

sen

tati

ve

bra

nd

na

me

(If

on

e i

s in

use

), N

OT

E:

Bra

nd

na

me

pro

du

cts

are

eli

gib

le f

or

reim

bu

rse

me

nt

in a

cco

rda

nce

wit

h O

AC

41

23

-6-2

1D

osa

ge

Fo

rm

Re

qu

ire

s P

rio

r

Au

tho

riza

tio

n o

r

Re

late

d C

on

dit

ion

Ap

pro

ve

d i

n C

laim

Co

ve

rag

e r

est

rict

ion

s o

r li

mit

ati

on

s fo

r sp

eci

fic

dru

gs

or

do

sag

e f

orm

s a

re l

iste

d

wit

h t

he

re

spe

ctiv

e d

rug

s b

elo

w.

Un

less

oth

erw

ise

re

stri

cte

d,

all

do

sag

e f

orm

s

an

d s

tre

ng

ths

of

a l

iste

d d

rug

are

eli

gib

le f

or

reim

bu

rse

me

nt

in a

cco

rda

nce

wit

h

OA

C 4

12

3-6

-21

.

C4

RIN

SU

LIN

RE

SP

ON

RE

LEA

SE

CO

MB

PIO

GLI

TA

ZO

NE

HC

L-G

LIM

EP

IRID

ED

UE

TA

CT

OR

AL

YE

S

RO

SIG

LIT

AZ

ON

E M

ALE

AT

E-G

LIM

EP

IRID

EA

VA

ND

AR

YL

OR

AL

YE

S

C4

GIN

SU

LIN

S

INS

ULI

N

INS

ULI

NS

CY

ES

All

str

en

gth

s a

nd

fo

rmu

lati

on

s o

f in

ject

ab

le i

nsu

lin

are

co

ve

red

fo

r a

pp

rop

ria

te

con

dit

ion

s a

llo

we

d i

n t

he

cla

im

J9A

INT

ES

TIN

AL

MO

TIL

ITY

ST

IMU

LAN

ME

TO

CLO

PR

AM

IDE

HC

L R

EG

LAN

OR

AL

NO

C3

HIO

DIN

E R

EP

LAC

EM

EN

T

PO

TA

SS

IUM

IO

DID

ES

SK

IO

RA

LY

ES

C3

BIR

ON

RE

PLA

CE

ME

NT

All

iro

n s

alt

s a

nd

ora

l d

osa

ge

fo

rms

are

co

ve

red

fo

r a

llo

we

d c

on

dit

ion

s

FE

FU

MA

RA

TE

W/

B1

2-V

IT C

-FA

-IF

CF

ER

OC

ON

OR

AL

YE

S

FE

RR

OU

S G

LUC

ON

AT

EF

ER

GO

NO

RA

LY

ES

FE

RR

OU

S S

ULF

AT

EF

EO

SO

LO

RA

LY

ES

PO

LYS

AC

CH

AR

IDE

IR

ON

CO

MP

LEX

F

ER

RE

X 1

50

OR

AL

YE

S

L6A

IRR

ITA

NT

S

ALO

E V

ER

AA

LOE

VE

RA

TO

PIC

AL

NO

CA

MP

HO

R &

ME

NT

HO

LS

AR

NA

TO

PIC

AL

NO

CA

MP

HO

R &

ME

NT

HO

L F

RE

EZ

E I

TT

OP

ICA

LN

O

CA

MP

HO

R-E

UC

ALY

PT

US

-ME

NT

HO

L V

ICK

S V

AP

OR

UB

TO

PIC

AL

NO

CA

PS

AIC

IN

AR

TH

RIT

IS P

AIN

RE

LIE

FT

OP

ICA

LN

O

CA

PS

AIC

IN I

N L

IDO

CA

INE

VE

HIC

LE

ZO

ST

RIX

TO

PIC

AL

NO

CA

PS

AIC

IN-M

EN

TH

OL-

ME

TH

YL

SA

LIC

YLA

TE

ZIK

ST

OP

ICA

LN

O

CA

PS

ICU

M O

LEO

RE

SIN

C

AP

SIC

UM

OLE

OR

ES

INT

OP

ICA

LN

O

CA

PS

ICU

M O

LEO

RE

SIN

T

RIX

AIC

INT

OP

ICA

LN

O

LIN

IME

NT

S &

RU

BS

BIO

FLE

XO

RT

OP

ICA

LN

O

LIN

IME

NT

S &

RU

BS

B

AN

ALG

TO

PIC

AL

NO

LIN

IME

NT

S &

RU

BS

S

ALO

NP

AS

TO

PIC

AL

NO

ME

NT

HO

LB

EN

GA

YT

OP

ICA

LN

O

ME

NT

HO

L P

AIN

RE

LIE

VIN

G P

AT

CH

TO

PIC

AL

NO

ME

NT

HO

L-M

ET

HY

L S

ALI

CY

LAT

E

TH

ER

A-G

ES

ICT

OP

ICA

LN

O

ME

TH

YL

SA

LIC

YLA

TE

ME

TH

YL

SA

LIC

YLA

TE

TO

PIC

AL

NO

TR

OLA

MIN

E S

ALI

CY

LAT

EM

OB

ISY

LT

OP

ICA

LN

O

TR

OLA

MIN

E S

ALI

CY

LAT

E

AN

ALG

ES

IC C

RE

ME

TO

PIC

AL

NO

TR

OLA

MIN

E S

ALI

CY

LAT

E

AS

PE

RC

RE

ME

TO

PIC

AL

NO

W9

AK

EK

YT

OLI

DE

S

TE

LIT

HR

OM

YC

IN

KE

TE

KO

RA

LN

O

L5O

KE

RA

T-G

LUC

OC

OR

T C

OM

B

Page 24: ACTION: Final ENACTED DATE: 08/19/2011 4:16 PM Appendix ......Representative brand name (If one is in use), NOTE: Brand name products are eligible for reimbursement in accordance with

AP

PE

ND

IX A

BW

C O

UT

PA

TIE

NT

M

ED

ICA

TIO

N F

OR

MU

LAR

Y

Pa

ge

24

of

42

Th

era

pe

uti

c C

lass

Co

de

Th

era

pe

uti

c C

lass

Co

de

De

scri

pti

on

2G

en

eri

c N

am

e

Re

pre

sen

tati

ve

bra

nd

na

me

(If

on

e i

s in

use

), N

OT

E:

Bra

nd

na

me

pro

du

cts

are

eli

gib

le f

or

reim

bu

rse

me

nt

in a

cco

rda

nce

wit

h O

AC

41

23

-6-2

1D

osa

ge

Fo

rm

Re

qu

ire

s P

rio

r

Au

tho

riza

tio

n o

r

Re

late

d C

on

dit

ion

Ap

pro

ve

d i

n C

laim

Co

ve

rag

e r

est

rict

ion

s o

r li

mit

ati

on

s fo

r sp

eci

fic

dru

gs

or

do

sag

e f

orm

s a

re l

iste

d

wit

h t

he

re

spe

ctiv

e d

rug

s b

elo

w.

Un

less

oth

erw

ise

re

stri

cte

d,

all

do

sag

e f

orm

s

an

d s

tre

ng

ths

of

a l

iste

d d

rug

are

eli

gib

le f

or

reim

bu

rse

me

nt

in a

cco

rda

nce

wit

h

OA

C 4

12

3-6

-21

.

L5A

KE

RA

TO

LYT

ICS

SIL

VE

R N

ITR

AT

E

SIL

VE

R N

ITR

AT

E A

PP

LIC

AT

OR

TO

PIC

AL

NO

UR

EA

UR

EA

TO

PIC

AL

NO

UR

EA

-HY

ALU

RO

NA

TE

SO

DIU

M

UR

EA

-HY

ALU

RO

NA

TE

SO

DIU

M S

US

PT

OP

ICA

LN

O

Q3

SLA

XA

TIV

E L

OC

AL/

RE

CT

AL

BIS

AC

OD

YL

DU

LCO

LAX

RE

CT

AL

NO

DO

CU

SA

TE

SO

DIU

MC

OLA

CE

RE

CT

AL

NO

GLY

CE

RIN

S

AN

I-S

UP

PR

EC

TA

LN

O

MIN

ER

AL

OIL

MIN

ER

AL

OIL

EN

EM

AR

EC

TA

LN

O

SO

DIU

M P

HO

SP

HA

TE

SP

HO

SP

HA

TE

EN

EM

AR

EC

TA

LN

O

D6

SLA

XA

TIV

ES

AN

D C

AT

HA

RT

ICS

All

la

xati

ve

s a

nd

bo

we

l p

rep

pro

du

cts

are

co

ve

red

fo

r a

llo

we

d c

on

dit

ion

s

D6

TLA

XA

TIV

ES

AN

D C

AT

HA

RT

ICS

BIS

AC

OD

YL

DU

LCO

LAX

OR

AL

YE

SB

ISA

CO

DY

L T

AB

& P

EG

33

50

-KC

L-S

OD

BIC

AR

B-N

AC

LH

ALF

LYT

ELY

OR

AL

YE

S

BIS

MU

TH

SU

BS

ALI

CY

LAT

EK

AO

PE

CT

AT

EO

RA

LY

ES

CA

LCIU

M P

OLY

CA

RB

OP

HIL

F

IBE

R T

AB

SO

RA

LY

ES

CA

SA

NT

HR

AN

OL-

DS

SD

OC

US

AT

E S

OD

IUM

CA

SA

NT

HR

AN

OL

OR

AL

YE

S

CE

LLU

LOS

EU

NIF

IBE

RO

RA

LY

ES

DO

CU

SA

TE

CA

LCIU

M

SU

R-Q

-LA

XO

RA

LY

ES

DO

CU

SA

TE

SO

DIU

M

CO

LAC

EO

RA

LY

ES

LAC

TU

LOS

E

CO

NS

TU

LOS

EO

RA

LY

ES

LUB

IPR

OS

TO

NE

AM

ITIZ

AO

RA

LY

ES

MA

GN

ES

IUM

CIT

RA

TE

MA

GN

ES

IUM

CIT

RA

TE

OR

AL

YE

S

MA

GN

ES

IUM

CIT

RA

TE

C

ITR

OM

AO

RA

LY

ES

MA

GN

ES

IUM

SU

LFA

TE

E

PS

OM

SA

LTO

RA

LY

ES

ME

TH

YLC

ELL

ULO

SE

CIT

RU

CE

LO

RA

LY

ES

MIL

K O

F M

AG

NE

SIA

MIL

K O

F M

AG

NE

SIA

OR

AL

YE

S

MIN

ER

AL

OIL

KO

ND

RE

MU

LO

RA

LY

ES

MIN

ER

AL

OIL

MIN

ER

AL

OIL

OR

AL

YE

S

PE

G 3

35

0-K

CL-

NA

BIC

AR

B-N

AC

L-N

A S

ULF

AT

EG

OLY

TE

LYO

RA

LY

ES

PE

G 3

35

0-K

CL-

SO

D B

ICA

RB

-NA

CL

NU

LYT

ELY

OR

AL

YE

S

PO

LYE

TH

YLE

NE

GLY

CO

L 3

35

0

GLY

CO

LAX

OR

AL

YE

S

PO

LYE

TH

YLE

NE

GLY

CO

L 3

35

0

MIR

ALA

XO

RA

LY

ES

PS

YLL

IUM

KO

NS

YL

OR

AL

YE

S

SE

NN

OS

IDE

SS

EN

OK

OT

OR

AL

YE

S

SE

NN

OS

IDE

S-D

OC

US

AT

E S

OD

IUM

SE

NN

A S

OR

AL

YE

S

SE

NN

OS

IDE

S-D

OC

US

AT

E S

OD

IUM

P

ER

I-C

OLA

CE

OR

AL

YE

S

SO

D P

HO

S M

ON

O-S

OD

PH

OS

DI

VIS

ICO

LO

RA

LY

ES

SO

DIU

M P

HO

SP

HA

TE

SP

HO

SP

HO

-SO

DA

OR

AL

YE

S

WH

EA

T D

EX

TR

IN

BE

NE

FIB

ER

OR

AL

NO

Page 25: ACTION: Final ENACTED DATE: 08/19/2011 4:16 PM Appendix ......Representative brand name (If one is in use), NOTE: Brand name products are eligible for reimbursement in accordance with

AP

PE

ND

IX A

BW

C O

UT

PA

TIE

NT

M

ED

ICA

TIO

N F

OR

MU

LAR

Y

Pa

ge

25

of

42

Th

era

pe

uti

c C

lass

Co

de

Th

era

pe

uti

c C

lass

Co

de

De

scri

pti

on

2G

en

eri

c N

am

e

Re

pre

sen

tati

ve

bra

nd

na

me

(If

on

e i

s in

use

), N

OT

E:

Bra

nd

na

me

pro

du

cts

are

eli

gib

le f

or

reim

bu

rse

me

nt

in a

cco

rda

nce

wit

h O

AC

41

23

-6-2

1D

osa

ge

Fo

rm

Re

qu

ire

s P

rio

r

Au

tho

riza

tio

n o

r

Re

late

d C

on

dit

ion

Ap

pro

ve

d i

n C

laim

Co

ve

rag

e r

est

rict

ion

s o

r li

mit

ati

on

s fo

r sp

eci

fic

dru

gs

or

do

sag

e f

orm

s a

re l

iste

d

wit

h t

he

re

spe

ctiv

e d

rug

s b

elo

w.

Un

less

oth

erw

ise

re

stri

cte

d,

all

do

sag

e f

orm

s

an

d s

tre

ng

ths

of

a l

iste

d d

rug

are

eli

gib

le f

or

reim

bu

rse

me

nt

in a

cco

rda

nce

wit

h

OA

C 4

12

3-6

-21

.

N1

CLE

UK

OC

YT

E (

WB

C)

ST

IMU

LAN

TS

FIL

GR

AS

TIM

NE

UP

OG

EN

INJE

CT

ION

NO

PE

GF

ILG

RA

ST

IM

NE

ULA

ST

AS

UB

-QN

O

Z4

BLE

UK

OT

RIE

NE

RE

CE

PT

OR

AN

TA

G

MO

NT

ELU

KA

ST

SO

DIU

M

SIN

GU

LAIR

OR

AL

YE

S

ZA

FIR

LUK

AS

T

AC

CO

LAT

EO

RA

LY

ES

W1

KLI

NC

OS

AM

IDE

S

CLI

ND

AM

YC

IN H

CL

CLI

ND

AM

YC

IN H

CL

OR

AL

NO

CLI

ND

AM

YC

IN P

ALM

ITA

TE

CLE

OC

IN P

ALM

ITA

TE

OR

AL

NO

M4

ILI

PO

TR

OP

IC/C

A C

HA

N B

LOC

K C

OM

BO

AM

LOD

IPIN

E B

ES

YLA

TE

-AT

OR

VA

ST

AT

IN

CA

LCIU

MC

AD

UE

TO

RA

LY

ES

M4

ELI

PO

TR

OP

ICS

FE

NO

FIB

RA

TE

TR

ICO

RO

RA

LY

ES

FE

NO

FIB

RA

TE

A

NT

AR

AO

RA

LY

ES

FIS

H O

ILF

ISH

OIL

OR

AL

YE

S

GE

MF

IBR

OZ

ILG

EM

FIB

RO

ZIL

OR

AL

YE

S

LEC

ITH

INLE

CIT

HIN

OR

AL

YE

S

NIA

CIN

NIA

SP

AN

OR

AL

YE

S

OM

EG

A-3

FA

TT

Y A

CID

SO

ME

GA

-3O

RA

LY

ES

OM

EG

A-3

-AC

ID E

TH

YL

ES

TE

RS

LOV

AZ

AO

RA

LY

ES

VIT

AM

INS

W/

LIP

OT

RO

PIC

SLI

PO

TR

IAD

OR

AL

YE

S

M4

CLI

PO

TR

OP

ICS

(C

ON

T 2

)

CH

OLI

NE

FE

NO

FIB

RA

TE

TR

ILIP

IXO

RA

LN

O

M4

FLI

PO

TR

OP

ICS

(C

ON

T)

EZ

ET

IMIB

EZ

ET

IAO

RA

LY

ES

H0

ALO

CA

L A

NE

ST

HE

TIC

S

BE

NZ

OC

AIN

E D

EN

TA

L P

AS

TE

OR

AB

AS

E-B

MU

CO

US

ME

MN

O

LID

OC

AIN

E H

CL

LID

OC

AIN

E H

CL

LOC

AM

UC

OU

S M

EM

NO

PH

EN

OL

CH

LOR

AS

EP

TIC

MU

CO

US

ME

MN

O

H0

BLO

CA

L A

NE

ST

HE

TIC

S (

CO

NT

)

BE

NZ

OC

AIN

E D

EN

TA

L G

EL

AN

BE

SO

LM

UC

OU

S M

EM

NO

BE

NZ

OC

AIN

E D

EN

TA

L G

EL

HU

RR

ICA

INE

MU

CO

US

ME

MN

O

BE

NZ

OC

AIN

E-M

EN

TH

OL

CE

PA

CO

L S

OR

E T

HR

OA

TM

UC

OU

S M

EM

NO

CE

TY

LPY

RID

INIU

M C

HLO

RID

E

CE

PA

CO

LM

UC

OU

S M

EM

NO

LID

OC

AIN

E H

CL

XY

LOC

AIN

EM

UC

OU

S M

EM

NO

LID

OC

AIN

E H

CL

VIS

CO

US

LID

OC

AIN

E H

CL

VIS

CO

US

MU

CO

US

ME

MN

O

R1

MLO

OP

DIU

RE

TIC

S

BU

ME

TA

NID

EB

UM

ET

AN

IDE

OR

AL

YE

S

FU

RO

SE

MID

ELA

SIX

OR

AL

YE

S

TO

RS

EM

IDE

D

EM

AD

EX

OR

AL

YE

S

Page 26: ACTION: Final ENACTED DATE: 08/19/2011 4:16 PM Appendix ......Representative brand name (If one is in use), NOTE: Brand name products are eligible for reimbursement in accordance with

AP

PE

ND

IX A

BW

C O

UT

PA

TIE

NT

M

ED

ICA

TIO

N F

OR

MU

LAR

Y

Pa

ge

26

of

42

Th

era

pe

uti

c C

lass

Co

de

Th

era

pe

uti

c C

lass

Co

de

De

scri

pti

on

2G

en

eri

c N

am

e

Re

pre

sen

tati

ve

bra

nd

na

me

(If

on

e i

s in

use

), N

OT

E:

Bra

nd

na

me

pro

du

cts

are

eli

gib

le f

or

reim

bu

rse

me

nt

in a

cco

rda

nce

wit

h O

AC

41

23

-6-2

1D

osa

ge

Fo

rm

Re

qu

ire

s P

rio

r

Au

tho

riza

tio

n o

r

Re

late

d C

on

dit

ion

Ap

pro

ve

d i

n C

laim

Co

ve

rag

e r

est

rict

ion

s o

r li

mit

ati

on

s fo

r sp

eci

fic

dru

gs

or

do

sag

e f

orm

s a

re l

iste

d

wit

h t

he

re

spe

ctiv

e d

rug

s b

elo

w.

Un

less

oth

erw

ise

re

stri

cte

d,

all

do

sag

e f

orm

s

an

d s

tre

ng

ths

of

a l

iste

d d

rug

are

eli

gib

le f

or

reim

bu

rse

me

nt

in a

cco

rda

nce

wit

h

OA

C 4

12

3-6

-21

.

W1

DM

AC

RO

LID

ES

AZ

ITH

RO

MY

CIN

AZ

ITH

RO

MY

CIN

OR

AL

NO

AZ

ITH

RO

MY

CIN

ZIT

HR

OM

AX

OR

AL

NO

CLA

RIT

HR

OM

YC

IN

BIA

XIN

OR

AL

NO

ER

YT

HR

OC

IN S

TE

AR

AT

EE

RY

TH

RO

CIN

ST

EA

RA

TE

OR

AL

NO

ER

YT

HR

OM

YC

INE

RY

-TA

BO

RA

LN

O

ER

YT

HR

OM

YC

IN E

TH

YLS

UC

CIN

AT

EE

RY

TH

RO

MY

CIN

ET

HY

LSU

CC

INA

TE

OR

AL

NO

C1

HM

AG

NE

SIU

M R

EP

LAC

EM

EN

TA

ll m

ag

ne

siu

m s

alt

s a

nd

ora

l d

osa

ge

fo

rms

ae

co

ve

ed

fo

r a

llo

we

d c

on

dit

ion

s

MA

GN

ES

IUM

CH

LOR

IDE

MA

G6

4O

RA

LY

ES

MA

GN

ES

IUM

GLU

CO

NA

TE

MA

G-G

OR

AL

YE

S

MA

GN

ES

IUM

LA

CT

AT

EM

AG

-TA

B S

RO

RA

LY

ES

MA

GN

ES

IUM

OX

IDE

MA

GO

XO

RA

LY

ES

H7

JM

AO

IS-N

ON

-SE

LEC

T &

IR

RE

VE

RS

IBL

PH

EN

ELZ

INE

SU

LFA

TE

N

AR

DIL

OR

AL

NO

TR

AN

YLC

YP

RO

MIN

E S

ULF

AT

ET

RA

NY

LCY

PR

OM

INE

SU

LFA

TE

OR

AL

NO

X2

AM

ED

SU

PP

LIE

S N

EE

DLE

S

Insu

lin

Sy

rin

ge

& N

ee

dle

ULT

ICA

RE

MIS

CE

LLN

O

C8

AM

ET

ALL

IC P

OIS

ON

AN

TID

OT

ES

SU

CC

IME

RC

HE

ME

TO

RA

LN

O

P5

SM

INE

RA

LOC

OR

TIC

OID

S

FLU

DR

OC

OR

TIS

ON

E A

CE

TA

TE

FLU

DR

OC

OR

TIS

ON

E A

CE

TA

TE

OR

AL

NO

Q6

GM

IOT

ICS

AN

D O

TH

ER

IN

TR

AO

CU

LA

AP

RA

CLO

NID

INE

HC

LIO

PID

INE

OP

HT

HA

LMIC

NO

BE

TA

XO

LOL

HC

LB

ET

OP

TIC

SO

PH

TH

ALM

ICN

O

BIM

AT

OP

RO

ST

LUM

IGA

NO

PH

TH

ALM

ICN

O

BR

IMO

NID

INE

TA

RT

RA

TE

A

LPH

AG

AN

PO

PH

TH

ALM

ICN

OB

RIM

ON

IDIN

E T

AR

TR

AT

E-T

IMO

LOL

MA

LEA

TE

CO

MB

IGA

NO

PH

TH

ALM

ICN

O

BR

INZ

OLA

MID

EA

ZO

PT

OP

HT

HA

LMIC

NO

CA

RB

AC

HO

LIS

OP

TO

CA

RB

AC

HO

LO

PH

TH

ALM

ICN

O

CA

RT

EO

LOL

HC

LC

AR

TE

OLO

L H

CL

OP

HT

HA

LMIC

NO

DO

RZ

OLA

MID

E

TR

US

OP

TO

PH

TH

ALM

ICN

O

DO

RZ

OLA

MID

E H

CL-

TIM

OLO

L M

ALE

AT

E

CO

SO

PT

OP

HT

HA

LMIC

NO

IMO

LOL

MA

LEA

TE

IST

ALO

LO

PH

TH

ALM

ICN

O

LAT

AN

OP

RO

ST

XA

LAT

AN

OP

HT

HA

LMIC

NO

LEV

OB

UN

OLO

L H

CL

BE

TA

GA

NO

PH

TH

ALM

ICN

O

PIL

OC

AR

PIN

E H

CL

ISO

PT

O C

AR

PIN

EO

PH

TH

ALM

ICN

O

TIM

OLO

L M

ALE

AT

ET

IMO

PT

ICO

PH

TH

ALM

ICN

O

TR

AV

OP

RO

ST

TR

AV

AT

AN

OP

HT

HA

LMIC

NO

W2

GM

ISC

AN

TIB

AC

TE

RIA

L C

HE

MO

TH

ER

FO

SF

OM

YC

IN T

RO

ME

TH

AM

INE

MO

NU

RO

LO

RA

LN

O

ME

TH

EN

AM

INE

HIP

PU

RA

TE

H

IPR

EX

OR

AL

NO

Page 27: ACTION: Final ENACTED DATE: 08/19/2011 4:16 PM Appendix ......Representative brand name (If one is in use), NOTE: Brand name products are eligible for reimbursement in accordance with

AP

PE

ND

IX A

BW

C O

UT

PA

TIE

NT

M

ED

ICA

TIO

N F

OR

MU

LAR

Y

Pa

ge

27

of

42

Th

era

pe

uti

c C

lass

Co

de

Th

era

pe

uti

c C

lass

Co

de

De

scri

pti

on

2G

en

eri

c N

am

e

Re

pre

sen

tati

ve

bra

nd

na

me

(If

on

e i

s in

use

), N

OT

E:

Bra

nd

na

me

pro

du

cts

are

eli

gib

le f

or

reim

bu

rse

me

nt

in a

cco

rda

nce

wit

h O

AC

41

23

-6-2

1D

osa

ge

Fo

rm

Re

qu

ire

s P

rio

r

Au

tho

riza

tio

n o

r

Re

late

d C

on

dit

ion

Ap

pro

ve

d i

n C

laim

Co

ve

rag

e r

est

rict

ion

s o

r li

mit

ati

on

s fo

r sp

eci

fic

dru

gs

or

do

sag

e f

orm

s a

re l

iste

d

wit

h t

he

re

spe

ctiv

e d

rug

s b

elo

w.

Un

less

oth

erw

ise

re

stri

cte

d,

all

do

sag

e f

orm

s

an

d s

tre

ng

ths

of

a l

iste

d d

rug

are

eli

gib

le f

or

reim

bu

rse

me

nt

in a

cco

rda

nce

wit

h

OA

C 4

12

3-6

-21

.

MIS

C A

NT

IBA

CT

ER

IAL

CH

EM

OT

HE

R (

CO

NT

)M

ET

HE

NA

MIN

E M

AN

DE

LAT

EM

AN

DE

LAM

INE

OR

AL

NO

ME

TH

EN

AM

INE

-HY

OS

C-M

ET

H B

LUE

-BE

NZ

AC

ID-P

HE

NY

L S

AL

PR

OS

ED

-DS

OR

AL

NO

ME

TH

EN

AM

INE

-HY

OS

-ME

TH

BLU

E-S

OD

PH

OS

-PH

EN

SA

LD

AR

CA

LMA

OR

AL

NO

TR

IME

TH

OP

RIM

PR

IMS

OL

OR

AL

NO

C3

MM

ISC

ELL

AN

EO

US

MIN

ER

AL

RE

PL

MU

LTIP

LE M

INE

RA

LS W

/ F

E-F

A-B

12

-VIT

C-

DS

SG

LUT

OF

AC

-MX

OR

AL

NO

L9A

MIS

CE

LLA

NE

OU

S T

OP

ICA

L A

GE

NT

S

EM

OLL

IEN

TC

ER

AV

ET

OP

ICA

LN

O

SO

AP

& C

LEA

NS

ER

SP

ER

I-W

AS

HT

OP

ICA

LN

O

UR

EA

CR

EA

MA

QU

A C

AR

ET

OP

ICA

LN

O

H2

HM

ON

OA

MIN

EO

XID

AS

E (

MA

O)

INH

IB

SE

LEG

ILIN

E T

D

EM

SA

MT

RA

NS

DE

RM

NO

B3

AM

UC

OLY

TIC

S

AC

ET

YLC

YS

TE

INE

AC

ET

YLC

YS

TE

INE

MIS

CE

LLN

O

DO

RN

AS

E A

LFA

IN

HA

L S

OLN

PU

LMO

ZY

ME

INH

ALA

TIO

NN

O

C6

ZM

ULT

IVIT

AM

IN P

RE

PA

RA

TIO

NS

All

co

mb

ina

tio

ns

an

d s

tre

ng

ths

of

ora

l d

osa

ge

fo

rms

are

co

ve

red

fo

r a

llo

we

d

con

dit

ion

s

B-C

OM

PLE

X W

/ C

& E

+ Z

N

ST

RE

SS

WIT

H Z

INC

OR

AL

YE

S

MU

LTIP

LE V

ITA

MIN

TA

BM

ULT

I-D

AY

OR

AL

YE

S

MU

LTIP

LE V

ITA

MIN

S W

/ M

INE

RA

LS

CE

NT

RU

MO

RA

LY

ES

Q6

JM

YD

RIA

TIC

S

AT

RO

PIN

E S

ULF

AT

EA

TR

OP

INE

SU

LFA

TE

OP

HT

HA

LMIC

NO

CY

CLO

PE

NT

OLA

TE

HC

LC

YC

LOG

YL

OP

HT

HA

LMIC

NO

CY

CLO

PE

NT

OLA

TE

HC

L A

K-P

EN

TO

LAT

EO

PH

TH

ALM

ICN

O

HO

MA

TR

OP

INE

HB

RH

OM

AT

RO

PA

IRE

OP

HT

HA

LMIC

NO

SC

OP

OLA

MIN

E H

BR

IS

OP

TO

HY

OS

CIN

EO

PH

TH

ALM

ICN

O

B4

CN

AR

C A

NT

ITU

SS

-AN

TIC

HO

LIN

CM

B

HY

DR

OC

OD

ON

E B

T-H

OM

AT

RO

PIN

E M

BR

HY

DR

OC

OD

ON

E B

T-H

OM

AT

RO

PIN

E M

BR

OR

AL

NO

B3

QN

AR

C A

NT

ITU

SS

-AN

TIH

IST

-DE

CO

NG

BR

OM

PH

EN

IRA

MIN

E-H

YD

RO

CO

D-P

SE

BR

OM

PH

EN

IRA

MIN

E-H

YD

RO

CO

D-P

SE

OR

AL

NO

PH

EN

YLE

PH

-CH

LOR

PH

EN

W/

HY

DR

OC

OD

ON

E S

YR

UP

H-C

TU

SS

IVE

OR

AL

NO

PH

EN

YLE

PH

RIN

E-B

RO

MP

HE

NP

OLY

-TU

SS

INO

RA

LN

OP

HE

NY

LEP

HR

INE

-CH

LOR

PH

EN

-

DIH

YD

RO

CO

DE

INE

C

OLD

CO

UG

H P

DO

RA

LN

OP

HE

NY

LEP

HR

INE

-DE

XB

RO

MP

HE

N-

HY

DR

OC

OD

ON

E

CY

TU

SS

-HC

OR

AL

NO

PH

EN

YLE

PH

RIN

E-P

YR

ILA

MIN

E W

/ C

OD

EIN

EP

RO

-RE

D A

CO

RA

LN

O

PH

EN

YLE

PH

RIN

E-P

YR

ILA

MIN

E-D

M

CO

DA

L-D

HO

RA

LN

O

PR

OM

ET

HA

ZIN

E V

C-C

OD

EIN

EP

RO

ME

TH

AZ

INE

VC

-CO

DE

INE

OR

AL

NO

Page 28: ACTION: Final ENACTED DATE: 08/19/2011 4:16 PM Appendix ......Representative brand name (If one is in use), NOTE: Brand name products are eligible for reimbursement in accordance with

AP

PE

ND

IX A

BW

C O

UT

PA

TIE

NT

M

ED

ICA

TIO

N F

OR

MU

LAR

Y

Pa

ge

28

of

42

Th

era

pe

uti

c C

lass

Co

de

Th

era

pe

uti

c C

lass

Co

de

De

scri

pti

on

2G

en

eri

c N

am

e

Re

pre

sen

tati

ve

bra

nd

na

me

(If

on

e i

s in

use

), N

OT

E:

Bra

nd

na

me

pro

du

cts

are

eli

gib

le f

or

reim

bu

rse

me

nt

in a

cco

rda

nce

wit

h O

AC

41

23

-6-2

1D

osa

ge

Fo

rm

Re

qu

ire

s P

rio

r

Au

tho

riza

tio

n o

r

Re

late

d C

on

dit

ion

Ap

pro

ve

d i

n C

laim

Co

ve

rag

e r

est

rict

ion

s o

r li

mit

ati

on

s fo

r sp

eci

fic

dru

gs

or

do

sag

e f

orm

s a

re l

iste

d

wit

h t

he

re

spe

ctiv

e d

rug

s b

elo

w.

Un

less

oth

erw

ise

re

stri

cte

d,

all

do

sag

e f

orm

s

an

d s

tre

ng

ths

of

a l

iste

d d

rug

are

eli

gib

le f

or

reim

bu

rse

me

nt

in a

cco

rda

nce

wit

h

OA

C 4

12

3-6

-21

.

NA

RC

AN

TIT

US

S-A

NT

IHIS

T-D

EC

ON

G (

CO

NT

)

PS

EU

DO

EP

H-B

RO

MP

HE

N W

/

HY

DR

OC

OD

ON

EV

ISV

EX

HC

OR

AL

NO

PS

EU

DO

EP

HE

D-B

RO

MP

HE

NB

RO

MC

OM

P H

CO

RA

LN

O

B4

QN

AR

C A

NT

ITU

SS

-DE

CO

NG

-EX

PE

CT

PS

EU

DO

EP

HE

DR

INE

W/

CO

D-G

G S

OLN

C

HE

RA

TU

SS

IN D

AC

OR

AL

NO

B4

SN

AR

C A

NT

ITU

SS

-EX

PE

CT

OR

AN

T C

MB

GU

AIF

EN

ES

IN W

/CO

DE

INE

GU

AIF

EN

ES

IN W

/CO

DE

INE

OR

AL

NO

B4

DN

AR

C A

NT

ITU

SS

IVE

-AN

TIH

IST

CM

BC

HLO

RP

HE

NIR

AM

INE

W/

HY

DR

OC

OD

ON

E

CR

SU

SP

T

US

SIO

NE

XO

RA

LN

OH

YD

RO

CO

D P

OLS

T-C

HLO

RP

HE

N P

OLS

T C

AP

SR

T

US

SIC

AP

SO

RA

LN

O

PR

OM

ET

HA

ZIN

E-C

OD

EIN

EP

RO

ME

TH

AZ

INE

-CO

DE

INE

OR

AL

NO

H3

MN

AR

C-N

ON

-SA

L A

NLG

-BA

RB

IT-X

AN

TH

BU

TA

LBIT

AL-

AP

AP

-CA

FF

W/

CO

DF

IOR

ICE

T W

/CO

DE

INE

OR

AL

NO

H3

XN

AR

CO

TIC

AN

ALG

/SA

LIC

YLA

TE

CO

MB

AS

PIR

IN W

ITH

CO

DE

INE

AS

PIR

IN W

ITH

CO

DE

INE

OR

AL

NO

H3

NN

AR

CO

TIC

AN

ALG

ES

IC/N

SA

ID C

OM

BO

HY

DR

OC

OD

ON

E-I

BU

PR

OF

EN

VIC

OP

RO

FE

NO

RA

LN

O

OX

YC

OD

ON

E-I

BU

PR

OF

EN

CO

MB

UN

OX

OR

AL

NO

H3

AN

AR

CO

TIC

AN

ALG

ES

ICS

AP

AP

-CA

FF

EIN

E-D

IHY

DR

OC

OD

EIN

ES

YN

ALG

OS

-DC

OR

AL

NO

CO

DE

INE

SU

LFA

TE

CO

DE

INE

SU

LFA

TE

OR

AL

NO

FE

NT

AN

YL

CIT

RA

TE

AC

TIQ

BU

CC

AL

NO

Cla

im m

ust

be

all

ow

ed

fo

r n

eo

pla

sm o

r m

ali

gn

an

cy (

bu

cca

l fo

rmu

lati

on

s o

nly

)

FE

NT

AN

YL

CIT

RA

TE

F

EN

TO

RA

BU

CC

AL

NO

Cla

im m

ust

be

all

ow

ed

fo

r n

eo

pla

sm o

r m

ali

gn

an

cy (

bu

cca

l fo

rmu

lati

on

s o

nly

)

FE

NT

AN

YL

TD

DU

RA

GE

SIC

TR

AN

SD

ER

MN

O

HY

DR

OC

OD

ON

E-A

CE

TA

MIN

OP

HE

NV

ICO

DIN

OR

AL

NO

All

str

en

gth

s a

nd

ora

l fo

rmu

lati

on

s o

f a

ceta

min

op

he

n a

nd

hy

dro

cod

on

e a

re

cov

ere

d

HY

DR

OM

OR

PH

ON

E H

CL

DIL

AU

DID

OR

AL

NO

LEV

OR

PH

AN

OL

TA

RT

RA

TE

LEV

O-D

RO

MO

RA

NO

RA

LN

O

ME

PE

RID

INE

HC

LD

EM

ER

OL

OR

AL

NO

ME

PE

RID

INE

-PR

OM

ET

HA

ZIN

EM

EP

ER

GA

NO

RA

LN

O

ME

TH

AD

ON

E H

CL

DO

LOP

HIN

EO

RA

LN

O

MO

RP

HIN

E S

ULF

AT

EA

VIN

ZA

OR

AL

NO

MO

RP

HIN

E S

ULF

AT

EK

AD

IAN

OR

AL

NO

MO

RP

HIN

E-N

ALT

RE

XO

NE

EM

BE

DA

OR

AL

NO

OP

IUM

TIN

CT

UR

E

PA

RE

GO

RIC

OR

AL

NO

OX

YC

OD

ON

E H

CL

OX

Y I

R,

OX

YC

ON

TIN

OR

AL

NO

OX

YC

OD

ON

E W

/ A

CE

TA

MIN

OP

HE

N

PE

RC

OC

ET

OR

AL

NO

All

str

en

gth

s a

nd

ora

l fo

rmu

lati

on

s o

f a

ceta

min

op

he

n a

nd

oxy

cod

on

e a

re c

ov

ere

d

OX

YC

OD

ON

E W

/ A

SP

IRIN

PE

RC

OD

AN

OR

AL

NO

OX

YM

OR

PH

ON

E H

CL

OP

AN

A,

OP

AN

A E

RO

RA

LN

O

Page 29: ACTION: Final ENACTED DATE: 08/19/2011 4:16 PM Appendix ......Representative brand name (If one is in use), NOTE: Brand name products are eligible for reimbursement in accordance with

AP

PE

ND

IX A

BW

C O

UT

PA

TIE

NT

M

ED

ICA

TIO

N F

OR

MU

LAR

Y

Pa

ge

29

of

42

Th

era

pe

uti

c C

lass

Co

de

Th

era

pe

uti

c C

lass

Co

de

De

scri

pti

on

2G

en

eri

c N

am

e

Re

pre

sen

tati

ve

bra

nd

na

me

(If

on

e i

s in

use

), N

OT

E:

Bra

nd

na

me

pro

du

cts

are

eli

gib

le f

or

reim

bu

rse

me

nt

in a

cco

rda

nce

wit

h O

AC

41

23

-6-2

1D

osa

ge

Fo

rm

Re

qu

ire

s P

rio

r

Au

tho

riza

tio

n o

r

Re

late

d C

on

dit

ion

Ap

pro

ve

d i

n C

laim

Co

ve

rag

e r

est

rict

ion

s o

r li

mit

ati

on

s fo

r sp

eci

fic

dru

gs

or

do

sag

e f

orm

s a

re l

iste

d

wit

h t

he

re

spe

ctiv

e d

rug

s b

elo

w.

Un

less

oth

erw

ise

re

stri

cte

d,

all

do

sag

e f

orm

s

an

d s

tre

ng

ths

of

a l

iste

d d

rug

are

eli

gib

le f

or

reim

bu

rse

me

nt

in a

cco

rda

nce

wit

h

OA

C 4

12

3-6

-21

.

H3

BN

AR

CO

TIC

AN

ALG

ES

ICS

(C

ON

T)

BU

TO

RP

HA

NO

L T

AR

TR

AT

ES

TA

DO

L N

AS

AL

NA

SA

LN

O

PE

NT

AZ

OC

INE

- A

CE

TA

MIN

OP

HE

NT

ALA

CE

NO

RA

LN

O

PE

NT

AZ

OC

INE

AN

D N

ALO

XO

NE

HC

LT

ALW

IN N

XO

RA

LN

O

TA

PE

NT

AD

OL

HC

L N

UC

YN

TA

OR

AL

NO

TR

AM

AD

OL

HC

LU

LTR

AM

OR

AL

NO

TR

AM

AD

OL-

AC

ET

AM

INO

PH

EN

ULT

RA

CE

TO

RA

LN

O

H3

YN

AR

CO

TIC

AN

TA

G,

PE

RIP

H-A

CT

ING

ME

TH

YLN

ALT

RE

XO

NE

BR

OM

IDE

RE

LIS

TO

RS

UB

-QN

O

H3

TN

AR

CO

TIC

AN

TA

GO

NIS

TS

NA

LTR

EX

ON

E H

CL

RE

VIA

OR

AL

NO

H3

UN

AR

CO

TIC

+N

ON

-SA

LIC

AN

ALG

CO

MB

O

AC

ET

AM

INO

PH

EN

-CO

DE

INE

TY

LEN

OL

W/C

OD

EIN

E N

O.3

OR

AL

NO

H3

RN

AR

C-S

ALI

C A

NLG

-BA

RB

-XA

NT

HIN

E

BU

TA

LBIT

AL-

AS

PIR

IN-C

AF

F W

/ C

OD

EIN

EF

IOR

INA

L W

ITH

CO

DE

INE

#3

OR

AL

NO

Q7

EN

AS

AL

AN

TIH

IST

AM

INE

AZ

ELA

ST

INE

HC

LA

ST

ELI

NN

AS

AL

YE

S

OLO

PA

TA

DIN

E H

CL

PA

TA

NA

SE

NA

SA

LY

ES

Q7

HN

AS

AL

MA

ST

CE

LL S

TA

BIL

IZE

RS

CR

OM

OLY

N S

OD

IUM

N

AS

ALC

RO

MN

AS

AL

YE

S

C6

NN

IAC

IN P

RE

PA

RA

TIO

NS

All

co

mb

ina

tio

ns

an

d s

tre

ng

ths

of

ora

l d

osa

ge

fo

rms

are

co

ve

red

fo

r a

llo

we

d

con

dit

ion

s

NIA

CIN

N

IAC

INO

RA

LY

ES

W2

FN

ITR

OF

UR

AN

DE

RIV

AT

IVE

S

NIT

RO

FU

RA

NT

OIN

MA

CR

OD

AN

TIN

OR

AL

NO

H2

EN

ON

-BA

RB

ITU

RA

TE

, S

ED

AT

IVE

CH

LOR

AL

HY

DR

AT

EC

HLO

RA

L H

YD

RA

TE

OR

AL

NO

CH

LOR

AL

HY

DR

AT

EN

OC

TE

CO

RA

LN

O

DIP

HE

NH

YD

RA

MIN

E H

CL

DIP

HE

NH

YD

RA

MIN

E H

CL

OR

AL

NO

DO

XE

PIN

HC

LD

OX

EP

IN H

CL

(SLE

EP

) T

AB

OR

AL

NO

ES

TA

ZO

LAM

PR

OS

OM

OR

AL

NO

ES

ZO

PIC

LON

ELU

NE

ST

AO

RA

LN

O

FLU

RA

ZE

PA

M H

CL

DA

LMA

NE

OR

AL

NO

TE

MA

ZE

PA

M

RE

ST

OR

ILO

RA

LN

O

TR

IAZ

OLA

MH

ALC

ION

OR

AL

NO

ZA

LEP

LON

SO

NA

TA

OR

AL

NO

ZO

LPID

EM

TA

RT

RA

TE

A

MB

IEN

OR

AL

NO

ZO

LPID

EM

TA

RT

RA

TE

SL

ED

LUA

RS

UB

LIN

GU

AL

NO

B4

EN

ON

-NA

RC

AN

TIT

US

S-A

NT

IHS

TC

MB

CA

R-B

-PE

N T

A/C

HLO

R-T

AN

CA

R-B

-PE

N T

A/C

HLO

R-T

AN

OR

AL

NO

CH

LOR

PH

EN

IRA

MIN

E-D

MC

HLO

RP

HE

NIR

AM

INE

-DM

OR

AL

NO

PR

OM

ET

HA

ZIN

E-D

MP

RO

ME

TH

AZ

INE

-DM

OR

AL

NO

Page 30: ACTION: Final ENACTED DATE: 08/19/2011 4:16 PM Appendix ......Representative brand name (If one is in use), NOTE: Brand name products are eligible for reimbursement in accordance with

AP

PE

ND

IX A

BW

C O

UT

PA

TIE

NT

M

ED

ICA

TIO

N F

OR

MU

LAR

Y

Pa

ge

30

of

42

Th

era

pe

uti

c C

lass

Co

de

Th

era

pe

uti

c C

lass

Co

de

De

scri

pti

on

2G

en

eri

c N

am

e

Re

pre

sen

tati

ve

bra

nd

na

me

(If

on

e i

s in

use

), N

OT

E:

Bra

nd

na

me

pro

du

cts

are

eli

gib

le f

or

reim

bu

rse

me

nt

in a

cco

rda

nce

wit

h O

AC

41

23

-6-2

1D

osa

ge

Fo

rm

Re

qu

ire

s P

rio

r

Au

tho

riza

tio

n o

r

Re

late

d C

on

dit

ion

Ap

pro

ve

d i

n C

laim

Co

ve

rag

e r

est

rict

ion

s o

r li

mit

ati

on

s fo

r sp

eci

fic

dru

gs

or

do

sag

e f

orm

s a

re l

iste

d

wit

h t

he

re

spe

ctiv

e d

rug

s b

elo

w.

Un

less

oth

erw

ise

re

stri

cte

d,

all

do

sag

e f

orm

s

an

d s

tre

ng

ths

of

a l

iste

d d

rug

are

eli

gib

le f

or

reim

bu

rse

me

nt

in a

cco

rda

nce

wit

h

OA

C 4

12

3-6

-21

.

B4

RN

ON

-NA

RC

AN

TIT

US

S-D

EC

ON

G-E

XP

CT

NO

PH

EN

YLE

PH

RIN

E W

/ D

M-G

GR

OB

ITU

SS

IN C

OU

GH

& C

OLD

CF

OR

AL

NO

PS

EU

DO

EP

HE

DR

INE

W/

DM

-GG

TA

BC

AP

MIS

T D

MO

RA

LN

O

H3

KN

ON

-SA

L A

NA

LG-B

AR

BIT

UR

AT

E C

MB

BU

TA

LBIT

AL-

AC

ET

AM

INO

PH

EN

P

HR

EN

ILIN

OR

AL

NO

H3

LN

ON

-SA

L A

NA

LG-B

AR

BIT

-XA

NT

HIN

E

BU

TA

LBIT

AL-

AP

AP

-CA

FF

EIN

E

FIO

RIC

ET

OR

AL

NO

H7

DN

OR

EP

INE

PH

/DO

PA

MIN

E R

EU

P I

NH

IB

BU

PR

OP

ION

HB

R

AP

LEN

ZIN

OR

AL

NO

BU

PR

OP

ION

HC

LW

ELL

BU

TR

INO

RA

LN

O

Q7

WN

OS

E P

RE

PS

AN

TIB

IOT

ICS

MU

PIR

OC

IN C

ALC

IUM

B

AC

TR

OB

AN

NA

SA

LN

AS

AL

YE

S

Q7

PN

OS

E P

RE

PS

AN

TII

NF

LAM

MA

TO

RY

BE

CLO

ME

TH

AS

ON

E D

IPR

OP

ION

AT

E

BE

CO

NA

SE

AQ

NA

SA

LY

ES

BU

DE

SO

NID

E

RH

INO

CO

RT

AQ

UA

NA

SA

LY

ES

CIC

LES

ON

IDE

OM

NA

RIS

NA

SA

LY

ES

FLU

NIS

OLI

DE

F

LUN

ISO

LID

EN

AS

AL

YE

S

FLU

TIC

AS

ON

E F

UR

OA

TE

VE

RA

MY

ST

NA

SA

LY

ES

FLU

TIC

AS

ON

E P

RO

PIO

NA

TE

F

LON

AS

EN

AS

AL

YE

S

MO

ME

TA

SO

NE

FU

RO

AT

E

NA

SO

NE

XN

AS

AL

YE

S

TR

IAM

CIN

OLO

NE

AC

ET

ON

IDE

NA

SA

CO

RT

AQ

NA

SA

LY

ES

Q7

YN

OS

E P

RE

PS

MIS

C O

TC

ON

LY

SA

LIN

ES

EA

SO

FT

NA

SA

LY

ES

Q7

AN

OS

E P

RE

PS

MIS

C R

X O

NLY

IPR

AT

RO

PIU

M B

RO

MID

EIP

RA

TR

OP

IUM

BR

OM

IDE

NA

SA

LY

ES

Q7

DN

OS

E P

RE

PS

VA

SO

CO

NS

TR

ICT

OR

S

OX

YM

ET

AZ

OLI

NE

HC

L1

2 H

OU

R N

AS

AL

SP

RA

YN

AS

AL

YE

S

PH

EN

YLE

PH

RIN

E H

CL

NE

O-S

YN

EP

HR

INE

NA

SA

LY

ES

S2

TN

SA

ID &

PR

OS

TA

GLA

ND

IN C

OM

BO

DIC

LOF

EN

AC

W/

MIS

OP

RO

ST

OL

AR

TH

RO

TE

C 5

0O

RA

LN

O

S2

PN

SA

ID &

PR

OT

ON

PU

MP

IN

HIB

CO

MB

Ina

ctiv

eP

RE

VA

CID

NA

PR

AP

AC

OR

AL

NO

S2

SN

SA

ID-1

ST

GE

N A

NT

IHIS

T-S

ED

AT

IVE

IBU

PR

OF

EN

-DIP

HE

NH

YD

RA

MIN

E

AD

VIL

PM

OR

AL

NO

S2

BN

SA

IDS

CE

LEC

OX

IBC

ELE

BR

EX

OR

AL

NO

DIC

LOF

EN

AC

PO

TA

SS

IUM

DIC

LOF

EN

AC

PO

TA

SS

IUM

OR

AL

NO

DIC

LOF

EN

AC

SO

DIU

MV

OLT

AR

EN

OR

AL

NO

ET

OD

OLA

CE

TO

DO

LAC

OR

AL

NO

FE

NO

PR

OF

EN

CA

LCIU

MF

EN

OP

RO

FE

N C

ALC

IUM

OR

AL

NO

FE

NO

PR

OF

EN

CA

LCIU

M

NA

LFO

NO

RA

LN

O

FLU

RB

IPR

OF

EN

FLU

RB

IPR

OF

EN

OR

AL

NO

Page 31: ACTION: Final ENACTED DATE: 08/19/2011 4:16 PM Appendix ......Representative brand name (If one is in use), NOTE: Brand name products are eligible for reimbursement in accordance with

AP

PE

ND

IX A

BW

C O

UT

PA

TIE

NT

M

ED

ICA

TIO

N F

OR

MU

LAR

Y

Pa

ge

31

of

42

Th

era

pe

uti

c C

lass

Co

de

Th

era

pe

uti

c C

lass

Co

de

De

scri

pti

on

2G

en

eri

c N

am

e

Re

pre

sen

tati

ve

bra

nd

na

me

(If

on

e i

s in

use

), N

OT

E:

Bra

nd

na

me

pro

du

cts

are

eli

gib

le f

or

reim

bu

rse

me

nt

in a

cco

rda

nce

wit

h O

AC

41

23

-6-2

1D

osa

ge

Fo

rm

Re

qu

ire

s P

rio

r

Au

tho

riza

tio

n o

r

Re

late

d C

on

dit

ion

Ap

pro

ve

d i

n C

laim

Co

ve

rag

e r

est

rict

ion

s o

r li

mit

ati

on

s fo

r sp

eci

fic

dru

gs

or

do

sag

e f

orm

s a

re l

iste

d

wit

h t

he

re

spe

ctiv

e d

rug

s b

elo

w.

Un

less

oth

erw

ise

re

stri

cte

d,

all

do

sag

e f

orm

s

an

d s

tre

ng

ths

of

a l

iste

d d

rug

are

eli

gib

le f

or

reim

bu

rse

me

nt

in a

cco

rda

nce

wit

h

OA

C 4

12

3-6

-21

.

NS

AID

S (

CO

NT

)IB

UP

RO

FE

NM

OT

RIN

OR

AL

NO

IND

OM

ET

HA

CIN

IND

OM

ET

HA

CIN

OR

AL

NO

KE

TO

PR

OF

EN

KE

TO

PR

OF

EN

OR

AL

NO

KE

TO

RO

LAC

TR

OM

ET

HA

MIN

EK

ET

OR

OLA

C T

RO

ME

TH

AM

INE

OR

AL

NO

Qu

an

tity

ma

y n

ot

exc

ee

d 2

0 u

nit

s o

r a

5 d

ay

su

pp

ly w

hic

he

ve

r is

le

ast

du

rin

g a

roll

ing

12

mo

nth

pe

rio

d.

ME

CLO

FE

NA

MA

TE

SO

DIU

MM

EC

LOF

EN

AM

AT

E S

OD

IUM

OR

AL

NO

NA

BU

ME

TO

NE

NA

BU

ME

TO

NE

OR

AL

NO

NA

PR

OX

EN

SO

DIU

M

NA

PR

OX

EN

OR

AL

NO

NA

PR

OX

EN

-ES

OM

EP

RA

ZO

LE M

AG

NE

SIU

MN

AP

RO

XE

N-E

SO

ME

PR

AZ

OLE

MA

GN

ES

IUM

OR

AL

NO

PIR

OX

ICA

MP

IRO

XIC

AM

OR

AL

NO

SU

LIN

DA

C

SU

LIN

DA

CO

RA

LN

O

TO

LME

TIN

SO

DIU

MT

OLM

ET

IN S

OD

IUM

OR

AL

NO

S2

DN

SA

IDS

(C

ON

T-A

)

ME

FE

NA

MIC

AC

IDM

EF

EN

AM

IC A

CID

OR

AL

NO

ME

FE

NA

MIC

AC

IDP

ON

ST

EL

OR

AL

NO

OX

AP

RO

ZIN

OX

AP

RO

ZIN

OR

AL

NO

S2

EN

SA

IDS

(C

ON

T-B

)

ME

LOX

ICA

MM

OB

ICO

RA

LN

O

S2

RN

SA

IDS

/DIE

TA

RY

SU

PP

CO

MB

O

Ina

ctiv

eIC

80

0O

RA

LN

O

U6

EO

INT

ME

NT

/CR

EA

M B

AS

ES

EM

OLL

IEN

TD

IAB

ET

IDE

RM

TO

PIC

AL

NO

VA

SE

LIN

E P

ET

RO

LEU

MV

AS

ELI

NE

PE

TR

OLE

UM

TO

PIC

AL

NO

Q2

CO

PH

TH

AN

TI-

INF

LAM

IM

MU

NO

MO

DU

LA

CY

CLO

SP

OR

INE

(O

PH

TH

)R

ES

TA

SIS

OP

HT

HA

LMIC

YE

S

Q6

UO

PH

TH

ALM

IC M

AS

T C

ELL

ST

AB

CR

OM

OLY

N S

OD

IUM

CR

OM

OLY

N S

OD

IUM

OP

HT

HA

LMIC

YE

S

M9

LO

RA

L A

NT

ICO

AG

ULA

NT

S,

CO

UM

AR

I

WA

RF

AR

IN S

OD

IUM

C

OU

MA

DIN

OR

AL

NO

D4

HO

RA

L M

UC

OS

ITIS

/ST

OM

AT

ITIS

AG

PO

VID

ON

E-S

OD

IUM

HY

ALU

RO

NA

TE

-

GLY

CY

RR

HE

TIN

IC A

CID

GE

LCLA

IRM

UC

OU

S M

EM

NO

Q8

FO

TIC

PR

EP

AR

AT

ION

S A

NT

I IN

FLA

CIP

RO

FLO

XA

CIN

-HY

DR

OC

OR

TIS

ON

EC

IPR

O H

CO

TIC

NO

W1

OO

XA

ZO

LDIN

ON

ES

LIN

EZ

OLI

DZ

YV

OX

OR

AL

NO

W8

DO

XID

IZIN

G A

GE

NT

S

DA

KIN

'S S

OLU

TIO

ND

AK

IN'S

MIS

CE

LLN

O

HY

DR

OG

EN

PE

RO

XID

EH

YD

RO

GE

N P

ER

OX

IDE

MIS

CE

LLN

O

G3

AO

XY

TO

CIC

S

ME

TH

YLE

RG

ON

OV

INE

MA

LEA

TE

ME

TH

ER

GIN

EO

RA

LN

O

Page 32: ACTION: Final ENACTED DATE: 08/19/2011 4:16 PM Appendix ......Representative brand name (If one is in use), NOTE: Brand name products are eligible for reimbursement in accordance with

AP

PE

ND

IX A

BW

C O

UT

PA

TIE

NT

M

ED

ICA

TIO

N F

OR

MU

LAR

Y

Pa

ge

32

of

42

Th

era

pe

uti

c C

lass

Co

de

Th

era

pe

uti

c C

lass

Co

de

De

scri

pti

on

2G

en

eri

c N

am

e

Re

pre

sen

tati

ve

bra

nd

na

me

(If

on

e i

s in

use

), N

OT

E:

Bra

nd

na

me

pro

du

cts

are

eli

gib

le f

or

reim

bu

rse

me

nt

in a

cco

rda

nce

wit

h O

AC

41

23

-6-2

1D

osa

ge

Fo

rm

Re

qu

ire

s P

rio

r

Au

tho

riza

tio

n o

r

Re

late

d C

on

dit

ion

Ap

pro

ve

d i

n C

laim

Co

ve

rag

e r

est

rict

ion

s o

r li

mit

ati

on

s fo

r sp

eci

fic

dru

gs

or

do

sag

e f

orm

s a

re l

iste

d

wit

h t

he

re

spe

ctiv

e d

rug

s b

elo

w.

Un

less

oth

erw

ise

re

stri

cte

d,

all

do

sag

e f

orm

s

an

d s

tre

ng

ths

of

a l

iste

d d

rug

are

eli

gib

le f

or

reim

bu

rse

me

nt

in a

cco

rda

nce

wit

h

OA

C 4

12

3-6

-21

.

D8

AP

AN

CR

EA

TIC

EN

ZY

ME

SA

ll o

ral

form

ula

tio

ns

of

the

se d

rug

s a

re c

ov

ere

d f

or

all

ow

ed

co

nd

itio

ns

AM

Y-L

IP-P

RO

T

PA

NC

RE

AS

E M

T 1

0O

RA

LY

ES

AM

Y-L

IP-P

RO

T

PA

NC

RE

LIP

AS

E (

LIP

-PR

OT

-AM

YL)

DR

CA

PO

RA

LY

ES

PA

NC

RE

LIP

AS

E (

LIP

-PR

OT

-AM

YL)

CR

EO

NO

RA

LY

ES

J1A

PA

RA

SY

MP

AT

HE

TIC

AG

EN

TS

BE

TH

AN

EC

HO

L C

HLO

RID

EU

RE

CH

OLI

NE

OR

AL

NO

CE

VIM

ELI

NE

HC

L E

VO

XA

CO

RA

LN

O

PIL

OC

AR

PIN

E H

CL

PIL

OC

AR

OR

AL

NO

C6

HP

ED

IAT

RIC

VIT

AM

IN P

RE

PA

RE

All

co

mb

ina

tio

ns

an

d s

tre

ng

ths

of

ora

l d

osa

ge

fo

rms

are

co

ve

red

fo

r a

llo

we

d

con

dit

ion

sP

ED

IAT

RIC

MU

LTIP

LE V

ITA

MIN

W/

MIN

ER

ALS

& C

CH

EW

C

ER

OV

ITE

JR

OR

AL

YE

S

W1

AP

EN

ICIL

LIN

S

AM

OX

ICIL

LIN

AM

OX

ICIL

LIN

OR

AL

NO

AM

OX

ICIL

LIN

& K

CLA

VU

LAN

AT

E

AU

GM

EN

TIN

OR

AL

NO

AM

OX

ICIL

LIN

(T

RIH

YD

RA

TE

)M

OX

AT

AG

OR

AL

NO

AM

PIC

ILLI

N T

RIH

YD

RA

TE

AM

PIC

ILLI

N T

RIH

YD

RA

TE

OR

AL

NO

DIC

LOX

AC

ILLI

N S

OD

IUM

DIC

LOX

AC

ILLI

N S

OD

IUM

OR

AL

NO

Ina

ctiv

eG

EO

CIL

LIN

OR

AL

NO

PE

NIC

ILLI

N V

PO

TA

SS

IUM

PE

NIC

ILLI

N V

PO

TA

SS

IUM

OR

AL

NO

D1

AP

ER

IOD

ON

TIA

L C

OLL

IN

HIB

ITO

RS

DO

XY

CY

CLI

NE

HY

CLA

TE

DO

XY

CY

CLI

NE

HY

CLA

TE

OR

AL

YE

S

A7

CP

ER

IPH

ER

AL

VA

SO

DIL

AT

OR

S

ISO

XS

UP

RIN

E H

CL

VA

SO

DIL

AN

OR

AL

YE

S

PA

PA

VE

RIN

E H

CL

PA

VA

BID

OR

AL

YE

S

C1

PP

HO

SP

AT

E R

EP

LAC

ME

NT

PH

OS

PA

TE

RE

PLA

CM

EN

TP

OT

AS

SIU

M &

SO

DIU

M P

HO

SP

HA

TE

SN

EU

TR

A-P

HO

SO

RA

LY

ES

M9

PP

LAT

ELE

T A

GG

RE

GA

TIO

N I

NH

IBIT

AS

PIR

IN-D

IPY

RID

AM

OLE

AG

GR

EN

OX

OR

AL

YE

S

CIL

OS

TA

ZO

LC

ILO

ST

AZ

OL

OR

AL

YE

S

CLO

PID

OG

RE

L B

ISU

LFA

TE

PLA

VIX

OR

AL

YE

S

DIP

YR

IDA

MO

LED

IPY

RID

AM

OLE

OR

AL

YE

S

PE

RS

AN

TIN

EP

ER

SA

NT

INE

OR

AL

YE

S

TIC

LOP

IDIN

E H

CL

TIC

LOP

IDIN

E H

CL

OR

AL

YE

S

B1

BP

LUM

AN

TIH

YP

ER

TE

N E

ND

O R

EC

AN

T

AM

BR

ISE

NT

AN

LET

AIR

ISO

RA

LY

ES

BO

SE

NT

AN

TR

AC

LEE

RO

RA

LY

ES

C1

DP

OT

AS

SIU

M R

EP

LAC

EM

EN

TA

ll p

ota

ssiu

m s

alt

s a

nd

ora

l d

osa

ge

fo

rms

are

co

ve

red

fo

r a

llo

we

d c

on

dit

ion

s

PO

TA

SS

IUM

BIC

AR

BO

NA

TE

EF

FE

R

KLO

R-C

ON

-EF

OR

AL

YE

S

PO

TA

SS

IUM

CH

LOR

IDE

K

LOR

-CO

NO

RA

LY

ES

Page 33: ACTION: Final ENACTED DATE: 08/19/2011 4:16 PM Appendix ......Representative brand name (If one is in use), NOTE: Brand name products are eligible for reimbursement in accordance with

AP

PE

ND

IX A

BW

C O

UT

PA

TIE

NT

M

ED

ICA

TIO

N F

OR

MU

LAR

Y

Pa

ge

33

of

42

Th

era

pe

uti

c C

lass

Co

de

Th

era

pe

uti

c C

lass

Co

de

De

scri

pti

on

2G

en

eri

c N

am

e

Re

pre

sen

tati

ve

bra

nd

na

me

(If

on

e i

s in

use

), N

OT

E:

Bra

nd

na

me

pro

du

cts

are

eli

gib

le f

or

reim

bu

rse

me

nt

in a

cco

rda

nce

wit

h O

AC

41

23

-6-2

1D

osa

ge

Fo

rm

Re

qu

ire

s P

rio

r

Au

tho

riza

tio

n o

r

Re

late

d C

on

dit

ion

Ap

pro

ve

d i

n C

laim

Co

ve

rag

e r

est

rict

ion

s o

r li

mit

ati

on

s fo

r sp

eci

fic

dru

gs

or

do

sag

e f

orm

s a

re l

iste

d

wit

h t

he

re

spe

ctiv

e d

rug

s b

elo

w.

Un

less

oth

erw

ise

re

stri

cte

d,

all

do

sag

e f

orm

s

an

d s

tre

ng

ths

of

a l

iste

d d

rug

are

eli

gib

le f

or

reim

bu

rse

me

nt

in a

cco

rda

nce

wit

h

OA

C 4

12

3-6

-21

.

R1

HP

OT

AS

SIU

M S

PA

RIN

G D

IUR

ET

ICS

R1

LP

OT

AS

SIU

M S

PA

RIN

G D

IUR

ET

ICS

AM

ILO

RID

E H

CL

AM

ILO

RID

E H

CL

OR

AL

YE

S

AM

ILO

RID

E H

CL-

HC

TZ

AM

ILO

RID

E H

CL-

HC

TZ

OR

AL

YE

S

EP

LER

EN

ON

EIN

SP

RA

OR

AL

YE

S

SP

IRO

NO

LAC

TO

NE

ALD

AC

TO

NE

OR

AL

YE

SS

PIR

ON

OLA

CT

ON

E &

HY

DR

OC

HLO

RO

TH

IAZ

IDE

A

LDA

CT

AZ

IDE

OR

AL

YE

S

SP

IRO

NO

LAC

TO

NE

-HC

TZ

SP

IRO

NO

LAC

TO

NE

-HC

TZ

OR

AL

YE

S

TR

IAM

TE

RE

NE

& H

YD

RO

CH

LOR

OT

HIA

ZID

ED

YA

ZID

EO

RA

LY

ES

TR

IAM

TE

RE

NE

W/H

CT

ZT

RIA

MT

ER

EN

E W

/HC

TZ

OR

AL

YE

S

C6

FP

RE

NA

TA

L V

ITA

MIN

PR

EP

AR

AT

ION

All

co

mb

ina

tio

ns

an

d s

tre

ng

ths

of

ora

l d

osa

ge

fo

rms

are

co

ve

red

fo

r a

llo

we

d

con

dit

ion

s

PR

EN

AT

AL

VIT

W/

DS

S-F

E F

UM

AR

AT

E-F

AP

RE

NA

TA

L 1

9O

RA

LY

ES

PR

EN

AT

AL

VIT

W/

FE

FU

MA

RA

TE

-FA

P

RE

NA

TA

L P

LUS

OR

AL

YE

S

G2

AP

RO

GE

ST

AT

ION

AL

AG

EN

TS

ME

DR

OX

YP

RO

GE

ST

ER

ON

E A

CE

TA

TE

ME

DR

OX

YP

RO

GE

ST

ER

ON

E A

CE

TA

TE

OR

AL

YE

S

L3A

PR

OT

EC

TIV

ES

L3B

PR

OT

EC

TIV

ES

ALU

MIN

UM

HY

DR

OX

IDE

DE

RM

AG

RA

NT

OP

ICA

LN

O

BE

NZ

OIN

BE

NZ

OIN

TO

PIC

AL

NO

DE

RM

AT

OLO

GIC

AL

PR

OD

UC

TS

MIS

CT

ET

RIX

TO

PIC

AL

NO

DIM

ET

HIC

ON

EP

RO

SH

IELD

PLU

ST

OP

ICA

LN

O

DIM

ET

HIC

ON

E

PA

CQ

UIN

ME

DIC

AT

ED

TO

PIC

AL

NO

HY

ALU

RO

NA

TE

SO

DIU

M

BIO

NE

CT

TO

PIC

AL

NO

HY

ALU

RO

NA

TE

SO

DIU

M (

EM

OLL

IEN

T)

HY

LIR

AT

OP

ICA

LN

O

ME

NT

HO

L-Z

INC

OX

IDE

CA

LMO

SE

PT

INE

TO

PIC

AL

NO

PE

TR

OLA

TU

M-Z

INC

OX

IDE

SE

NS

I-C

AR

ET

OP

ICA

LN

O

PE

TR

OLA

TU

M-Z

INC

OX

IDE

SE

NS

I-C

AR

ET

OP

ICA

LN

O

SK

IN P

RO

TE

CT

AN

TS

MIS

CP

ELE

VE

RU

S G

OLD

TO

PIC

AL

NO

SK

IN P

RO

TE

CT

AN

TS

MIS

C

ALO

E V

ES

TA

TO

PIC

AL

NO

SO

DIU

M H

YA

LUR

ON

AT

ES

OD

IUM

HY

ALU

RO

NA

TE

TO

PIC

AL

NO

TA

LC T

OP

ICA

L P

OW

DE

R

T

ALC

TO

PIC

AL

PO

WD

ER

TO

PIC

AL

NO

TIN

CT

UR

E O

F B

EN

ZO

INT

INC

TU

RE

OF

BE

NZ

OIN

TO

PIC

AL

NO

PR

OT

EC

TIV

ES

(C

ON

T)

WO

UN

D C

LEA

NS

ER

SP

ELE

VE

RU

ST

OP

ICA

LN

O

ZIN

C O

XID

ED

ES

ITIN

TO

PIC

AL

NO

ZIN

C O

XID

EB

OU

DR

EA

UX

ST

OP

ICA

LN

O

D4

JP

RO

TO

N P

UM

P I

NH

IBIT

OR

S

ES

OM

EP

RA

ZO

LE M

AG

NE

SIU

M

NE

XIU

MO

RA

LN

O

LAN

SO

PR

AZ

OLE

P

RE

VA

CID

OR

AL

NO

OM

EP

RA

ZO

LEP

RIL

OS

EC

OR

AL

NO

Page 34: ACTION: Final ENACTED DATE: 08/19/2011 4:16 PM Appendix ......Representative brand name (If one is in use), NOTE: Brand name products are eligible for reimbursement in accordance with

AP

PE

ND

IX A

BW

C O

UT

PA

TIE

NT

M

ED

ICA

TIO

N F

OR

MU

LAR

Y

Pa

ge

34

of

42

Th

era

pe

uti

c C

lass

Co

de

Th

era

pe

uti

c C

lass

Co

de

De

scri

pti

on

2G

en

eri

c N

am

e

Re

pre

sen

tati

ve

bra

nd

na

me

(If

on

e i

s in

use

), N

OT

E:

Bra

nd

na

me

pro

du

cts

are

eli

gib

le f

or

reim

bu

rse

me

nt

in a

cco

rda

nce

wit

h O

AC

41

23

-6-2

1D

osa

ge

Fo

rm

Re

qu

ire

s P

rio

r

Au

tho

riza

tio

n o

r

Re

late

d C

on

dit

ion

Ap

pro

ve

d i

n C

laim

Co

ve

rag

e r

est

rict

ion

s o

r li

mit

ati

on

s fo

r sp

eci

fic

dru

gs

or

do

sag

e f

orm

s a

re l

iste

d

wit

h t

he

re

spe

ctiv

e d

rug

s b

elo

w.

Un

less

oth

erw

ise

re

stri

cte

d,

all

do

sag

e f

orm

s

an

d s

tre

ng

ths

of

a l

iste

d d

rug

are

eli

gib

le f

or

reim

bu

rse

me

nt

in a

cco

rda

nce

wit

h

OA

C 4

12

3-6

-21

.

PR

OT

ON

PU

MP

IN

HIB

ITO

RS

(C

ON

T)

OM

EP

RA

ZO

LE-S

OD

IUM

BIC

AR

BO

NA

TE

ZE

GE

RID

OR

AL

NO

PA

NT

OP

RA

ZO

LE S

OD

IUM

PR

OT

ON

IXO

RA

LN

O

RA

BE

PR

AZ

OLE

SO

DIU

M

AC

IPH

EX

OR

AL

NO

B1

DP

ULM

ON

AR

Y A

NT

IHY

PE

RT

EN

SIV

ES

SIL

DE

NA

FIL

CIT

RA

TE

(P

ulm

on

ary

)R

EV

AT

IOO

RA

LY

ES

C7

AP

UR

INE

IN

HIB

ITO

RS

ALL

OP

UR

INO

L A

LLO

PU

RIN

OL

OR

AL

YE

S

FE

BU

XO

ST

AT

ULO

RIC

OR

AL

YE

S

S2

IP

YR

IMID

INE

SY

NT

HE

SIS

IN

HIB

ITR

LEF

LUN

OM

IDE

LEF

LUN

OM

IDE

OR

AL

YE

S

W1

QQ

UIN

OLO

NE

S

CIP

RO

FLO

XA

CIN

HC

LC

IPR

OO

RA

LN

O

GE

MIF

LOX

AC

IN M

ES

YLA

TE

FA

CT

IVE

OR

AL

NO

LEV

OF

LOX

AC

INLE

VA

QU

INO

RA

LN

O

MO

XIF

LOX

AC

IN H

CL

AV

ELO

XO

RA

LN

O

NO

RF

LOX

AC

IN

NO

RO

XIN

OR

AL

NO

OF

LOX

AC

INO

FLO

XA

CIN

OR

AL

NO

Q3

BR

EC

TA

L LO

WE

R B

OW

EL

PR

EP

HY

DR

OC

OR

TIS

ON

E

CO

LOC

OR

TR

EC

TA

LY

ES

HY

DR

OC

OR

TIS

ON

E A

CE

TA

TE

C

OR

TIF

OA

MR

EC

TA

LY

ES

Q3

AR

EC

TA

L P

RE

PA

RA

TIO

NS

HY

DR

OC

OR

TIS

ON

EP

RO

CT

OC

OR

TR

EC

TA

LN

OH

YD

RO

CO

RT

ISO

NE

AC

ET

AT

E W

/

PR

AM

OX

INE

P

RO

CT

OF

OA

M-H

CR

EC

TA

LN

O

ST

AR

CH

T

UC

KS

RE

CT

AL

NO

A4

UR

EN

IN I

NH

IB/T

HIA

ZID

E D

IUR

ET

IC

ALI

SK

IRE

N-H

CT

ZT

EK

TU

RN

A H

CT

OR

AL

NO

A4

TR

EN

IN I

NH

IBIT

OR

, D

IRE

CT

ALI

SK

IRE

N F

UM

AR

AT

ET

EK

TU

RN

AO

RA

LY

ES

A4

WR

EN

IN-I

NH

/AN

GIO

TE

NS

IN-R

EC

-AN

T

ALI

SK

IRE

N-V

ALS

AR

TA

NV

ALT

UR

NA

OR

AL

NO

W9

CR

IFA

MY

CIN

S/R

ELA

TE

D A

NT

IBIO

TIC

S

RIF

AX

IMIN

XIF

AX

AN

OR

AL

NO

L5G

RO

SA

CE

A A

GE

NT

S,

TO

PIC

AL

ME

TR

ON

IDA

ZO

LEM

ET

RO

GE

LT

OP

ICA

LY

ES

H3

OS

ALI

CY

L A

NLG

-BA

RB

ITU

R-X

AN

TH

INE

BU

TA

LBIT

AL-

AS

PIR

IN-C

AF

FE

INE

F

IOR

INA

LO

RA

LN

O

H3

DS

ALI

CY

LAT

E A

NA

LGE

SIC

S

AC

ET

AM

INO

PH

EN

-SA

LIC

YLA

MID

E-

PH

EN

YLT

OLO

XA

MIN

EB

E-F

LEX

PLU

SO

RA

LN

OA

PA

P-S

ALI

CY

LAM

IDE

-PH

EN

YLT

OLO

X-

CA

FF

EIN

E

DU

RA

BA

CO

RA

LN

O

Page 35: ACTION: Final ENACTED DATE: 08/19/2011 4:16 PM Appendix ......Representative brand name (If one is in use), NOTE: Brand name products are eligible for reimbursement in accordance with

AP

PE

ND

IX A

BW

C O

UT

PA

TIE

NT

M

ED

ICA

TIO

N F

OR

MU

LAR

Y

Pa

ge

35

of

42

Th

era

pe

uti

c C

lass

Co

de

Th

era

pe

uti

c C

lass

Co

de

De

scri

pti

on

2G

en

eri

c N

am

e

Re

pre

sen

tati

ve

bra

nd

na

me

(If

on

e i

s in

use

), N

OT

E:

Bra

nd

na

me

pro

du

cts

are

eli

gib

le f

or

reim

bu

rse

me

nt

in a

cco

rda

nce

wit

h O

AC

41

23

-6-2

1D

osa

ge

Fo

rm

Re

qu

ire

s P

rio

r

Au

tho

riza

tio

n o

r

Re

late

d C

on

dit

ion

Ap

pro

ve

d i

n C

laim

Co

ve

rag

e r

est

rict

ion

s o

r li

mit

ati

on

s fo

r sp

eci

fic

dru

gs

or

do

sag

e f

orm

s a

re l

iste

d

wit

h t

he

re

spe

ctiv

e d

rug

s b

elo

w.

Un

less

oth

erw

ise

re

stri

cte

d,

all

do

sag

e f

orm

s

an

d s

tre

ng

ths

of

a l

iste

d d

rug

are

eli

gib

le f

or

reim

bu

rse

me

nt

in a

cco

rda

nce

wit

h

OA

C 4

12

3-6

-21

.

SA

LIC

YLA

TE

AN

ALG

ES

ICS

(C

ON

T)

AS

PIR

INA

SP

IRIN

OR

AL

NO

AS

PIR

IN B

UF

FE

RE

D (

CA

CA

RB

-MG

CA

RB

-MG

OX

)B

UF

FE

RIN

OR

AL

NO

AS

PIR

IN W

/AN

TA

CID

AS

PIR

IN W

/AN

TA

CID

OR

AL

NO

AS

PIR

IN-A

CE

TA

MIN

OP

HE

N-C

AF

FE

INE

EX

CE

DR

INO

RA

LN

O

AS

PIR

IN-A

L H

YD

RO

-MG

HY

DR

O-C

A C

AR

BA

SC

RIP

TIN

OR

AL

NO

AS

PIR

IN-A

PA

P-S

ALI

CY

LAM

IDE

-CA

FF

EIN

E

LEV

AC

ET

OR

AL

NO

AS

PIR

IN-C

AF

FE

INE

AN

AC

INO

RA

LN

O

CH

OLI

NE

MA

G T

RIS

ALI

CY

LAT

ET

RIL

ISA

TE

OR

AL

NO

DIF

LUN

ISA

LD

OLO

BID

OR

AL

NO

ME

PR

OB

AM

AT

E-A

SP

IRIN

EQ

UA

GE

SIC

OR

AL

NO

SA

LSA

LAT

ED

ISA

LCID

OR

AL

NO

D4

LS

ALI

VA

SU

BS

TIT

UT

E A

GE

NT

S

AR

TIF

ICIA

L S

ALI

VA

A

QU

OR

AL

MU

CO

US

ME

MN

O

MIS

C T

HR

OA

T P

RO

DU

CT

SO

AS

ISM

UC

OU

S M

EM

NO

V1

TS

EL

ES

TR

OG

EN

RE

CE

PT

MO

DU

LAT

OR

S

TA

MO

XIF

EN

CIT

RA

TE

TA

MO

XIF

EN

CIT

RA

TE

OR

AL

YE

S

H7

ES

ER

OT

ON

IN-2

AN

TA

G/R

EU

P I

NH

IB

NE

FA

ZO

DO

NE

HC

LN

EF

AZ

OD

ON

E H

CL

OR

AL

NO

TR

AZ

AD

ON

E H

CL

TR

AZ

OD

ON

E H

CL

OR

AL

NO

H7

CS

ER

OT

ON

IN-N

OR

EP

INE

PH

RE

UP

IN

HI

DE

SV

EN

LAF

AX

INE

SU

CC

INA

TE

P

RIS

TIQ

OR

AL

NO

DU

LOX

ET

INE

HC

L C

YM

BA

LTA

OR

AL

NO

VE

NLA

FA

XIN

E H

CL

EF

FE

XO

RO

RA

LN

O

H2

SS

ER

TO

NIN

SP

EC

RE

UP

IN

HIB

-SS

RI

CIT

ALO

PR

AM

HY

DR

OB

RO

MID

E

CE

LEX

AO

RA

LN

O

ES

CIT

ALO

PR

AM

OX

ALA

TE

LE

XA

PR

OO

RA

LN

O

FLU

OX

ET

INE

HC

LP

RO

ZA

CO

RA

LN

OA

ll o

ral

form

ula

tio

ns

an

d s

tre

ng

ths

are

co

ve

red

FLU

VO

XA

MIN

E M

ALE

AT

E

LUV

OX

CR

OR

AL

NO

PA

RO

XE

TIN

E H

CL

PA

XIL

OR

AL

NO

PA

RO

XE

TIN

E M

ES

YLA

TE

P

EX

EV

AO

RA

LN

O

SE

RT

RA

LIN

E H

CL

ZO

LOF

TO

RA

LN

O

L7A

SH

AM

PO

OS

INF

AN

T C

AR

E P

RO

DU

CT

SB

AB

Y S

HA

MP

OO

TO

PIC

AL

NO

H6

HS

KE

LET

AL

MU

SC

LE R

ELA

XA

NT

SE

xclu

din

g B

acl

ofe

n a

nd

Da

ntr

ole

ne

, a

ge

nts

in

th

is c

lass

are

U6

JS

OLV

EN

TS

U6

KS

OLV

EN

TS

MIN

ER

AL

OIL

MIN

ER

AL

OIL

MIS

CE

LLN

O

RU

BB

ING

ALC

OH

OL

RU

BB

ING

ALC

OH

OL

MIS

CE

LLN

O

H7

ZS

SR

I/A

NT

IPS

YC

HO

TIC

, C

OM

BIN

AT

IO

OLA

NZ

AP

INE

-FLU

OX

ET

INE

HC

LS

YM

BY

AX

OR

AL

NO

Page 36: ACTION: Final ENACTED DATE: 08/19/2011 4:16 PM Appendix ......Representative brand name (If one is in use), NOTE: Brand name products are eligible for reimbursement in accordance with

AP

PE

ND

IX A

BW

C O

UT

PA

TIE

NT

M

ED

ICA

TIO

N F

OR

MU

LAR

Y

Pa

ge

36

of

42

Th

era

pe

uti

c C

lass

Co

de

Th

era

pe

uti

c C

lass

Co

de

De

scri

pti

on

2G

en

eri

c N

am

e

Re

pre

sen

tati

ve

bra

nd

na

me

(If

on

e i

s in

use

), N

OT

E:

Bra

nd

na

me

pro

du

cts

are

eli

gib

le f

or

reim

bu

rse

me

nt

in a

cco

rda

nce

wit

h O

AC

41

23

-6-2

1D

osa

ge

Fo

rm

Re

qu

ire

s P

rio

r

Au

tho

riza

tio

n o

r

Re

late

d C

on

dit

ion

Ap

pro

ve

d i

n C

laim

Co

ve

rag

e r

est

rict

ion

s o

r li

mit

ati

on

s fo

r sp

eci

fic

dru

gs

or

do

sag

e f

orm

s a

re l

iste

d

wit

h t

he

re

spe

ctiv

e d

rug

s b

elo

w.

Un

less

oth

erw

ise

re

stri

cte

d,

all

do

sag

e f

orm

s

an

d s

tre

ng

ths

of

a l

iste

d d

rug

are

eli

gib

le f

or

reim

bu

rse

me

nt

in a

cco

rda

nce

wit

h

OA

C 4

12

3-6

-21

.

V1

ES

TE

RO

ID A

NT

INE

OP

LAS

TIC

S

ME

GE

ST

RO

L A

CE

TA

TE

ME

GE

ST

RO

L A

CE

TA

TE

OR

AL

YE

S

L5B

SU

NS

CR

EE

NS

SU

NS

CR

EE

N L

OT

ION

TO

TA

L B

LOC

KT

OP

ICA

LN

O

J5E

SY

MP

AT

HO

MIM

ET

IC A

GE

NT

S

PH

EN

YLE

PH

RIN

E H

CL

NE

O-S

YN

EP

HR

INE

OR

AL

NO

PS

EU

DO

EP

HE

DR

INE

HC

LS

UD

AF

ED

OR

AL

NO

H2

XT

CA

/BE

NZ

OD

IAZ

EP

INE

CO

MB

IN

AM

ITR

IPT

YLI

NE

-CH

LOR

DIA

ZE

PO

XID

EA

MIT

RIP

TY

LIN

E-C

HLO

RD

IAZ

EP

OX

IDE

OR

AL

NO

H2

WT

CA

/PH

EN

OT

HIA

ZIN

E C

OM

BIN

AT

ION

PE

RP

HE

NA

ZIN

E-A

MIT

RIP

TY

LIN

EP

ER

PH

EN

AZ

INE

-AM

ITR

IPT

YLI

NE

OR

AL

NO

W1

CT

ET

RA

CY

LIN

ES

DE

ME

CLO

CY

CLI

NE

HC

LD

EM

EC

LOC

YC

LIN

E H

CL

OR

AL

NO

DO

XY

CY

CLI

NE

DO

XY

CY

CLI

NE

OR

AL

NO

DO

XY

CY

CLI

NE

(R

OS

AC

EA

)O

RA

CE

AO

RA

LN

O

DO

XY

CY

CLI

NE

HY

CLA

TE

DO

RY

XO

RA

LN

O

DO

XY

CY

CLI

NE

MO

NO

HY

DR

AT

ED

OX

YC

YC

LIN

E M

ON

OH

YD

RA

TE

OR

AL

NO

MIN

OC

YC

LIN

E H

CL

SO

LOD

YN

OR

AL

NO

TE

TR

AC

YC

LIN

E H

CL

TE

TR

AC

YC

LIN

E H

CL

OR

AL

NO

R1

FT

HIA

ZID

E D

IUR

ET

ICS

AN

D R

ELA

CH

LOR

OT

HIA

ZID

EC

HLO

RO

TH

IAZ

IDE

OR

AL

YE

S

HY

DR

OC

HLO

RO

TH

IAZ

IDE

HY

DR

OC

HLO

RO

TH

IAZ

IDE

OR

AL

YE

S

IND

AP

AM

IDE

IND

AP

AM

IDE

OR

AL

YE

S

ME

TO

LAZ

ON

EM

ET

OLA

ZO

NE

OR

AL

YE

S

P3

AT

HY

RO

ID H

OR

MO

NE

S

LEV

OT

HY

RO

XIN

E S

OD

IUM

S

YN

TH

RO

IDO

RA

LY

ES

LIO

TH

YR

ON

INE

SO

DIU

MC

YT

OM

EL

OR

AL

YE

S

TH

YR

OID

AR

MO

UR

TH

YR

OID

OR

AL

YE

S

TH

YR

OID

TH

YR

OID

OR

AL

YE

S

Q5

BT

OP

ICA

L A

NT

IBA

CT

ER

IALS

CA

DE

XO

ME

R I

OD

INE

IOD

OS

OR

BT

OP

ICA

LN

O

CH

LOR

HE

XID

INE

GLU

CO

NA

TE

BE

TA

SE

PT

TO

PIC

AL

NO

CLI

OQ

UIN

OL-

HY

DR

OC

OR

TIS

ON

EC

LIO

QU

INO

L-H

YD

RO

CO

RT

ISO

NE

TO

PIC

AL

NO

HE

XA

CH

LOR

OP

HE

NE

P

HIS

OH

EX

TO

PIC

AL

NO

HY

DR

OC

OR

TIS

ON

E-I

OD

OQ

UIN

OL

HY

DR

OC

OR

TIS

ON

E-I

OD

OQ

UIN

OL

TO

PIC

AL

NO

IOD

OQ

UIN

OL-

HY

DR

OC

OR

TIS

ON

E-A

LOE

PO

LYS

AC

CH

AR

IDE

ALC

OR

TIN

AT

OP

ICA

LN

O

PO

VID

ON

E-I

OD

INE

BE

TA

DIN

ET

OP

ICA

LN

O

ZE

PH

IRA

N C

HLO

RID

EZ

EP

HIR

AN

CH

LOR

IDE

TO

PIC

AL

NO

Q5

WT

OP

ICA

L A

NT

IBIO

TIC

S

BA

CIT

RA

CIN

ZIN

CB

AC

ITR

AC

IN

TO

PIC

AL

NO

BA

CIT

RA

CIN

-PO

LYM

YX

IN B

PO

LYS

PO

RIN

TO

PIC

AL

NO

CLI

ND

AM

YC

IN P

HO

SP

HA

TE

CLE

OC

IN-T

TO

PIC

AL

NO

Page 37: ACTION: Final ENACTED DATE: 08/19/2011 4:16 PM Appendix ......Representative brand name (If one is in use), NOTE: Brand name products are eligible for reimbursement in accordance with

AP

PE

ND

IX A

BW

C O

UT

PA

TIE

NT

M

ED

ICA

TIO

N F

OR

MU

LAR

Y

Pa

ge

37

of

42

Th

era

pe

uti

c C

lass

Co

de

Th

era

pe

uti

c C

lass

Co

de

De

scri

pti

on

2G

en

eri

c N

am

e

Re

pre

sen

tati

ve

bra

nd

na

me

(If

on

e i

s in

use

), N

OT

E:

Bra

nd

na

me

pro

du

cts

are

eli

gib

le f

or

reim

bu

rse

me

nt

in a

cco

rda

nce

wit

h O

AC

41

23

-6-2

1D

osa

ge

Fo

rm

Re

qu

ire

s P

rio

r

Au

tho

riza

tio

n o

r

Re

late

d C

on

dit

ion

Ap

pro

ve

d i

n C

laim

Co

ve

rag

e r

est

rict

ion

s o

r li

mit

ati

on

s fo

r sp

eci

fic

dru

gs

or

do

sag

e f

orm

s a

re l

iste

d

wit

h t

he

re

spe

ctiv

e d

rug

s b

elo

w.

Un

less

oth

erw

ise

re

stri

cte

d,

all

do

sag

e f

orm

s

an

d s

tre

ng

ths

of

a l

iste

d d

rug

are

eli

gib

le f

or

reim

bu

rse

me

nt

in a

cco

rda

nce

wit

h

OA

C 4

12

3-6

-21

.

TO

PIC

AL

AN

TIB

IOT

ICS

(C

ON

T)

ER

YT

HR

OM

YC

IN

ER

YT

OP

ICA

LN

O

ER

YT

HR

OM

YC

IN-B

EN

ZO

YL

PE

RO

XID

EE

RY

TH

RO

MY

CIN

-BE

NZ

OY

L P

ER

OX

IDE

TO

PIC

AL

NO

GE

NT

AM

ICIN

SU

LFA

TE

GE

NT

AM

ICIN

SU

LFA

TE

TO

PIC

AL

NO

MU

PIR

OC

IN C

ALC

IUM

BA

CT

RO

BA

NT

OP

ICA

LN

ON

EO

MY

CIN

-BA

CIT

RA

CIN

-PO

LYM

YX

IN W

/

LID

OC

AIN

EN

EO

SP

OR

IN P

LUS

TO

PIC

AL

NO

NE

OM

YC

IN-P

OLY

MY

XIN

B-G

RA

MIC

IDIN

N

EO

SP

OR

INT

OP

ICA

LN

O

Q5

XT

OP

ICA

L A

NT

IBIO

TIC

S S

TE

RO

ID

NE

OM

YC

IN-P

OLY

MY

XIN

-HC

C

OR

TIS

PO

RIN

TO

PIC

AL

NO

Q5

FT

OP

ICA

L A

NT

IFU

NG

ALS

BU

TE

NA

FIN

E H

CL

ME

NT

AX

TO

PIC

AL

NO

CIC

LOP

IRO

X

LOP

RO

XT

OP

ICA

LN

O

CLO

TR

IMA

ZO

LELO

TR

IMIN

AF

TO

PIC

AL

NO

CLO

TR

IMA

ZO

LE W

/ B

ET

AM

ET

HA

SO

NE

LOT

RIS

ON

ET

OP

ICA

LN

O

EC

ON

AZ

OLE

NIT

RA

TE

EC

ON

AZ

OLE

NIT

RA

TE

TO

PIC

AL

NO

GE

NT

IAN

VIO

LET

GE

NT

IAN

VIO

LET

TO

PIC

AL

NO

KE

TO

CO

NA

ZO

LE

EX

TIN

AT

OP

ICA

LN

O

MIC

ON

AZ

OLE

NIT

RA

TE

MIC

AT

INT

OP

ICA

LN

O

MIC

ON

AZ

OLE

NIT

RA

TE

ZE

AS

OR

B-A

FT

OP

ICA

LN

OM

ICO

NA

ZO

LE-Z

INC

OX

IDE

-WH

ITE

PE

TR

OLA

TU

M

VU

SIO

NT

OP

ICA

LN

O

NA

FT

IFIN

E H

CL

NA

FT

INT

OP

ICA

LN

O

NY

ST

AT

INM

YC

OS

TA

TIN

TO

PIC

AL

NO

NY

ST

AT

IN-T

RIA

MC

INO

LON

EM

YC

OLO

G_

IIT

OP

ICA

LN

O

OX

ICO

NA

ZO

LE N

ITR

AT

EO

XIS

TA

TT

OP

ICA

LN

O

SA

LIC

YLI

C A

CID

& B

EN

ZO

IC A

CID

BE

NS

AL

HP

TO

PIC

AL

NO

SE

RT

AC

ON

AZ

OLE

NIT

RA

TE

ER

TA

CZ

OT

OP

ICA

LN

O

SU

LCO

NA

ZO

LE N

ITR

AT

E

EX

ELD

ER

MT

OP

ICA

LN

O

TE

RB

INA

FIN

E H

CL

LAM

ISIL

AT

TO

PIC

AL

NO

TO

LNA

FT

AT

E

TIN

AC

TIN

TO

PIC

AL

NO

Q5

ET

OP

ICA

L A

NT

I-IN

FLA

MM

AT

OR

Y

DIC

LOF

EN

AC

SO

DIU

M

VO

LTA

RE

NT

OP

ICA

LN

O

Q5

NT

OP

ICA

L A

NT

INE

OP

LAS

TIC

S

DIC

LOF

EN

AC

SO

DIU

M (

AC

TIN

IC K

ER

AT

OS

ES

)S

OLA

RA

ZE

TO

PIC

AL

YE

S

FLU

OR

OU

RA

CIL

CA

RA

CT

OP

ICA

LY

ES

Q5

PT

OP

ICA

L A

NT

INF

LAM

MA

TO

RY

PR

EP

ALC

LOM

ET

AS

ON

E D

IPR

OP

ION

AT

EA

CLO

VA

TE

TO

PIC

AL

NO

AM

CIN

ON

IDE

A

MC

INO

NID

ET

OP

ICA

LN

O

BE

TA

ME

TH

AS

ON

E D

IPR

OP

ION

AT

ED

IPR

OLE

NE

TO

PIC

AL

NO

BE

TA

ME

TH

AS

ON

E V

ALE

RA

TE

LU

XIQ

TO

PIC

AL

NO

Page 38: ACTION: Final ENACTED DATE: 08/19/2011 4:16 PM Appendix ......Representative brand name (If one is in use), NOTE: Brand name products are eligible for reimbursement in accordance with

AP

PE

ND

IX A

BW

C O

UT

PA

TIE

NT

M

ED

ICA

TIO

N F

OR

MU

LAR

Y

Pa

ge

38

of

42

Th

era

pe

uti

c C

lass

Co

de

Th

era

pe

uti

c C

lass

Co

de

De

scri

pti

on

2G

en

eri

c N

am

e

Re

pre

sen

tati

ve

bra

nd

na

me

(If

on

e i

s in

use

), N

OT

E:

Bra

nd

na

me

pro

du

cts

are

eli

gib

le f

or

reim

bu

rse

me

nt

in a

cco

rda

nce

wit

h O

AC

41

23

-6-2

1D

osa

ge

Fo

rm

Re

qu

ire

s P

rio

r

Au

tho

riza

tio

n o

r

Re

late

d C

on

dit

ion

Ap

pro

ve

d i

n C

laim

Co

ve

rag

e r

est

rict

ion

s o

r li

mit

ati

on

s fo

r sp

eci

fic

dru

gs

or

do

sag

e f

orm

s a

re l

iste

d

wit

h t

he

re

spe

ctiv

e d

rug

s b

elo

w.

Un

less

oth

erw

ise

re

stri

cte

d,

all

do

sag

e f

orm

s

an

d s

tre

ng

ths

of

a l

iste

d d

rug

are

eli

gib

le f

or

reim

bu

rse

me

nt

in a

cco

rda

nce

wit

h

OA

C 4

12

3-6

-21

.

TO

PIC

AL

AN

TIN

FLA

MM

AT

OR

Y P

RE

P (

CO

NT

)C

LOB

ET

AS

OL

PR

OP

ION

AT

EO

LUX

TO

PIC

AL

NO

CLO

BE

TA

SO

L P

RO

PIO

NA

TE

C

LOB

EX

TO

PIC

AL

NO

CLO

CO

RT

OLO

NE

PIV

ALA

TE

C

LOD

ER

MT

OP

ICA

LN

O

DE

SO

NID

EV

ER

DE

SO

TO

PIC

AL

NO

DE

SO

XIM

ET

AS

ON

ET

OP

ICO

RT

TO

PIC

AL

NO

DIF

LOR

AS

ON

E D

IAC

ET

AT

ED

IFLO

RA

SO

NE

DIA

CE

TA

TE

TO

PIC

AL

NO

DIF

LOR

AS

ON

E D

IAC

ET

AT

E

AP

EX

ICO

N E

TO

PIC

AL

NO

FLU

OC

INO

LON

E A

CE

TO

NID

E

DE

RM

A-S

MO

OT

HE

-FS

TO

PIC

AL

NO

FLU

OC

INO

NID

EV

AN

OS

TO

PIC

AL

NO

FLU

RA

ND

RE

NO

LID

E

CO

RD

RA

NT

OP

ICA

LN

O

FLU

TIC

AS

ON

E P

RO

PIO

NA

TE

CU

TIV

AT

ET

OP

ICA

LN

O

HA

LCIN

ON

IDE

HA

LOG

TO

PIC

AL

NO

HA

LOB

ET

AS

OL

PR

OP

ION

AT

E

ULT

RA

VA

TE

TO

PIC

AL

NO

HY

DR

OC

OR

TIS

ON

EC

OR

TIZ

ON

E 1

0T

OP

ICA

LN

O

HY

DR

OC

OR

TIS

ON

E A

CE

TA

TE

HY

DR

OC

OR

TIS

ON

ET

OP

ICA

LN

O

HY

DR

OC

OR

TIS

ON

E B

UT

YR

AT

EC

OR

TA

IDT

OP

ICA

LN

OH

YD

RO

CO

RT

ISO

NE

BU

TY

RA

TE

HY

DR

OP

HIL

IC

LIP

O B

AS

ELO

CO

ID L

IPO

CR

EA

MT

OP

ICA

LN

O

HY

DR

OC

OR

TIS

ON

E P

RO

BU

TA

TE

P

AN

DE

LT

OP

ICA

LN

O

HY

DR

OC

OR

TIS

ON

E V

ALE

RA

TE

VA

LIS

ON

ET

OP

ICA

LN

O

HY

DR

OC

OR

TIS

ON

E-A

LOE

VE

RA

H

YD

RO

CO

RT

ISO

NE

-ALO

E V

ER

A C

RE

AM

T

OP

ICA

LN

O

MO

ME

TA

SO

NE

FU

RO

AT

EE

LOC

ON

TO

PIC

AL

NO

PR

ED

NIC

AR

BA

TE

DE

RM

AT

OP

TO

PIC

AL

NO

TR

IAM

CIN

OLO

NE

AC

ET

ON

IDE

KE

NA

LOG

TO

PIC

AL

NO

Q5

RT

OP

ICA

L A

NT

IPA

RA

SIT

ICS

W4

MT

OP

ICA

L A

NT

IPA

RA

SIT

ICS

CR

OT

AM

ITO

N

EU

RA

XT

OP

ICA

LN

O

LIN

DA

NE

LIN

DA

NE

TO

PIC

AL

NO

MA

LAT

HIO

NO

VID

ET

OP

ICA

LN

O

NIT

AZ

OX

AN

IDE

ALI

NIA

OR

AL

NO

PE

RM

ET

HR

IN

AC

TIC

INT

OP

ICA

LN

O

PY

RE

TH

RIN

S-P

IPE

RO

NY

L B

UT

OX

IDE

R

IDT

OP

ICA

LN

O

W8

NT

OP

ICA

L A

NT

ISE

PT

DR

YIN

G A

GE

NT

S

FO

RM

ALD

EH

YD

EF

OR

MA

LAZ

TO

PIC

AL

NO

Q5

VT

OP

ICA

L A

NT

IVIR

ALS

AC

YC

LOV

IRZ

OV

IRA

XT

OP

ICA

LN

O

PE

NC

ICLO

VIR

D

EN

AV

IRT

OP

ICA

LN

O

L9D

TO

PIC

AL

HY

PE

RP

IGM

EN

TA

TIO

N A

G

ME

TH

OX

SA

LEN

OX

SO

RA

LEN

TO

PIC

AL

YE

S

T0

DT

OP

ICA

L H

YP

ER

TR

ICH

OT

C-E

YE

LAS

H

BIM

AT

OP

RO

ST

LAT

ISS

ET

OP

ICA

LN

O

Page 39: ACTION: Final ENACTED DATE: 08/19/2011 4:16 PM Appendix ......Representative brand name (If one is in use), NOTE: Brand name products are eligible for reimbursement in accordance with

AP

PE

ND

IX A

BW

C O

UT

PA

TIE

NT

M

ED

ICA

TIO

N F

OR

MU

LAR

Y

Pa

ge

39

of

42

Th

era

pe

uti

c C

lass

Co

de

Th

era

pe

uti

c C

lass

Co

de

De

scri

pti

on

2G

en

eri

c N

am

e

Re

pre

sen

tati

ve

bra

nd

na

me

(If

on

e i

s in

use

), N

OT

E:

Bra

nd

na

me

pro

du

cts

are

eli

gib

le f

or

reim

bu

rse

me

nt

in a

cco

rda

nce

wit

h O

AC

41

23

-6-2

1D

osa

ge

Fo

rm

Re

qu

ire

s P

rio

r

Au

tho

riza

tio

n o

r

Re

late

d C

on

dit

ion

Ap

pro

ve

d i

n C

laim

Co

ve

rag

e r

est

rict

ion

s o

r li

mit

ati

on

s fo

r sp

eci

fic

dru

gs

or

do

sag

e f

orm

s a

re l

iste

d

wit

h t

he

re

spe

ctiv

e d

rug

s b

elo

w.

Un

less

oth

erw

ise

re

stri

cte

d,

all

do

sag

e f

orm

s

an

d s

tre

ng

ths

of

a l

iste

d d

rug

are

eli

gib

le f

or

reim

bu

rse

me

nt

in a

cco

rda

nce

wit

h

OA

C 4

12

3-6

-21

.

Q5

KT

OP

ICA

L IM

MU

NO

SU

PP

RE

SS

IVE

AG

T

PIM

EC

RO

LIM

US

E

LID

EL

TO

PIC

AL

YE

S

TA

CR

OLI

MU

SP

RO

TO

PIC

TO

PIC

AL

YE

S

Q5

HT

OP

ICA

L LO

CA

L A

NE

ST

HE

TIC

S

BE

NZ

OC

AIN

E

BE

NZ

OC

AIN

E A

ER

OS

OL

10

%

TO

PIC

AL

NO

BU

TA

MB

EN

-TE

TR

AC

AIN

E-B

EN

ZO

CA

INE

C

ET

AC

AIN

ET

OP

ICA

LN

O

DIB

UC

AIN

ED

IBU

CA

INE

TO

PIC

AL

NO

ET

HY

L C

HLO

RID

EE

TH

YL

CH

LOR

IDE

TO

PIC

AL

NO

HY

DR

OC

OR

TIS

ON

E A

CE

-PR

AM

OX

INE

-ALO

E

PO

LYS

AC

CH

NO

VA

CO

RT

TO

PIC

AL

NO

LID

OC

AIN

E

AN

EC

RE

AM

TO

PIC

AL

NO

LID

OC

AIN

E H

CL

RE

GE

NE

CA

RE

HA

TO

PIC

AL

NO

LID

OC

AIN

E P

AT

CH

LI

DO

DE

RM

TO

PIC

AL

NO

Cla

im m

ust

be

all

ow

ed

fo

r p

ost

he

rpe

tic

ne

ura

lgia

LID

OC

AIN

E-H

YD

RO

CO

RT

ISO

NE

AC

ET

AT

E

LID

AM

AN

TLE

HC

TO

PIC

AL

NO

LID

OC

AIN

E-P

RIL

OC

AIN

EE

MLA

TO

PIC

AL

NO

LID

OC

AIN

E-T

ET

RA

CA

INE

PA

TC

HS

YN

ER

AT

OP

ICA

LN

OP

EN

TA

FLU

OR

OP

RO

PA

NE

-

TE

TR

AF

LUO

RO

ET

HA

NE

AE

RO

PE

NT

AF

LUO

RO

PR

OP

AN

E-

TE

TR

AF

LUO

RO

ET

HA

NE

AE

RO

T

OP

ICA

LN

O

PR

AM

OX

INE

HC

LS

AR

NA

SE

NS

ITIV

ET

OP

ICA

LN

O

PR

AM

OX

INE

HC

L-H

YD

RO

CO

RT

ISO

NE

PR

AM

OS

ON

ET

OP

ICA

LN

O

T0

BT

OP

ICA

L P

LEU

RO

MU

TIL

IN D

ER

IV.

CA

LCIP

OT

RIE

NE

-BE

TA

ME

TH

AS

ON

E

DIP

RO

PIO

NA

TE

A

LTA

BA

XT

OP

ICA

LY

ES

Q5

AT

OP

ICA

L P

RE

PA

RA

TIO

NS

, M

ISC

EM

OLL

IEN

TC

ET

AP

HIL

TO

PIC

AL

NO

SO

DIU

M C

HLO

RID

E

S

OD

IUM

CH

LO

RID

E E

XT

ER

NA

L S

OLN

TO

PIC

AL

NO

Q5

ST

OP

ICA

L S

ULF

ON

AM

IDE

S

MA

FE

NID

E A

CE

TA

TE

S

ULF

AM

YLO

NT

OP

ICA

LN

O

SIL

VE

R S

ULF

AD

IAZ

INE

S

ILV

AD

EN

ET

OP

ICA

LN

O

SU

LFA

CE

TA

MID

E S

OD

IUM

W/

SU

LFU

RR

OS

AD

ER

MT

OP

ICA

LN

O

SU

LFA

CE

TA

MID

E S

OD

IUM

-SU

LFU

RR

OS

ULA

TO

PIC

AL

NO

T0

AT

OP

ICA

L V

IT D

AN

ALO

G/S

TE

RO

ID

CA

LCIP

OT

RIE

NE

-BE

TA

ME

TH

AS

ON

E

DIP

RO

PIO

NA

TE

TA

CLO

NE

XT

OP

ICA

LY

ES

L0B

TO

PIC

AL/

MU

CO

US

ME

MB

RA

NC

E/S

UB

CO

LLA

GE

NA

SE

SA

NT

YL

TO

PIC

AL

NO

PA

PA

IN-U

RE

A

ALL

AN

EN

ZY

ME

TO

PIC

AL

NO

PA

PA

IN-U

RE

A

KO

VIA

OIN

TM

EN

TT

OP

ICA

LN

O

PA

PA

IN-U

RE

A-C

HLO

RO

PH

YLL

INA

LLA

NF

ILLE

NZ

YM

ET

OP

ICA

LN

O

TR

YP

SIN

TR

YP

SIN

TO

PIC

AL

NO

TR

YP

SIN

W/

CA

ST

OR

OIL

& P

ER

UV

IAN

BA

LSA

MG

RA

NU

LEX

TO

PIC

AL

NO

Page 40: ACTION: Final ENACTED DATE: 08/19/2011 4:16 PM Appendix ......Representative brand name (If one is in use), NOTE: Brand name products are eligible for reimbursement in accordance with

AP

PE

ND

IX A

BW

C O

UT

PA

TIE

NT

M

ED

ICA

TIO

N F

OR

MU

LAR

Y

Pa

ge

40

of

42

Th

era

pe

uti

c C

lass

Co

de

Th

era

pe

uti

c C

lass

Co

de

De

scri

pti

on

2G

en

eri

c N

am

e

Re

pre

sen

tati

ve

bra

nd

na

me

(If

on

e i

s in

use

), N

OT

E:

Bra

nd

na

me

pro

du

cts

are

eli

gib

le f

or

reim

bu

rse

me

nt

in a

cco

rda

nce

wit

h O

AC

41

23

-6-2

1D

osa

ge

Fo

rm

Re

qu

ire

s P

rio

r

Au

tho

riza

tio

n o

r

Re

late

d C

on

dit

ion

Ap

pro

ve

d i

n C

laim

Co

ve

rag

e r

est

rict

ion

s o

r li

mit

ati

on

s fo

r sp

eci

fic

dru

gs

or

do

sag

e f

orm

s a

re l

iste

d

wit

h t

he

re

spe

ctiv

e d

rug

s b

elo

w.

Un

less

oth

erw

ise

re

stri

cte

d,

all

do

sag

e f

orm

s

an

d s

tre

ng

ths

of

a l

iste

d d

rug

are

eli

gib

le f

or

reim

bu

rse

me

nt

in a

cco

rda

nce

wit

h

OA

C 4

12

3-6

-21

.

W4

ET

RIC

HO

MO

NA

CID

ES

ME

TR

ON

IDA

ZO

LE

FLA

GY

L E

RO

RA

LN

O

H2

UT

RIC

YC

LIC

AN

TID

EP

RE

SS

RE

LAT

ED

AM

ITR

IPT

YLI

NE

HC

LE

LAV

ILO

RA

LN

O

AM

OX

AP

INE

A

SC

EN

DIN

OR

AL

NO

CLO

MIP

RA

MIN

E H

CL

CLO

MID

OR

AL

NO

DE

SIP

RA

MIN

E H

CL

NO

RP

RA

MIN

EO

RA

LN

O

DO

XE

PIN

HC

LS

INE

QU

AN

OR

AL

NO

IMIP

RA

MIN

E H

CL

TO

FR

AN

IL

OR

AL

NO

IMIP

RA

MIN

E P

AM

OA

TE

TO

FR

AN

IL-P

MO

RA

LN

O

MA

PR

OT

ILIN

E H

CL

LUD

IOM

ILO

RA

LN

O

NO

RT

RIP

TY

LIN

E H

CL

PA

ME

LOR

OR

AL

NO

PR

OT

RIP

TY

LIN

E H

CL

VIV

AC

TIL

OR

AL

NO

TR

IMIP

RA

MIN

E M

ALE

AT

E

SU

RM

ON

TIL

OR

AL

NO

S2

JT

UM

OR

NE

CR

OS

IS F

AC

TO

R I

NH

IBIT

AD

ALI

MU

MA

BH

UM

IRA

SU

B-Q

YE

S

ET

AN

ER

CE

PT

EN

BR

EL

SU

B-Q

YE

S

H7

YT

X F

OR

AT

TN

DE

F-A

DH

D,

NR

I-T

YP

E

AT

OM

OX

ET

INE

HC

L S

TR

AT

TE

RA

OR

AL

YE

S

R1

AU

NIA

RY

TR

AC

T A

NT

ISP

AS

MO

DIC

FE

SO

TE

RO

DIN

E F

UM

AR

AT

ET

OV

IAZ

OR

AL

YE

S

FLA

VO

XA

TE

HC

LF

LAV

OX

AT

E H

CL

OR

AL

YE

S

OX

YB

UT

YN

IN C

HLO

RID

ED

ITR

OP

AN

XL

OR

AL

YE

S

OX

YB

UT

YN

IN C

HLO

RID

EO

XY

BU

TY

NIN

CH

LOR

IDE

OR

AL

YE

S

OX

YB

UT

YN

IN C

HLO

RID

E T

DG

ELN

IQU

ET

RA

NS

DE

RM

YE

S

OX

YB

UT

YN

IN T

D P

AT

CH

O

XY

TR

OL

TR

AN

SD

ER

MY

ES

TO

LTE

RO

DIN

E T

AR

TR

AT

E

DE

TR

OL

OR

AL

YE

S

TR

OS

PIU

M C

HLO

RID

E

SA

NC

TU

RA

OR

AL

YE

S

R5

BU

RIN

AR

Y A

NE

LGE

SIC

AG

EN

TS

PE

NT

OS

AN

PO

LYS

ULF

AT

E S

OD

IUM

ELM

IRO

NO

RA

LY

ES

R5

AU

RIN

AR

Y A

NE

ST

HE

TIC

S

PH

EN

AZ

OP

YR

IDIN

E H

CL

PH

EN

AZ

OP

YR

IDIN

E H

CL

OR

AL

YE

S

R1

SU

RIN

AR

Y P

H M

OD

IFIE

RS

CIT

RIC

AC

ID &

D-G

LUC

ON

IC A

CID

R

EN

AC

IDIN

IRR

IGA

TIO

NY

ES

Ina

ctiv

eU

RO

QID

-AC

ID N

O.2

OR

AL

YE

SP

OT

PH

OS

MO

NO

BA

SIC

W/S

OD

PH

OS

DI

&

MO

NO

BA

SK

-PH

OS

NE

UT

RA

LO

RA

LY

ES

PO

TA

SS

IUM

& S

OD

IUM

AC

ID P

HO

SP

HA

TE

S

K-P

HO

S M

.F.

OR

AL

YE

S

PO

TA

SS

IUM

CIT

RA

TE

UR

OC

IT-K

OR

AL

YE

S

PO

TA

SS

IUM

CIT

RA

TE

& C

ITR

IC A

CID

CY

TR

A-K

OR

AL

YE

S

SO

DIU

M C

ITR

AT

E &

CIT

RIC

AC

IDC

YT

RA

-2O

RA

LY

ES

Page 41: ACTION: Final ENACTED DATE: 08/19/2011 4:16 PM Appendix ......Representative brand name (If one is in use), NOTE: Brand name products are eligible for reimbursement in accordance with

AP

PE

ND

IX A

BW

C O

UT

PA

TIE

NT

M

ED

ICA

TIO

N F

OR

MU

LAR

Y

Pa

ge

41

of

42

Th

era

pe

uti

c C

lass

Co

de

Th

era

pe

uti

c C

lass

Co

de

De

scri

pti

on

2G

en

eri

c N

am

e

Re

pre

sen

tati

ve

bra

nd

na

me

(If

on

e i

s in

use

), N

OT

E:

Bra

nd

na

me

pro

du

cts

are

eli

gib

le f

or

reim

bu

rse

me

nt

in a

cco

rda

nce

wit

h O

AC

41

23

-6-2

1D

osa

ge

Fo

rm

Re

qu

ire

s P

rio

r

Au

tho

riza

tio

n o

r

Re

late

d C

on

dit

ion

Ap

pro

ve

d i

n C

laim

Co

ve

rag

e r

est

rict

ion

s o

r li

mit

ati

on

s fo

r sp

eci

fic

dru

gs

or

do

sag

e f

orm

s a

re l

iste

d

wit

h t

he

re

spe

ctiv

e d

rug

s b

elo

w.

Un

less

oth

erw

ise

re

stri

cte

d,

all

do

sag

e f

orm

s

an

d s

tre

ng

ths

of

a l

iste

d d

rug

are

eli

gib

le f

or

reim

bu

rse

me

nt

in a

cco

rda

nce

wit

h

OA

C 4

12

3-6

-21

.

R1

IU

RIN

AR

YT

RA

CT

AN

TIS

PA

S-M

(3)S

EL

DA

RIF

EN

AC

IN H

YD

RO

BR

OM

IDE

EN

AB

LEX

OR

AL

YE

S

SO

LIF

EN

AC

IN S

UC

CIN

AT

EV

ES

ICA

RE

OR

AL

YE

S

Q4

WV

AG

INA

L A

NT

IBIO

TIC

S

ME

TR

ON

IDA

ZO

LE

VA

ND

AZ

OLE

VA

GIN

AL

YE

S

Q4

FV

AG

INA

L A

NT

IFU

NG

ALS

MIC

ON

AZ

OLE

NIT

RA

TE

MO

NIS

TA

T 3

VA

GIN

AL

YE

S

TE

RC

ON

AZ

OLE

T

ER

ZO

LV

AG

INA

LY

ES

Q4

BV

AG

INA

L A

NT

ISE

PT

ICS

OX

YQ

UIN

OLO

NE

SU

LFA

TE

-PH

4T

RIM

O-S

AN

VA

GIN

AL

NO

Q4

KV

AG

INA

L E

ST

RO

GE

N P

RE

PA

RA

TIO

N

ES

TR

AD

IOL

ES

TR

AD

IOL

VA

GIN

AL

VA

GIN

AL

NO

Q4

SV

AG

INA

L S

ULF

ON

AM

IDE

S

SU

LFA

NIL

AM

IDE

A

VC

VA

GIN

AL

YE

S

W1

JV

AN

CO

MY

CIN

AN

D D

ER

IVA

TIV

ES

VA

NC

OC

IN H

CL

VA

NC

OC

IN H

CL

OR

AL

NO

VA

NC

OM

YC

IN H

CL

VA

NC

OM

YC

IN H

CL

INT

RA

VE

NN

O

A7

JV

AS

OD

ILA

TO

RS

, C

OM

BIN

AT

ION

ISO

SO

RB

IDE

DIN

ITR

AT

E-H

YD

RA

LAZ

INE

HC

LB

IDIL

OR

AL

YE

S

U6

NV

EH

ICLE

S

U6

PV

EH

ICLE

S

CO

CO

A B

UT

TE

RC

OC

OA

BU

TT

ER

TO

PIC

AL

NO

SO

RB

ITO

LS

OR

BIT

OL

MIS

CE

LLN

O

C6

AV

ITA

MIN

A P

RE

PA

RA

TIO

NS

VIT

AM

IN A

VIT

AM

IN A

OR

AL

YE

S

C6

BV

ITA

MIN

B P

RE

PA

RA

TIO

NS

All

co

mb

ina

tio

ns

an

d s

tre

ng

ths

of

ora

l d

osa

ge

fo

rms

are

co

ve

red

fo

r a

llo

we

d

con

dit

ion

s

B-C

OM

PLE

X W

/ C

& F

OLI

C A

CID

N

EP

HR

OC

AP

SO

RA

LY

ES

B-C

OM

PLE

X W

/ C

-BIO

TIN

-MIN

ER

ALS

& F

OLI

C

AC

IDD

IAT

X Z

NO

RA

LY

ES

FO

LIC

AC

ID-P

YR

IDO

XIN

E-C

YA

NO

CO

BA

LAM

IN

FO

LBIC

OR

AL

YE

S

FO

LIC

AC

ID-P

YR

IDO

XIN

E-C

YA

NO

CO

BA

LAM

IN

FO

LTX

OR

AL

YE

S

FO

LIC

AC

ID-V

ITA

MIN

B6

-VIT

AM

IN B

12

F

OLG

AR

D R

XO

RA

LY

ES

L-M

ET

HY

LFO

LAT

E W

/ V

IT B

12

-VIT

B6

-VIT

B2

C

ER

EF

OLI

NO

RA

LY

ES

L-M

ET

HY

LFO

LAT

E W

/ V

IT B

6-V

IT B

12

M

ET

AN

XO

RA

LY

ES

L-M

ET

HY

LFO

LAT

E-M

ET

HY

LCO

BA

LAM

IN-

AC

ET

YLC

YS

TC

ER

EF

OLI

N N

AC

OR

AL

YE

S

L-M

ET

HY

LFO

LAT

E-M

ET

HY

LCO

BA

LAM

IN-

AC

ET

YLC

YS

T

L-M

ET

HY

LFO

LAT

E-M

ET

HY

LCO

BA

LAM

IN-

AC

ET

YLC

YS

TO

RA

LY

ES

PO

TA

SS

IUM

AM

INO

BE

NZ

OA

TE

AM

INO

BE

NZ

OA

TE

PO

TA

SS

IUM

OR

AL

YE

S

Page 42: ACTION: Final ENACTED DATE: 08/19/2011 4:16 PM Appendix ......Representative brand name (If one is in use), NOTE: Brand name products are eligible for reimbursement in accordance with

AP

PE

ND

IX A

BW

C O

UT

PA

TIE

NT

M

ED

ICA

TIO

N F

OR

MU

LAR

Y

Pa

ge

42

of

42

Th

era

pe

uti

c C

lass

Co

de

Th

era

pe

uti

c C

lass

Co

de

De

scri

pti

on

2G

en

eri

c N

am

e

Re

pre

sen

tati

ve

bra

nd

na

me

(If

on

e i

s in

use

), N

OT

E:

Bra

nd

na

me

pro

du

cts

are

eli

gib

le f

or

reim

bu

rse

me

nt

in a

cco

rda

nce

wit

h O

AC

41

23

-6-2

1D

osa

ge

Fo

rm

Re

qu

ire

s P

rio

r

Au

tho

riza

tio

n o

r

Re

late

d C

on

dit

ion

Ap

pro

ve

d i

n C

laim

Co

ve

rag

e r

est

rict

ion

s o

r li

mit

ati

on

s fo

r sp

eci

fic

dru

gs

or

do

sag

e f

orm

s a

re l

iste

d

wit

h t

he

re

spe

ctiv

e d

rug

s b

elo

w.

Un

less

oth

erw

ise

re

stri

cte

d,

all

do

sag

e f

orm

s

an

d s

tre

ng

ths

of

a l

iste

d d

rug

are

eli

gib

le f

or

reim

bu

rse

me

nt

in a

cco

rda

nce

wit

h

OA

C 4

12

3-6

-21

.

VIT

AM

IN B

PR

EP

AR

AT

ION

S (

CO

NT

)P

OT

AS

SIU

M A

MIN

OB

EN

ZO

AT

EP

OT

AB

AO

RA

LY

ES

VIT

AM

INS

W/

LIP

OT

RO

PIC

S

BA

LAN

CE

D B

-10

0O

RA

LY

ES

C6

TV

ITA

MIN

B1

PR

EP

AR

AT

ION

S

All

co

mb

ina

tio

ns

an

d s

tre

ng

ths

of

ora

l d

osa

ge

fo

rms

are

co

ve

red

fo

r a

llo

we

d

con

dit

ion

s

TH

IAM

INE

HC

L B

-1O

RA

LY

ES

C6

LV

ITA

MIN

B1

2 P

RE

PA

RA

TIO

NS

All

co

mb

ina

tio

ns

an

d s

tre

ng

ths

of

ora

l d

osa

ge

fo

rms

are

co

ve

red

fo

r a

llo

we

d

con

dit

ion

s

CY

AN

OC

OB

ALA

MIN

V

ITA

MIN

B-1

2O

RA

LY

ES

C6

RV

ITA

MIN

B2

PR

EP

AR

AT

ION

S

All

co

mb

ina

tio

ns

an

d s

tre

ng

ths

of

ora

l d

osa

ge

fo

rms

are

co

ve

red

fo

r a

llo

we

d

con

dit

ion

s

RIB

OF

LAV

IN

VIT

AM

IN B

-2O

RA

LY

ES

C6

QV

ITA

MIN

B6

PR

EP

AR

AT

ION

S

All

co

mb

ina

tio

ns

an

d s

tre

ng

ths

of

ora

l d

osa

ge

fo

rms

are

co

ve

red

fo

r a

llo

we

d

con

dit

ion

s

PY

RID

OX

INE

V

ITA

MIN

B-6

OR

AL

YE

S

C6

CV

ITA

MIN

C P

RE

PA

RA

TIO

NS

All

co

mb

ina

tio

ns

an

d s

tre

ng

ths

of

ora

l d

osa

ge

fo

rms

are

co

ve

red

fo

r a

llo

we

d

con

dit

ion

s

AS

CO

RB

IC A

CID

VIT

AM

IN C

OR

AL

YE

S

C6

DV

ITA

MIN

D P

RE

PA

RA

TIO

NS

All

co

mb

ina

tio

ns

an

d s

tre

ng

ths

of

ora

l d

osa

ge

fo

rms

are

co

ve

red

fo

r a

llo

we

d

con

dit

ion

s

ER

GO

CA

LCIF

ER

OL

CA

LCIF

ER

OL

OR

AL

YE

S

C6

EV

ITA

MIN

E P

RE

PA

RA

TIO

NS

All

co

mb

ina

tio

ns

an

d s

tre

ng

ths

of

ora

l d

osa

ge

fo

rms

are

co

ve

red

fo

r a

llo

we

d

con

dit

ion

s

B-C

OM

PLE

X W

/ C

& E

+ Z

N

Z-G

EN

OR

AL

YE

S

VIT

AM

IN E

V

ITA

MIN

EO

RA

LY

ES

C6

KV

ITA

MIN

K P

RE

PA

RA

TIO

NS

All

co

mb

ina

tio

ns

an

d s

tre

ng

ths

of

ora

l d

osa

ge

fo

rms

are

co

ve

red

fo

r a

llo

we

d

con

dit

ion

s

PH

YT

ON

AD

ION

E

ME

PH

YT

ON

OR

AL

YE

S

A1

BX

AN

TH

INE

S

AM

INO

PH

YLL

INE

AM

INO

PH

YLL

INE

Ora

lN

O

TH

EO

PH

YLL

INE

TH

EO

PH

YLL

INE

Ora

lN

O

TH

EO

PH

YLL

INE

ELI

XIR

ELI

XO

PH

YLL

INO

ral

NO

C3

CZ

INC

RE

PLA

CE

ME

NT

All

zin

c sa

lts

an

d o

ral

do

sag

e f

orm

s a

re c

ov

ere

d f

or

all

ow

ed

co

nd

itio

ns

ZIN

C S

ULF

AT

EO

RA

ZIN

CO

RA

LY

ES


Recommended